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ABSTRACT
Long term exposure to peroxisome proliferating compounds in rats, mice and rabbits 
lead to the onset of hepatocarcinogenesis by non-genotoxic mechanisms. This onset of 
this disease is linked to the induction of enzymes from the Cytochrome P4504A 
(CYP4A) sub-family. This induction has been attributed to an increase in transcription 
of the genes for these enzymes.
The aim of this thesis was to compare the transcriptional regulation of the rat and 
human CYP4A genes in order to predict the susceptibility of man to the same 
peroxisomal proliferation seen in the rat and other responsive species. In order to 
undertake this project it was necessary to isolate the rat CYP4A genes with their 
upstream regulatory regions and their human analogues. Once isolated the promoter 
regions of the gene could be analysed in the hope that the elements in the rat gene that 
made it susceptible to induction by peroxisome proliferation could be identified and 
searched for in the human sequence. Transcriptional activation assays could also be 
performed as a further indication of the inducibility of the human gene by peroxisome 
proliferators.
In this Thesis I report on the following results:
1) We succeeded in isolating a gene (including its 5' regulatory region) from the 
human CYP4A family which had strong homology in exonic regions with the CYP4A11 
cDNA sequence published by Palmer et al [1993b]. The gene was sub-cloned into 
manageable sections and inserted into plasmid vectors for ease of handling. The clones 
were partially sequenced and good consensus contigs obtained for 9.5kb of the isolated 
gene. From the contig sequences a comparison of the human gene to other members 
of the CYP4A family was performed and it was determined that, although the whole of 
the coding region had not been sequenced, the gene belonged to the CYP4A family.
2) Using part of the cloned gene in genomic Southern blotting analysis we determined 
that the multiplicity of CYP4A forms seen in the rat and rabbit is not seen in humans. 
While we could not rule out the presence of very closely related isoforms, the weight 
of evidence points to a single CYP4A form in man.
3) Limited analysis on the role of PPAR in the regulation of this gene has proved 
inconclusive. The gene does share several regulatory motifs with other members of the 
CYP4A family and more sequencing of the promoter region may complete the picture.
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mRNA Messenger ribonucleic acid
MW Molecular weight
NAD(P) Nicotinamide adenine dinucleotide (phosphate)
NaoAc Sodium acetate
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PCR Polymerase chain reaction
PEG Polyethylene Glycol
pfu Plaque forming units
32p Phosphorous 32
PPRE Peroxisome proliferator responsive element
RAR Retinoic acid receptor
RNA Ribonucleic acid
rpm Revolutions per minute
RT Room temperature
RXR Retinoid X receptor
SDS Sodium Dodecyl Sulphate
SSC Standard saline citrate buffer
35S Sulphur 35
TBE Tris/borate EDTA buffer
TE Tris/EDTA buffer
TEMED N,N,N,N'-tetramethylethylenediamine
TR Thyroid hormone receptor
Tris 2-amino-2-hydroxymethylpropane- 1,3-diol
UV Ultra violet
VDR Vitamin D3 receptor
XGal 5-bromo-4-chloro-3 -indoyl-P-D-galactosidase
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CHAPTER 1 
INTRODUCTION
CHAPTER 1 : INTRODUCTION
1.1 INTRODUCTION
The following PhD thesis concerns the regulation of rat and human Cytochrome P450 
IV (CYP4) genes. The literature survey has been divided into 3 main areas; an 
overview of the cytochrome P450 superfamily, a focus on the P450IV family in 
particular, and finally the ways in which the expression of the different genes are 
regulated.
1.2 THE P450 SUPERFAMILY
1.2.1 STRUCTURE AND FUNCTION OF THE CYTOCHROME P450 
SUPERFAMILY
Cytochrome P450 (EC 1.14.14.1) is a family of haem -containing isoenzymes which 
perform a wide range of oxidative reactions. Their role is to metabolise a broad 
spectrum of endogenous substrates such as bile acids, steroids, fatty acids, 
prostaglandins and leukotrienes. They are also responsible for the Phase 1 metabolism 
of many xenobiotics by introducing polar hydroxy groups which give a 'handle' for 
further conjugation by phase II enzymes, and subsequent excretion from the body. 
However, the metabolites fi’om some of the above reactions may be toxic and some 
have been implicated in toxicity, including the initiation or promotion of tumour 
formation [Ortiz de Montellano, 1986; Guengerich and Macdonald, 1990; Porter and 
Coon, 1991]. Examples of the range of reactions catalysed by different P450s are 
shown in Figure 1.1.
The haem group is part of a protoporphyrin IX prosthetic group which is attached to 
protein domains containing many a  helices and P sheets. The P450 enzymes are 
usually membrane bound in the smooth endoplasmic reticulum (SER) or, in a few 
cases, the mitochondrial inner membrane. The membrane binding of P450s is mediated 
by the NH2 -terminus of the protein which forms one or two hehces in the membrane. 
The mitochondrial forms have leader sequences on the NH2 -terminus which direct 
them to the correct membrane [Black, 1992].
Due to their membrane bound nature it has been difficult to solublise P450s to study 
their structure by X-ray crystallography. However the bacterial camphor hydroxylase 
CYPlOl (formally P450cam) is a soluble form and its crystal structure has been 
determined [Poulos et a l , 1987]. This structure has been used as a template for the 
computer modelling of other P450 isoforms with some success [Poulos, 1991].
1) Aliphatic oxidation R-CH3 R-CH2OH
2) N Dealkylation
3 ) O Dealkylation
R-NH-CH2 [R-NH-CH2 OH] R-NH2 + HCHO
R-O-CH2 [R-O-CH2 OH] R-OH + HCHO
4) S Dealkylation R-S-CH2 [R-S-CH2 OH] R-SH + HCHO
O
5) Oxidative deamination R-CH-CH3 [R-C-CH3] —^ R-C-CH3 + NH3
NH2 NH2
6 ) Sulfoxide formation
OH O
H+
R1-S-R2 [Ri-S-R2]+ R1-S-R2 + H+
7) N-oxidation
H-*
(CH3)3N [(CH3)3N-0H]+ ->(CH3)3N+-0- + H+
8 )N-hydroxylation
OH
RJ-N-R2  ^Rj-N-R2
9) Oxidative dehalogenation
OH
I
Rj-CH-X -> [Ri-C-X] Ri-C=0 + HX
I I I
R2 R2  R2
R3 R3 R3
l e -  I H+ I
10) Reductive dehalogenation Rj-CH-X [R]-C*-X] —^ Rj-CH + HX
Figure 1.1 Examples of the types of reaction performed by P450s (taken from [Nebert 
and Gonzalez; 1987])
The SER bound isoforms generally receive both of their electrons from a closely 
associated flavoprotein, NADPH-P450 oxidoreductase. However in some cases 
cytochrome bs donates the second electron. A single oxidreductase molecule may be 
associated with 50-100 P450 molecules arranged concentrically round it. [Nebert and 
Gonzalez, 1987]. In contrast the mitochondrial P450s receive both of their electrons 
from the iron sulphur protein adrenodoxin via NADPH-adrenodoxin oxidoreductase. 
This latter source is similar to that in the bacterial P450cam isoform which receives its 
electrons from the iron-sulphur protein puteroredoxin. This implies an evolutionary 
link between the mitochondria and bacteria [Gonzalez 1990].
The equation for the P450 catalysed mixed function oxidase reaction, where RH 
represents the substrate and ROH the oxidised product, is as follows:
RH + O2  + NADPH + H+ -> ROH + H2 O + NADP".
The actual reaction is cyclical and involves the reduction of molecular oxygen by the 
stepwise addition of 2 electrons. The electrons are transferred from NAD(P)H via 
either NADPH-cytochrome P450 reductase or in some microsomal systems, 
cytochrome bs [Schenkman et a l , 1976]. The oxygen-oxygen bond is split by the 
addition of 2 protons and the formation of an active oxygen species and water. The 
cycle is shown in Figure 1.2 [taken from Porter and Coon, 1991].
1.2.2 fflSTORY OF THE CYTOCHROME P450 SUPERFAMILY
The P450 enzymes were first identified in the 1950's as mixed function oxidases. 
Subsequently they were shown to be membrane bound cytochromes which gave a 
characteristic absorbance peak at 450nm when reduced and bound to carbon monoxide 
(CO). It was also noted that the activity of the enzyme system could be induced in the 
livers of experimental animals by the pre-treatment with various compounds such as 
benzpyrene or phenobarbitone [Nebert and Gonzalez, 1987].
Subsequently, a diverse range of inducers and substrates have been identified and it 
became obvious that more than one isoform of P450 isoform existed. With the 
refinement of protein separation techniques coupled to the production of monoclonal 
antibodies during the 1970s and early '80s many new forms were purified and 
characterised from different species. As each new form was discovered, it was 
assigned a name by the workers involved resulting in a large number of trivial names 
and problems of duplication. As the number of members of this superfamily was still 
increasing it became necessary to devise a universal classification system.
ROH RH
(R0H)Fe3* (RH)Fe3*
y  /  r h ( h ) 2
(R -)(F e -O H p ^^  (RH)Fe2*
4  k " '’ '  ' '  Ï '  B-,ZH*
2e-,2H  j xOH XOOH
HjO  RH(Fe-O)®*
(RH)Fen0 2 >
(RH)Fe3*(01) (RH)Fe3*(0?)
2H+ 
H2 O2
I
Figure 1.2 The mechanism of action of Cytochrome P450 (taken from [Porter and 
Coon; 1991].
Fe represents the haem iron in the active site, RH the substrate, RH(H)2  a reduction 
product, ROH a monooxygenase product, and XOOH a peroxy compound that can 
serve as an alternative oxygen donor.
In the mid '80s, the technique of cDNA cloning in expression libraries was well 
established. By screening a library with an antibody raised against a particular isoform 
it was possible to isolate and sequence the cDNA corresponding to the mRNA coding 
for the protein. This allowed the amino acid sequence to be deduced and in 1987 a 
classification system was devised using amino acid sequence comparison. [Nebert,
1987]
1.2.3 NOMENCLATURE AND CLASSIFICATION OF CYTOCHROME P450s
P450 enzymes with more than 40% homology were classified as belonging to the same 
family which was given a roman numeral, (e.g. P450 IV family). Within each family 
proteins with greater than 60% homology were classified into the same sub family and 
given an arabic letter (e.g. P450IVA). Each member of the sub-family was given a 
unique arabic number (e.g. P450IVA1). At the time this lead to 10 families including 
65 different isoforms.
This nomenclature was up-dated in 1989 [Nebert et al , 1989] but in 1991, as 
complexity increased (27 gene families containing a total of 154 genes), it was decided 
that the system should be rationalised and that the roman numerals should be replaced 
with arabic ones (to shorten the names). The mRNA and protein for all species was 
designated as 'GYP', followed by the family number and then the sub-family letter and 
individual number. Thus the enzyme previously called P450IVA1 became CYP4A1. 
The cDNA and Gene for non-mouse species was italicised (e.g. CYP4A1) , while in the 
mouse it was written in lower case with a hyphen (eg Cyp4a-J0). [Nebert et al , 
1991].
The latest review of the P450 superfamily [Nelson et a l , 1993] lists 221 different 
genes and 12 putative pseudogenes characterised by December 1992. These have been 
assigned to 31 eukaryotic (including 11 mammalian and 3 plant species) and 11 
prokaryotic families. In the last two years the search for P450s has spread to a much 
wider range of species, an indication of the evolutionary importance of the P450 
superfamily [Nelson e / a / , 1993].
1.2.4 EVOLUTION OF THE 450 SUPERFAMILY
By comparing the P450 cDNA and protein sequences it was possible to determine the 
evolution of the superfamily and it was proposed that there was a common ancestral 
gene 3,500 million years ago. The ages of the gene families also vaiy but as they are
found in bacteria , plants and animals an ancestral gene must have existed before the 
divergence of those kingdoms [Nebert et al , 1989b; Nebert and Nelson, 1991]. 
Figure 1.3 shows a proposed evolutionary tree based on computer determined amino 
acid similarities.
J05,
JOT.
4.0 3.0 2.0 1.0 0
EVOLUTIONARY DISTANCE
Figure 1.3 Evolution of the P450 families (taken from [Nebert and Nelson; 1991]). 
The amino acid sequences of a representative member of each sub-family were 
compared by unweighted pair group method of analysis (UPGMA) and plotted as a 
branch tree analysis.
Sequence similarity studies have shown that the sub-families diverged at a later date 
and that individual members diverged later still. This is confirmed by the fact that 
members of the same sub-family often map to the same chromosomal locus and usually 
have the same number of introns and exons. An example of this is illustrated by the 
rat CYP2D family (2D 1-5) which are adjacent to each other on chromosome 15 
[Gonzalez et a l , 1987] and probably as a result of gene duplication events. The genes 
are non-segregating as they remain in the same 'gene cluster' [Nebert and Nelson, 
1991]
It is now believed that the divergence in the sub-families is due to a combination of 
gene duplication, gene conversion and gene mutation events [Gonzalez, 1990]. This 
can be seen in the CYP17 and CYP 21 families which share all but 2 introns and the 
CYP2 and CYP4 families which share 4 introns, 2 of which are common with the 
CYP 11 family. [Nebert et al, 1991]. It has been proposed that the divergence seen in 
the sub-families , notably in the CYP2 family, may be attributed to the time when 
animals began to eat plants. The plants began to produce defence compounds, 
(phytoelexins), which the animals were forced to evolve enzymes to detoxify 
[Gonzalez, 1990, 1992].
All P450 proteins also show a region of striking similarity centred around a cysteine 
residue towards the carboxy-terminal of the protein. This is the point of attachment to 
the haem moiety and is obviously vital for the function of the protein as this liganding 
region has been highly conserved. [Nebert and Gonzalez, 1987]
1.2.5 MAMMALIAN P450 ISOFORMS
There are 12 mammalian P450 families and these can be divided into two groups: those 
involved with steroid and bile acid synthesis (7 families) and those involved in the 
metabolism of xenobiotics (5 families) although this division is not exclusive 
[Gonzalez, 1992; Nelson et a l , 1993]. The former group is highly conserved across 
the species and are among the oldest forms. For this reason it has been proposed that 
they are responsible for the maintenance of steroid levels in lipid membranes, which 
! play a key role in membrane integrity. Their highly conserved nature implies that 
mutations in these genes may proves disadvantageous and are therefore not carried 
forward [Gonzalez, 1992].
The xenobiotic metabolising families {CYP 1 to 2) have probably evolved due to the 
need to remove toxins in the diet. Their diversity has been the result of gene 
duplication and mutational events which have conferred an evolutionary advantage to 
the animals concerned. This diversity is best seen in the rodent CYP2 family where 25
rat genes, in 7 sub-families, have been identified [Nebert and Nelson, 1991; Nelson et 
a l  1993].
Humans have fewer xenobiotic metabolising isoforms in comparison to the rodents. 
The continuation of the species without these isoforms implies that humans do not 
encounter the same toxic challenges as rodents. To date thirty xenobiotic metabolising 
isoforms have been identified in humans by either protein isolation or cDNA cloning 
[Guengerich, 1992b]. Several of these forms have been shown to be prone to genetic 
polymorphism (e.g. CYP2D6 and CYP2E1) which may effect the ability of an 
individual to handle certain drugs or toxic chemicals [Gonzalez et al 1988, 
Guengerich, 1991; Gonzalez, 1992].
1.3 REGULATION OF CYTOCHROME P450 GENE EXPRESSION
1.3.1 OVERVIEW OF P450 REGULATION
The expression of the P450 genes is controlled in a complex system of interacting 
factors which allow the regulatory input from endogenous and xenobiotic compounds. 
There are examples of this control at every stage in the process from gene to protein 
[Goldfarb, 1990; Okey, 1990; Porter and Coon, 1991]. The different stages of 
regulation are shown in Figure 1.4 along with a list of the P450 isoforms controlled at 
each point.
As P450 is an enzyme system the effect of inhibitor is also discussed.
1.3.2 GENE ACTIVATION
Before a gene can be expressed it must be unwound from its tight association with 
chromatin. This unwinding process requires the association of regulatory proteins and 
is often linked to specific cytidine déméthylation events [Goldfarb, 1990]. This 
activation is seen in the developmental regulation of CYP2E1 in the rat [Umeno et al,
1988].
1.3.3 TRANSCRIPTIONAL REGULATION
The next stage in regulation is at the point of transcription where the majority of all 
genes (not just P450s) are controlled. For the gene to be transcribed a series of 
proteins must bind to the DNA so that RNA Polymerase can bind and start to 
synthesise the mRNA. The proteins bind to specific palindromic sites in the 5' non­
coding region of the gene.
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A well documented P450 transcriptional activating factor is the Ah receptor [Burbach 
et aî, 1992] which controls the induction of CYPlAl and CYP1A2 by aromatic 
hydrocarbons such as TCDD (Dioxin) [Nebert and Gonzalez, 1987, Landers and 
Bunce, 1991]. The uninduced Ah receptor is found in the cytoplasm as a 280kdal 
complex of 90kdal Ah Ligand binding subunit (ALBS) and 90kdal heat shock protein. 
The binding of an Ah ligand causes the dissociation of the heat-shock proteins, the 
dimérisation of the ALBS with a second receptor protein and the subsequent migration 
of the newly formed complex into the nucleus. This second protein is the Ah receptor 
nuclear translocation ARNT factor and forms a 176kdal dimer with the ALBS 
[Hoffman et al, 1991; Reyes et al, 1992]. This dimérisation process is mediated by the 
action of protein kinase C on one of the subunits [Carrier et al, 1992].
The dimer then activates CYPlAl gene transcription by binding to specific cz^-acting 
elements in the gene promotor. These elements are called Ah regulatory elements 
(AhREs) or Xenobiotic regulatory elements (XREs) and are found upstream of the 
CYPlAl gene in mouse, rat and human [Hankinson, 1993]. The XREs are also the 
binding site for a repressor of the Ah receptor which down-regulates the response to 
Dioxin in cell culture [Watson et al, 1992].
It was originally thought that the ALBS was a member of the steroid hormome 
receptor family [Nebert and Gonzalez, 1987] but sequence analysis of both the ALBS 
and ARNT genes show that rather than the Zinc finger motif seen in the steroid 
hormone receptors these proteins have a helix-tum-helix domain and bear more 
resemblance to the Drosophila proteins sim and per which are dimeric transcription 
factors [Hankinson, 1993]. The receptors do require Zn^ "'' to bind to the XREs, a 
feature also seen in glucocorticoid receptors [Saatcioglu et al; 1990].
It has been postulated that there may also be some role for the cAMP 2nd messenger 
system as the levels of some P450 mRNAs seem to be modulated by the action of the 
peptide hormone ACTH. It has been postulated that this works in the regulation of a 
putative Steroid Hydroxylase Inducing Protein (SHIP) which in turn binds to cAMP 
responsive elements (CREs) in the promoters of the steroid hydroxylase genes CYP 17 
and CYP21A1 [Nebert and Gonzalez 1987]. A 47 kdal protein has been identified that 
binds a CRE on the CYP 17 gene promoter [Lund et a l , 1990]. A putative binding site 
for this receptor has been identified in the CYPllA gene but this differs from the CRE 
sites [Ahlgren a / , 1990].
Recently a new receptor has been characterised which is a possible intermediate in the 
inducing effect of peroxisome proliferators on CYP4A in the mouse which has been 
called the Peroxisome Proliferator-Activated Receptor (PPAR) [Issemann and Green,
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1990]. This receptor belongs to the steroid hormone receptor superfamily and is 
discussed in Section 1.6 .
It is important to note that not all P450 genes require ligand associated induction for 
transcription. CYP2E1 has a constitutive activity that is regulated by a hepatic 
transcription factor HNF-1 which was isolated from hepatocytes. This factor binds to a 
cis-acting element in the 5' region of the CYP2EJ gene and activates the gene soon 
after birth in rats [Ueno and Gonzalez, 1990].
1.3.4 mRNA PROCESSING AND STABILITY
The next potential control stage is the mRNA processing where the intronic sequences 
are spliced out of the coding sequence. Some P450s are regulated by alternative 
splicing, which can lead to more than 1 gene product. Human CYP2A3 mRNA is 
spliced into 2  products on which codes for the functional protein and one which is 
inactive [Okino a l , 1987]. During CYP4A1 processing an extra 75bp sequence can 
be retained in the 3' non-coding region of the mRNA [Eamshaw et a l , 1988]. The 
significance of this is unclear but was thought to effect the stability of the mRNA since 
the extra sequence can form a large hairpin loop it may effect CYP4A1 mRNA stability 
or rate of translation. [Brawerman, 1989].
Inaccurate or aberrant splicing can be seen in the regulation of the human CYP2D6 
mRNA which has lead to a polymorphic effect in the metabolism of Debrisoquine 
[Gonzalez et a l , 1988]. A point mutation (G to A) at the intron 3/exon 4 boundary has 
been identified as the cause of the aberrant splicing and is the major cause of the 
polymorphism in human CYP2D6 [Gough et al, 1990].
The stability of the mRNA is another important control point as the longer the half life 
of the mRNA the more copies of the protein can be translated off it. This control can 
be seen in the CYPlAl and CYP1A2 in rat hepatocytes where the induction of mRNA 
levels is much greater than the increase in transcription [Pasco et a l , 1988]. Message 
stability has also been reported in the regulation of rat CYP3A1 as a result of the 
induction by macrolide antibiotics [Ryan et a l , 1985]
The control of CYPllBl by ACTH has been postulated to be at the mRNA stability 
level and not just the transcriptional level (cf. the other steroid processing P450s) 
[Boggaram et a l , 1989]. A similar regulation is seen in the control of the mRNA for 
CYP 19 by steroids and gonadotrophins in rat granulosa cells [Fitzpatrick and Richards,
1991]. This stability is well documented in the control of CYP2E1 where the effects of 
diabetes and fasting are similar and both cause a 1 0  fold induction in the enzyme
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activity. The induction by fasting is at the transcription level whereas diabetes results 
in mRNA stability [Song et a l , 1987].
1.3.5 PROTEIN STABLISATION AND PHOSPHORYLATION
The final stage of regulation is the control of the proteins by stablisation and 
phosphorylation. This has been shown for a range of P450s in vitro when incubated 
with protein kinases and recent evidence shows that CYP2B1 and 2B2 are both down 
regulated by phosphorylation in vivo. These studies indicate the involvement of cAMP 
dependant protein kinases and suggest that phosphorylation is a quick method of 
controlling the enzyme activity [0-Bartlomowicz and Oesch, 1990].
Protein stablisation has been observed in the regulation of CYP2E1 where the active 
enzyme is stabilised by small molecules such as acetone and ethanol, without a 
corresponding induction of mRNA levels [Song et al, 1989].
1.3.6 SEX-SPECIFIC AND DEVELOPMENTAL REGULATION
Many of the P450 genes cited above are under developmental regulation (eg CYP2Ê1) 
and others are sex specific. Both types are under hormonal control and it is possible to 
alter the expression of the genes by removal of the hormone source, especially with the 
isoforms controlled by sex hormones [Porter and Coon, 1991]. CYP2C11 is male 
specific and controlled by testosterone, while CYP2C7 is expressed in both sexes 
[Strazielle et a l , 1991]. Mouse Cyp4a-12 is predominantly expressed in the male [Bell 
et al, 1993]. Bovine CYPllA and CYP17A are under tight hormonal control (ACTH) 
via cAMP responsive elements (CREs) as is to be expected for genes involved in the 
production of hormones [Waterman a/, 1990].
1.3.7 ENZYME IN fflBm O N
As cytochrome P450 is an enzyme it is important to consider possible inhibitors that 
may effect its function. There are four stages of the oxidoreductive cycle where the 
system could be inhibited: the binding of the substrate, the transfer of electrons from 
the reductase system, the binding of molecular oxygen and the oxygen insertion step 
itself [Tester and Jenner, 1981].
The inhibitors can be reversible, semi-reversible or irreversible (the latter known as 
suicide inhibitors). While all three types of inhibition occur at the active site before 
the catalytic event, any inhibition afterwards is usually semi or totally irreversible 
[Ortiz de Montellano, 1986].
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1.3.7.1 Reversible Inhibition
The structure of the inhibitor varies with the active site of the target enzyme but there 
is usually competitive binding by hydrogen bonding or electrostatic attraction. Binding 
can occur with the haem moiety or hydrophobic/hydrophilic groups in the active site. 
Cyanide will bind ferric haem (giving an absorbance peak at 430nm) while carbon 
monoxide will bind ferrous haem (peak at 450nm - the basis of the P450 assay). 
Alcohols, ethers and ketones show weak biding to the haem and lipophillic moieties, 
whereas pyridines and imidazoles show a much stronger binding [Ortiz de Montellano 
and Reich, 1984].
1.3.7.2 Semi/irreversible Inhibition
These are usually catalysis-dependent inhibitors (ie they require metabolism to the 
active form before they can bind or alter the enzyme activity). The main modes of 
action are covalent binding to proteins, some irreversible binding to the haem and 
alkylation/degradation of the haem group.
Covalent binding occurs with sulphur containing compounds such as carbon 
disulphide, chloramphenicol and parathion (parathion shows 90% binding of [^^S] 
groups [Halpert et al 1980] ). However this is a minor effect when compared to haem 
alkylation and the enzyme can function with a degree of haem binding.
Compounds which bind the haem group include aryl and aromatic amines and acyl 
hydrazines (eg isoniazid) which bind semi reversibly [Moloney et al , 1984]. 
Terminally substituted olefins and acetylenes can form irreversible covalent bonds with 
the haem group. Haem breakdown may be caused by peroxides and halocarbons (eg 
CCI4) although these usually require metabolism to active species. This group contains 
the 'suicide substrates' and are often metabolised by the same enzyme they inhibit. It is 
for this reason that the haem group has been described as the 'Achilles Heel' of the 
cytochrome P450 system [Ortiz de Montellano, 1986].
The above inhibitors have been used as tools for the study of P450 isoforms. As it is 
possible to inhibit an individual or closely related group of isoforms it is possible to 
determine their role in the metabolism within the cell without the need for individual 
expression systems in artificial cell lines.
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1.4 THE P450IV FAMILY
1.4.1 MEMBERS OF THE P450IV FAMILY
In 1982 a new form of P450 was isolated from rat liver microsomes that catalysed the 
©-hydroxylation of lauric acid and was induced in rat liver and kidney by the 
hypolipedaemic drug clofibrate [Gibson et a l , 1982; Sharma et al, 1988b]. This new 
isoform had a characteristic absorbance maximum at 452nm and was therefore 
designated P452 [Tamburini et a l , 1984]. Western blotting of the protein with a 
polyclonal antibody to this enzyme showed 2 bands at 51,500 and 52,000 dal with the 
P452 activity found in the lower band [Hardwick et a l , 1987].
In 1987, the cDNA for this P450 enzyme was isolated and was shown to have less that 
35% homology to any other previously isolated P450 and so P452 was designated as 
the first member of a new gene family P450IVA1 (later CYP4A1). [Hardwick et al, 
1987; Eamshaw et a l , 1988; Nebert et a l , 1987].
Work on pregnant rabbit lung tissue also revealed a progesterone inducible isoform, 
designated P-450p-2, which also displayed ©-hydroxylase activity towards 
prostaglandins Ei, E2 , Ai, A% and F2 a- The corresponding cDNA was isolated and 
sequenced and the deduced amino acid sequence was found to be 74% homologous to 
P450IVA1 This isoform was therefore included in the IV family and designated 
P450IVA4. {CYP4A4) [Matsubaru et a l , 1987].
In 1989 the full length gene sequence for the rat CYP4A1 gene was published [Kimura 
et a l , 1989a] with that of a closely related gene CYP4A2, which is constitutively 
expressed in kidney but only shows clofibrate induction in liver. Also isolated by the 
same group was the cDNA for a related gene, designated CYP4A3, and it was 
proposed that this was responsible for the second band detected on western blots. 
[Kimura et a l , 1989b]
In the same year a human P450 cDNA was isolated from a lung cDNA library using 
the rat CYP4A1 cDNA as a probe [Nhamburo et a l , 1989]. This coded for a protein 
of 59,588 dal with 51% amino acid homology to CYP4A1. This protein was shown to 
be constitutively expressed in the lung but could not be found in the liver of human 
patients. This gene was found to be similar to recently isolated genes in the rat and 
rabbit [Gasser and Philpot, 1989] and all three were classified as belonging to the 
CYP4B sub-family.
Work on rabbit lung CYP4A4 showed that the isoform had very low lauric acid ©- 
hydroxylase activity [Yamamoto et a l , 1984]. However screening of a rabbit kidney 
cDNA library with a probe derived from the CYP4A4 cDNA identified 3 more rabbit
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forms CYP4A5-7 [Johnson et a l , 1990] which did hydroxilate lauric acid in the o- 
position.
An investigation of P450 activities in rat prostate lead to the identification of a fourth 
rat member of the CYP4A family which showed 76%, 71% and 71% amino acid 
similarity with CYP4A1, 4A2 and 4AS respectively. Further analysis revealed that this 
form, designated CFP4/15 was also expressed in the kidney [Stromstedt et a l , 1990].
In the 1991 review of the P450 superfamily [Nebert et a l , 1991], the first human 
CYP4A form was reported by Hardwick (personal communication) and this was 
designated CYP4A9. Our interests in human CYP4A genes lead us to make enquiries 
concerning this gene but no reply was obtained from Dr Gonzalez or Dr Hardwick. 
The same gene was cited in the 1993 review [Nelson et a l , 1993] but the continuing 
lack of details lead to doubts regarding its existence.
In 1991 a new gene of the CYP4 family was identified in the cockroach {Blaberus 
discoidalis) [Bradfield et al , 1991]. The gene showed 35% sequence similarity to 
CYP4A1 and contained a 13 base-pair (bp) sequence common to all CYP4 genes. 
While this gene did not sufficiently satisfy the 40% rule for classification into an 
existing family it was considered to be close enough and named CYP4C1 [Nebert and 
Nelson, 1991]. Its proposed function was the control of energy substrate mobilisation 
in the fat bodies of the cockroach and was under hormonal control. CYP4 genes have 
also been identified \n Drosophilla Melangaster and have been designated CYP4D and 
CYP4E{GdXiù\û.et al 1992, Nelson e /a / 1993]
In 1992 the first murine member of the CYP4A family was reported [Henderson et a l ,
1992] and this was designated Cyp4a-J0. It showed 92% sequence similarity with rat 
CYP4A1 and western blot analysis of mouse liver and kidney showed three and four 
forms respectively. This was to be expected considering the multiple forms seen in the 
rat {4APS + 8) and rabbit.(444-7).
Also in 1992 a 52kdal protein was isolated from human kidney microsomes which 
showed lauric acid ©-hydroxylation activity [Kawashima et a l , 1992]. Amino acid 
sequencing of the NH2  terminal of the protein showed strong homology (75-80%) 
with other members of the CYP4A family. In 1993 the full length cDNA for this 
protein was isolated from a human kidney library using the CYP4A4 cDNA as a probe 
and was designated CYP4A11 [Palmer et a l , 1993b]. Using PCR, Bell et al also 
isolated partial fragments of the human CYP4A11 cDNA along with partial cDNAs 
form mouse and guinea pig (designated Cyp4a-12 and CYP4A13 respectively) [Bell et 
al, 1993].
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Recently the genomic sequences for CYP4A4 [Palmer et al, 1993a] and CYP4A6 
[Muerhoff et al, 1992] have been determined. These contain the 5' regulatory regions 
of the genes and have proved a useful comparison to the promoter region of the human 
gene we have isolated. Work in hepatic tumour cell lines has identified another 
member of the CYP4 family, designated CYP4F1, which shows 43-45% amino acid 
similarity to the other rat CYP4 family genes. Expression of this form is elevated in 
hepatic carcinogenesis whereas the other rat forms are down regulated, implying 
differential regulation of this form [Chen and Hardwick, 1993].
The 1993 review of the P450 superfamily [Nelson et a l , 1993] listed a total of 22 
genes in the CYP4 family, although some of these are by personal communication and 
may therefore be duplications of identified genes. The full list is shown in Table 1.1.
1.4.2 THE PHYSIOLOGICAL ROLE OF CYP4 FAMILY
Members of the CYP4 family were first identified by their ability to hydroxylate lauric 
acid (C12) at the © and (©-1) position [Gibson et a l , 1982]. Modelling of the active 
sites of these enzymes show them to be highly structured to suit their substrates 
[CaJacob et al , 1988; D. Lewis personal communications]. While the range of 
different substrates and inducers is diverse, molecular modelling techniques show that 
their 3D structures are very similar [Sharma et a l , 1989].
The role of the CLP44/peroxisomal system has been identified as a clearance system 
for long chain and substituted fatty acids [Sharma et al, 1988b]. The mitochondrial (3- 
oxidation pathway is not efficient in handling such lipids which are abundant in cases of 
metabolic stress, such as starvation or diabetes [Hawkins et a l , 1987]. The long 
chain/substituted fatty acids are ©-hydroxylated by CYP4A isoforms in the smooth 
endoplasmic reticulum and then cytosolic oxidation converts them to dicarboxylic 
acids. These enter the peroxisome without the need for a carnitine shuttle (unlike the 
mitochondrial system), and are chain shortened by the peroxisomal (3-oxidation 
enzymes; [Lazarow et al, 1982]. The shortened fatty acids can then be handled by the 
mitochondrial system. [Sharma et al, 1987]. This role of the peroxisomes is illustrated 
in patients with Zellweger syndrome, a peroxisome deficiency disease, where long 
chain fatty acids accumulate in the liver [Moser et al, 1984]. The peroxisomal p- 
oxidation pathway is shown in Figure 1.5.
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GENE SPECIES TISSUE REFERENCE
CYP4A1 rat liver, kidney Hardwick e /ûr/, 1987
CYP4A2 rat liver, kidney Kimura et a l , 1989a
CYP4A3 rat liver, kidney Kimura e /a / ,  1989a
CYP4A4 rabbit lung, liver, kidney, uterus Matsubaru et a l , 1987
CYP4A5 rabbit liver, kidney, small intestine Johnson e /a / , 1990
CYP4A6 rabbit kidney, liver Johnson e /ûr/, 1990
CYP4A7 rabbit kidney Johnson e /a / ,  1990
CYP4A8 rat prostate, kidney, retina Stromstedt et a l , 1990
CYP4A9 human ? Hardwick (per. com.)
Cyp4a-10 mouse liver, kidney Henderson <ar/, 1992
CYP4A11 human kidney, liver Palmer a /, 1993b
Bell etal\993
Cyp4a-12 mouse liver Bell et al 1993
CYP4A13 guinea pig liver Bell e / a / 1993
CYP4B1 human lung, liver, kidney, intestine Nhamburo et a l , 1989
rabbit Gasser and Philpot, 1989
rat Gasser and Philpot, 1989
CYP4C1 cockroach fat bodies Bradfield et a l , 1991
CYP4D1 Drosophila ? Gandhi e fa /, 1992
CYP4E1 Drosophila ? Snyder e/or/, 1981
CYP4F1 rat carcinoma cell line Chen and Hardwick, 1992
CYP4F2 human ? Chen (per. com.)
CYP4F3 human ? Kusunose (per. com.)
Table 1.1 Summary of CYP4 Family taken from [Nelson et al 1993]. (per. com.) 
indicates a personal communication cited in the review.
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Figure 1.5 The proposed metabolism of lauric acid (C12) by enzymes of the CYP4A 
family and peroxisomal P-oxidation pathway. The Enoyl CoA hydratase and P- 
hydroxyacyl dehydrogenase functions are performed by the bifunctional enzyme but 
have been depicted seperately for clarity.
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Apart from long chain saturated fatty acids, the CYP4A family is involved in the 
metabolism arachadonic acid, a long chain, unsaturated fatty acid. This is an important 
precursor of immunological signalling compounds [Capdevilla et al , 1983, 1984; 
Bains et a l , 1985]. The major metabolite of the o-hydroxylation of arachadonic acid 
is 20-Hydroxyeicosatetraenoic Acid (20 HETE) which is a potent vasoconstrictor due 
to its inhibitoiy effect on the Na'^/K'  ^ -ATPase pump [Schwartzman, 1989; Carrol et 
al, 1990]. This work has been explored in spontaneously hypertensive rats (SHR) 
which show that CYP4A2 mediates this response [Iwai and Inagami, 1991]. The 
involvement of a P45Ô in this role has been confirmed with the use of specific P450 
inhibitors which reverse the vasoconstriction [Kauser et a l , 1991]. Conversely 19(R) 
HETE, the (o - l)  metabolite of arachadonic acid is a potent vasodilator and so the 
control of the o/(©-l) hydroxylation of arachadonic acid is an important control point 
for kidney function [Ma et a l , 1993].
In situ hybridisation experiments using radiolabelled oligonucleotide probes have 
shown that CYP4A2 is constitutively expressed in the renomedullary region of the 
kidney. CYP4A1 and CYP4A3 are found in the proximal tubule and the levels of their 
mRNA are induced by clofibrate administration [Hardwick, 1991].
CYP4A1 and CYP4A2 also metabolise prostaglandins Ai, Ei and P2 a by ©- 
hydroxylation although the turnover is only 10% of that for fatty acids. [Kupfer and 
Navarro, 1976; Kupfer et al, 1978; Muerhoff et al, 1989, Aoyama et al, 1990]. 
However CYP4A4 plays a major role in the oxidation of prostaglandins during 
pregnancy in rabbit lungs [Matsubara et a l , 1989]. CYP4A4 is a poor metaboliser of 
lauric acid and is not induced by Clofibrate and it is possible that the corresponding rat 
gene has yet to be discovered, although CYP4A2 shows some similar properties.
The substrate specificity of the CYP4A isoforms and the tissues in which they are 
expressed are sumarised in Table 1.2.
1.4.3 INDUCTION OF MEMBERS OF THE CYP4 FAMILY BY 
ENDOGENOUS AND XENOBIOTIC FACTORS.
P4504A1 was first identified in rat by its inducibility (6-10 fold) by the hypolipidaemic 
drug clofibrate which was used to lower the levels of blood lipids, a possible cause of 
ischemic heart disease and athlerosclerosis in humans. Other drugs of this type are 
benzafibrate, ciprofibrate, nafenopin and Wy-14,643. [Hawkins et a l , 1987].
CYP4A1 is also induced by phthalate ester plasticisers, compounds formerly used to 
increase the elasticity of many plastic products including blood transfusion bags and 
food wrappings. These esters can migrate from the plastic and accumulate in the body 
as they are not easily degraded. Examples of these are di (2 -ethylhexyl)phthalate
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Family Member Tissue
Distribution
Substrates Induction
CYP4A1 (rat) Liver, kidney Fatty acids Induced by clofibrate in liver and 
kidney
CYP4A2 (rat) Liver, kidney Fatty acids and 
prostaglandins
Induced by clofibrate and starvation in 
liver
High constitutive activity in kidney.
CYP4AS (rat) Liver, kidney Fatty acids Induced by clofibrate and 
starvation/diabetes in liver and 
kidneys.
CYP4A4 Liver, kidney. Lung, Fatty acids and Induced in all tissues by progesterone
(rabbit) Uterus prostaglandins and pregnancy.
CYP4A5
(rabbit)
Liver, kidney, small 
intestine
Fatty acids Induced by clofibrate in liver, 
refractive in kidney
CYP4A6
(rabbit)
Liver, kidney Fatty acids and 
prostaglandins
Induced by clofibrate in liver and 
kidney.
CYP4A7
(rabbit)
Liver, kidney Fatty acids and 
prostaglandins
Induced by clofibrate in liver, 
refractive in kidney
CYP4A8 (rat) Kidney, prostate, 
retina
Fatty acids and 
prostaglandins
Induced by androgens
Cyp4a~10
(mouse)
Liver, kidng Fatty acids Induced by Methylclofenapate in liver 
and kidney
CYP4A11
(human)
Liver, kidney Fatty acids N/A
Cyp4a-12
(mouse)
Liver Fatty acids Induced by Methylclofenapate in liver 
and kidney
CYP4A12
(guinea-pig)
Liver Fatty acids Refractive to Methylclofenapate
Table 1 . 2  Tissue distribution and inducibility of the CYP4A family. For sources see 
Table 1.1.
(N/A - No human induction studies performed by author [Bell et al, 1993])
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(DEHP) and di (2-ethyl-hexyl)adipate (DEHA). [Lake et a l , 1975].
Lastly there is some evidence that CYP4A1 can also be induced by a cocktail of 
polychlorinated biphenyls known by the collective name of Arochlor 1254 [Borlakoglu 
e ta l , 1989].
The structures of some of these compounds are shown in Figure 1.6.
Physiological factors such as high fat diets, starvation and diabetes can also lead to the 
induction of CYP4A1 . The mechanism of these inductions are not clear although all 
three states can lead to an increase in circulating long chain fatty acids (LCFAs), the 
preferred substrates of CYP4A1, a 'substrate overload'.[Hawkins et a l , 1987]. Work 
on streptozotocin-induced diabetes shows that the resulting hyperketonaemia caused 
by the increased levels of LCFAs also plays a part in the induction of the enzyme 
[Barnett et al , 1990]. Modified long chain fatty acids also show peroxisome 
proliferative properties and are metabolised via the peroxisomal P-oxidation system 
[Hvattum et a l , 1991].
The effect of peroxisome proliferators on the various members of the CYP4A family 
are shown in Table 1.2 (above).
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Figure 1.6 Some common peroxisome proliferators.
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1.5 PEROXISOME PROLIFERATION AND NON-GENOTOXIC 
HEPATOCARCINQGENESIS
1.5.1 PEROXISOMES
Peroxisomes are small organelles found in animal and plant cells and can be located 
using catalase as a peroxisomal marker enzyme [Levine et a l , 1977]. Peroxisomes 
consist of a granular matrix and a urate oxidase core [Reddy and Lalwani, 1983] and 
contain fatty acid P-oxidation enzymes which differ from their mitochondrial 
counterparts in that they are KCN-insensitive and do not require a carnitine shuttle 
system [Lalwani et al; 1981]. Another difference is that the hydroxyacyl CoA 
dehydrogenase and the enoyl CoA hydratase activity are combined in one enzyme unit 
while they are separate in the mitochondrial system. These enzymes are induced by the 
peroxisome proliferators and so form a link in the alternative peroxisomal p-oxidation 
pathway for long chain fatty acids. See Figure 1.5 (above)[Hawkins et a l , 1987].
1.5.2 PEROXISOME PROLIFERATION
The physiological response of the liver to peroxisome proliferators has been 
extensively studies. As their name implies a major effect is the increase in size and 
number of the peroxisomes [Lock et al, 1989]. However there is also an increase in the 
size of the whole liver (Hepatomegaly) due to an increase in the size and number of 
hepatocytes [Hawkins et al, 1987]. The coordinated induction of the CYP4A enzymes 
and those in the peroxisomal p-oxidation pathway has lead to the proposal that the 
CYP4A enzymes are involved in the proliferation process [Sharma et al, 1989a; 
Gibson 1992].
The mechanism of the proliferative effect is unclear and two theories have been 
proposed. The first (classical) theory is that the peroxisomal proteins are made in the 
lumen of the ER and then incorporated into vesicles which bud off the Golgi [De Duve 
and Baudhuin, 1966]. The second and more widely held theory is that the peroxisomal 
proteins are synthesised on free polysomes, incorporate into existing peroxisomes 
which then undergo fission to increase the population. For the first theory to be 
possible the lipid and protein makeup of the peroxisomes would be similar to that of 
the ER. As this similarity has not been observed the evidence points to the second 
theory [Lazarow et a l , 1982].
The precise mechanism by which peroxisome proliferators cause the morphological 
and enzyme changes mentioned above is unclear. There are two theories which could 
explain the effects, one working at a genetic level and one at the level of protein
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regulation. The two theories are not mutually exclusive and it is probable that both are 
involved in peroxisome proliferation.
1 .5.2.1 Substrate overioad theory
It has been noted that Diabetes and starvation induce high levels of long chain fatty 
acids to accumulate in the liver show a degree of peroxisome proliferation. The same 
response has been observed for high fat diets [Hawkins et al, 1987]. It has been 
proposed that this accumulation of fatty acids upsets the homeostasis and the 
peroxisomes are activated to redress the balance. It has also proposed that peroxisome 
proliferators also increase the levels of long chain fatty acids and this is the substrate 
overload theory [Sharma et al 1988a].
The up regulation of the peroxisomal P-oxidation is mirrored by a down regulation of 
. the equivalent mitochondrial pathway by the blocking of the carnitine shuttle [Lake et 
al, 1989] and the sequestration of CoA by direct binding to peroxisome proliferators 
[Bronfman et al, 1989]. This pathway requires the induction of the activity of the 
CYP4A enzymes which convert the long chain fatty acids into dicarboxilic acids, a 
proposed preferred substrate for the peroxisomes [Sharma et al, 1989a]. This 
induction has been demonstrated and shown to occur before the induction of the 
peroxisomal enzymes [Makowska et al, 1990; Milton et al, 1990; Bell et al, 1991].
1.5.2.2 Receptor Mediated Response
The substrate overload theory can explain the peroxisomal proliferation effects due to 
high levels of fatty acids. However, there is a requirement to explain how such a 
structurally diverse group of compounds such as the peroxisome proliferators act with 
a common result. The discovery of the Peroxisome Proliferator Associated Receptor 
(PPAR) has provided an answer to this question [Issemann and Green, 1990]. The 
structure, function and role of PPAR in peroxisome proliferation is discussed in 
Section 1 .6 .
1.5.3 POSSIBLE MECHANISMS OF HEPATOCARCINOGENESIS
Carcinogenesis is a multi-event process and can be divided into four stages; Initiation, 
promotion, progression and metastasis [Green, 1991]. Initiation is caused by DNA 
damage to key growth regulatory genes and is usually caused by genotoxic chemicals, 
exposure to radiation or viruses. Normally this damage is detected and repaired. 
Promotion occurs when the initiated effected cells may undergo hyperplasia due to the 
action of growth factors and hormones and non-genotoxic (epigenetic) compounds. 
The final 2 stages are characterised by the uncontrolled amplification of genes, loss of
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oncogenic control and chromosomal rearrangements. This process results in metastasis 
and invasion of other tissues.
Studies of peroxisome proliferators in rodents have shown that long term chronic 
exposure can cause the formation of liver tumours. These effects have also been seen 
to a lesser extent in rabbits and hamsters, but have not been seen in the guinea-pig or 
the marmoset. [Lake et a l , 1989] Studies also showed that this response is seen in 
several strains of rat [Makowska et a l , 1990]. Short term studies with peroxisome 
proliferators have not shown any genotoxic effects in the Ames test. 
Hepatocarcinogenesis was not seen in rodents until barely sub-lethal doses were 
administered [Hawkins et al, 1987]. It has therefore been proposed that the 
peroxisome proliferators are epigenetic carcinogens and that they are promoters rather 
than initiators of the hepatocarcinogenesis [Rao and Reddy, 1991; Green, 1991].
There are various theories to explain this phenomenon.
1.5.3.1 Oxidative Stress Theoiy
A possible mechanism of the hepatocarcinogenesis resulting from long term 
administration of peroxisome proliferators lies in the induction of the peroxisomal 13- 
oxidation enzymes. These enzymes produce H2 O2 as a by product of the oxidation of 
fatty acids (See Figure 1.5) and normally this is broken down by the catalase in the 
peroxisomes and by glutathione peroxidase in the cytoplasm. However during 
peroxisome proliferation the p-oxidation enzymes are induced by up to 30 fold while 
the catalase is only induced by 2 fold [Ready and Lalwani, 1983; Hawkins et al , 
1987]. It has been shown that the levels of glutathione peroxidase are also decreased 
on administration of peroxisome proliferators.
This substantial increase in H2 O2  has the potential to induce DNA damage due to the 
formation of the DNA adduct 8 -hydroxydeoxyguanosine or 5-Hydroxymethyl-2'- 
deoxyuridine which causes aberrant coding during DNA replication and leads to 
hepatocarcingenesis [Kuchino et al 1987; Marsman et al , 1988; Srinivasan, and 
Glauert, 1990]. Another indicator of the oxidation state of the cell is the accumulation 
of lipofuscin, the oxidation product of long chain fatty acids and membrane lipid 
peroxidation. This can be seen in histology preparations of liver which has undergone 
peroxisome proliferation. [Mitchell e /a /, 1985].
The ratio of the induced enzymes {CYP4A1 and acyl CoA oxidase) to the 
detoxification enzymes (Catalase and glutathione peroxidase) has been proposed as a 
good indicator to the species susceptibility to hepatocarcinogenesis [Gibson, 1989]. 
Rats and mice show a dose dependant increases in this ratio, rabbits and hamsters an
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intermediate increase and guinea pigs and marmosets no significant increase at all 
[Gibson, 1989]. This then may be a possible indicator of a species susceptibility to 
peroxisome proliferator induced hepatocarcinomas.
1.5.3.2 Spontaneous Lesion Promotion Theory.
A second theoiy proposes that the spontaneous promotion of cells already containing 
spontaneous lesions (ie DNA damage) by the peroxisome proliferators lead to the 
production of tumours following long term exposure [Schulte-Herman et a l , 1981, 
1983]. It has also been shown that peroxisome proliferators can inhibit apoptosis 
(programmed cell death) which could also contribute to the induction of the 
hepatocarcinomas [Bursch et a l , 1984]. This inhibition of apoptosis is also seen in the 
livers of rats treated with Wy-1,643 although not in the same manner as 
phenobarbitone [Cattley and Popp, 1989]. It is therefore possible that the peroxisome 
proliferators cause the tumour formation by a combination of promotion of 
spontaneous! lesions and an inhibition of apoptosis [Cattley and Popp, 1989].
1.5.3.3 Sustained Tissue Growth Theory
As previously described the peroxisome proliferators cause a proliferation of the sub- 
cellular organelles and the induction of S-phase DNA synthesis followed by mitotic 
activity. This organelle proliferation can also be demonstrated in isolated hepatocytes 
[Butterworth et al , 1987]. The sustained tissue growth theory proposes that the 
rapidly dividing cells are more prone to DNA replication errors which cannot be 
handled by the repair machinery. The dividing cells also contain larger amounts of 
single stranded DNA which is more prone to alteration and mis-copying. It has been 
proposed that this loss of control may result from the abnormal expression of 
oncogenes and so cause the initiation of tumours [Ames and Gold, 1990].
The possible role of oncogenes has been explored by various groups and possible role 
of c-fos, c-myc, p53 and Ha-ras have been investigated [Thompson et al, 1986; 
Cherkaoui-Malki et al 1990, F. McNae, personal communication]. These factors are 
involved in the normal controlled growth and regeneration of the liver. It has been 
shown that the induction of c-fos and c-myc oncogenes occurs within hours of dosing 
with nafenopin and may therefore be a contributing factor to the uncontrolled growth 
of the tissue during hepatocarcinogenesis [Bentley et a l , 1987].
1.5.4 IMPLICATIONS OF PEROXISOME PROLIFERATION FOR HUMAN 
DISEASE
The effect of peroxisome proliferators is species and strain specific. Studies on 
different rat strains have indicated a variation in peroxisome proliferation [Makowska
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et al, 1991]. This effect has also been seen in mice, rabbits and hamsters but not in 
guinea-pig or marmoset [Orton et <ar/,1984; Lake et al, 1989; Agius et al, 1991]. In 
order to extrapolate the animal toxicology data to man it is necessary to understand the 
mechanism of this induction.
Patients treated with clofibrate at a therapeutic level have shown a small amount of 
peroxisomal proliferation although the constitutive levels of peroxisomes do fluctuate 
significantly. With the establishment of human liver banks a wider understanding of 
the human P450 activity has been achieved [Guengerich and Shimada, 1991].
The number of human CYP4 proteins detected in the liver varies from group to group 
depending on the source and specificity of the antibodies used [Dirven et a l , 1991; 
Chinje, 1992; Forrester et a l , 1992]. Work on human liver microsomes has shown 2 
bands which cross-react with the rat CYP4A1 antibody in western blot analysis [Dirven 
et al , 1991]. However the stronger staining band (51 Kd) does not show any 
correlation with the laurate o-hydroxylation activity and so is possibly not responsible 
for the laurate activity in the human. The o /(o -l)  hydroxylation activities are also of a 
different ratio to those in the rat. [Dirven et a l , 1991].
However western blotting analysis of human liver samples in our laboratories
[Chinje, 1992] showed only one band cross-reacting with a polyclonal antibody to 
CYP4A1 and another group [Forrester et al, 1992] showed three bands. This variation 
in the precise numbers of human CYP4A proteins can be explained by the different 
specificities of the antibodies used by each group.
As it is not ethically possible to do dosing studies on humans, and the control of 
CYP4A1 has been identified at a transcriptional level [Hardwick et al , 1987], the 
next stage in the evaluation the risk of peroxisome proliferators to humans is the 
isolation and comparison of CYP4A genes from a peroxisomal proliferator responsive 
species (e.g. rat) and human.
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1.6 THE NUCLEAR HORMONE RECEPTOR SUPERFAMILY AND ITS 
ROLE IN TRANSCRIPTIONAL REGULATION.
1.6.1 NUCLEAR HORMONE RECEPTOR FAMILY
The nuclear hormone receptor superfamily is a group of more than 30 structurally 
similar DNA-binding proteins which exhibit transcriptional regulation when bound to 
responsive elements in the 5' regulatory region of a gene [O'Malley, 1991; Gronmeyer, 
1992: Green 1993]. Some of the receptors have been well characterised and their 
ligands identified; these include the receptors for oestrogen (ER), thyroid hormone 
(TR), vitamin D3 (VDR), retinoic acid (RAR, RXR) and peroxisome proliferators 
(PPAR). There are also members of this family whose ligands have not been identified 
but share sufficient similarity to be classed in the family. These are the 'orphan' 
receptors [Issemann and Green, 1992] whose role is undetermined. They may be 
obsolete or play some role in the regulation of other receptors [O'Maley and Conneely, 
1992].
The receptors demonstrate a similar mode of action. A receptor binds its ligand in the 
cytoplasm and undergoes a conformational change (possibly the dissociation of heat 
shock protein 90 [Poellinger, 1992] which releases it to form homodimers or in some 
cases hetero-dimers with other members of the family. The dimers then bind to a 
specific recognition sequence upstream of the target gene causing transcriptional 
modulation [Green and Chambon, 1988]. This is illustrated in figure 1.7.
Dimer formation is achieved by the association of binding regions at the N- 
terminal region of the protein while DNA binding is achieved by zinc finger, motifs 
[Schwabe and Rhodes, 1991]. Target recognition is achieved by the C terminus which 
is adjacent to the major grove of the DNA helix. The receptor also contains a nuclear 
location signal (NLS) and acts as a transcriptional activating factor (TAP) 
[Gronemeyer, 1992]. These features are located in five domains whose structure and 
arrangement are well conserved among the other members of the receptor family. 
These similarities between the receptors have allowed chimeric receptors to be 
constructed with the ligand binding site of one receptor replaced with that of another. 
Such an approach was used by Issemann and Green during the discovery of the mouse 
Peroxisome Proliferator Associated Receptor (PPAR) [Issemann and Green, 1992; 
Gotllicher c/a/, 1992].
1.6.2 THE PEROXISOME PROLIFERATOR ASSOCIATED RECEPTOR
While cloning members of the steroid hormone receptor superfamily Green and co- 
workers [Issemann and Green, 1992] discovered a cDNA which coded for a receptor
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similar in structure to that for oestrogen. Using recombinant cloning techniques they 
replaced the ligand binding domain of the oestragen receptor with that from the new 
cDNA. The resulting chimeric (PAR/Oestogen) receptor was co-transfected with the 
oestrogen promoter on a Camatine acetyl transferase reporter gene vector into a Cos 1 
cell line. The chimeric receptor activated the oestrogen response promoter when the 
cell was challenged with peroxisome proliferators.
This result was even more significant as the degree of CAT induction was in the same 
rank order as the potency of the peroxisome proliferators observed in in vivo studies. 
However the study was not able to show any DNA or peroxisome proliferator binding 
properties for the intact PPAR and previous work has found no evidence for the 
existence of such a receptor in rat liver [Milton et al, 1984].
Homologues of the mouse (m)PPAR have been identified in rat (97% similarity) 
[Gottlicher et al, 1992], Xenopus laevis (3 forms - 77%, 55% and 50% respectively) 
[Dreyer et al, 1992] and Human (85%) [Sher al, 1993]. A PPAR-like receptor, 
NUC 1, with a lower sequence homology (64%) has also been identified in humans and 
this may indicate the presence of another family of related receptors [Schmidt et al, 
1992].
This model of peroxisome proliferators acting through these receptors to up-regulate 
the transcription of the target genes is attractively simple. A single receptor type 
dimerises on binding a specific ligand and is translocated to the nucleus where 
transcriptional regulation is achieved by binding to specific sequences in the DNA. 
This simple situation has been made more complex by the identification of a series of 
receptors that bind retinoic acid and are capable of forming heterodimers with other 
members of the nuclear hormone receptor family [Carlberg et al, 1993].
1.6.3 THE RETINOIC ACH) RECEPTORS
During studies on mPPAR it became apparent that the action of the receptor was being 
attenuated by another nuclear factor. This was subsequently identified as the retinoic 
acid receptor (RAR) [Leid et al, 1992]. Further work on this new factor revealed 
there to be six different nuclear receptors that bound retinoic acid; 3 binding the all- 
trans form (RARa, P, y) and 3 binding the 9-cis retinoic acid (RXRa, p, y) [Levin et 
al, 1992; Heyman et al, 1992]. It was subsequently shown that the transcriptional 
activation of PPAR could be maximally attenuated by the addition of activated RXR to 
the test system [Johnson et al, 1992].
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1.6.4 NUCLEAR HORMONE RECEPTOR RESPONSIVE ELEMENTS
As previously discussed the nuclear receptor proteins bind to specific DNA sequence 
motifs located in the regulatory regions of the genes they control. When these 
receptors were first studied they were identified as binding pallindromic repeat 
sequences. It has since become apparent that the binding sites are usually made up of 
imperfect tandem repeats [Carlberg et al, 1993; Green, 1993].
The responsive element for PPAR (designated the PPRE) was first identified [Osumi et 
al, 1991; Tugwood et al 1991] in the 5' flanking region of the rat acyl CoA oxidase 
gene, a key enzyme in the peroxisomal P-oxidation pathway. It was shown to be an 
imperfect repeat;
5' (-573bp)CGTGACCT7TGTCCTGG (-556bp) 3'
This motif has also been identified in the 5' flanking regions of the genes for rat 3- 
ketoacyl CoA-thiolase (another member of the peroxisomal p-oxidation pathway) 
[Kliewer 1992a] and rabbit CYP4A6 [Muerhoff e/a/, 1992].
As the responsive elements for the different receptors all contained DNA sequence 
motifs that were almost identical it became clear that their specificity came from more 
than just the nucleotide sequence itself. Comparison of the response elements showed 
that the spacing between the repeat elements was crucial for the receptor recognition. 
Umesono et al [1991] examined the direct repeat (DR) spacing of the heterodimers of 
RXR with VDR, TR and RAR and found them to be 3, 4 and 5 respectively calling this 
the 3,4,5 rule. The homodimers of these receptors bind alternative spaced elements 
RXR (DRl) and VDR (DR6 ) [Green, 1993]. The orphan receptor COUP-TF 
(Chicken ovalbumin upstream promotor transcription factor) [Cooney et al, 1992] has 
been shown to bind an RE with DR2 spacing. These alternative REs indicate an 
important role for the RXR receptor in modulating the activity of the other members of 
the hormone receptor family.
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1.7 AIMS OF THIS PROJECT
The project described in this thesis was designed to compare the transcriptional 
regulation of rat and human genes of the CYP4A families with a view to understanding 
the species differences seen on administration of peroxisome proliferators. It was 
hoped that if the regulation of the human gene was under a significantly different 
control mechanism to that of the rat then the non-responsive nature of the higher 
animals (i.e. monkey) to peroxisome proliferation could be extrapolated to humans and 
thus rule out the possibility of hepatocarcinomas following the administration of 
hypolipidaemic drugs. In order to fiilfil this research mission the following targets 
were identified.
i) Isolation of the full length coding regions of human CYP4A genes along with their 
regulatory regions. The comparative regulation studies could not be performed on the 
cDNAs as they lacked the 5' non-coding and flanking regions responsible for the 
regulation of the genes.
ii) Once a putative human CYP4A gene has been isolated sequencing of the coding 
region will determine if the gene(s) has sufficient amino acid homology to be classed in 
the CYP4A family. The comparison would only be possible with the complete 
sequence of the exons.
iii) Sequencing of the S' flanking regions of the human genes would identify potential 
regulatory sequences. By comparing the arrangement of such sequences, the 
differential regulation of the genes could be explored.
iv) Comparison of the regulatory regions of the human CYP4A gene(s) to those of the 
rat (a representative responsive species) and an examination of their responses to 
peroxisome proliferators and PPAR.
v) By studying the differences between responsive and non responsive species 
(including man), at a gene level it was hoped to gain an insight into the susceptibility of 
humans to peroxisome proliferator induced hepatocarcinogenesis.
vi) In both the rat and the rabbit there are more than one CYP4A protein. It was 
therefore important to determine whether there was the same multiplicity in humans. 
This would be of significant interest for the understanding of the human response to 
peroxisome proliferators.
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CHAPTER 2 
MATERIALS AND METHODS
CHAPTER 2 - MATERIALS AND METHODS
2.1 MATERIALS
2.1.1 CHEMICALS
All chemicals and reagents used in the experimental work were of Molecular biology 
grade and were purchased from BDH Chemicals Ltd, Poole, Dorset unless listed below.
Applied Biosystems Ltd : Alconox detergent.
Difco laboratories USA : Bacto-Agar.
Gibco BRL : tetramethylethylenediamine (Temed.), agarose, urea,
Isopropyl-P-D-thiogalactosidase (IPTG), X-Gal.
National Diagnostics ; 30% (w/v) acrylamide solution, 2% (v/v) N,N' Methylene 
Bisacrylamide solution.
Oxoid Ltd : bacto-tryptone and yeast extract.
Sigma Chemical Co. : Bromophenol blue, citric acid (trisodium salt), Ethylene-diamine 
tetra-acetic acid (EDTA), Ethidium bromide, spermidine trihydrochloride and sodium 
chloride.
Wardray Ltd : RG developer and Fixer.
2.1.2 RADIOCHEMICALS
ICN Flow: Deoxycytidine 5'-[a^^P] triphosphate triethylamine salt. spec, activity 
>3000Ci/mmol
Amersham: Deoxyadenosine 5'-[a^^S] thiotriphosphate, triethyl ammonium salt. Spec, 
activity >1200Ci/mmol
2.1.3 ENZYMES AND KITS
Amersham UK : Multiprime, Megaprime and Nick-Translation Kits, Hybond nylon 
blotting membrane.
Applied Biosystems Inc : Tag Dye Primer Cycle Sequencing Kit, Dye labelled primers. 
Bio 101 inc : Geneclean II kit
Cambridge Biosciences Ltd : Sequenase dideoxy sequencing Kit, Ml 3 Reverse primer.
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Gibco BRL : Restriction enzymes, T4 DNA ligase, DNAse 1, RNAse A, T7 and SP6  
sequencing primers, DNA markers, Glassmax purification columns.
Pharmacia : Restriction enzymes and markers (Geneva), calf intestine alkaline 
phosphatase, Nick columns.
2.1.4 PLASTICWARE
Scotlab Ltd : 0.5 and 1.5ml eppendorf microcentrifuge tubes.
Greiner Ltd : 14ml polypropylene tubes, sterile innoculating loops, 22.5x22.5cm dishes, 
90mm petri dishes.
Falcon Ltd : 50ml polypropylene tubes, flexible microtitre plates with lids, plate seals
2.1.5 BACTERIOPHAGE, BACTERIA AND PLASMIDS
Bacteriophage : The source of bacteriophage recombinants was an EMBLSa Human 
Placental Genomic Libraiy purchased from Clonetech Ltd.see Figure 2.1
Bacteria : see Table 2.1
Plasmids : see Figures 2.2, 2.3 and 2.4 .
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RESTRICTION MAP
Drat 2674 1 
8*7*12531 Aat» 2617 
SspI 2501V
Xmnl 2294
Sea I 2177
,AVul 2066 
Aval 2059
Aval 1837 
. Bgl\ 1613
CfrlOl 1779 A
Ndel 183
Nar I 235
Bgll 245
\  £coRI 396'
BspM I433 |-Ctonîig 
Hina» 447J  Site
MultiplefVul 276 
Pvul 306
pUC 9
2686 bp
M l  908 'X
/
"a
MULTIPLE CLONING SUE
1 2 3 4  (1 2 3 4 5 6 7 8  9 10 11) 5 6 7 8
THR MET ILE THR pro ser leu ala ala gly arg arg lie pro gly ASN SER LEU ALA
ATG ACC ATG ATT ACG CCA AGC TTG GCT GCA GGT CGA CGG ATC CCC GGG AAT TCA CTG GCC
Hind III Psf I Sa/ 1 
Acc I 
Nine II
BamH I
Sma I 
Xma I
EcoR I
Figure 2.2 Restriction map and multiple cloning site of pUC9 [Norrander et al 1983]
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RESTRICTION MAP
Xmn I 1991 
Sea 11872
pGEM®-7Zf(+) 
plasmid
(3000 bp)
T7>
Apa I
1 start 
14
Aat II 20
Sph 1 26
Xba 1 31
Xho 1 37
EcoR 1 43
Kpn 1 53
Sma 1 56
Csp45 1 61
Cla 1 67
Hind III 72
BamH 1 78
Sac 1 91
BstX 1 100
Nsi 1 109
123
MULTIPLE CLONING SITE
T7 Transcription Start
TGTAA TACGA CTCAC TATAG GGCGA ATTGG GCCCG ACGTC GCATG CTCCT CTAGA
17 Promoter
Apa Aat II sph r Xba I
CTCGA GGAAT TCGGT ACCCC GGGTT CGAAA TCGAT AAGCT TGGAT CCGGA
Xho I fco R  I Kpn I Sma I C s p 4 5 1 Cla Hind III BamH  I
SP6 Transcription Start 
< 1
GAGCT CCCAA CGCGT TGGAT GCATA GCTTG AGTAT TCTAT AGTGT
S a d *  B s t x r
CACCT AAAT 
SP6 Promoter
A/s/1*
Figure 2.3 Restriction map and multiple cloning site of pGEM7zf(+) (Promega)
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RESTRICTION MAP
N ae1131
Ssp 1442
SspI 2850 Ssp 119
Xmn I 2645 Nae I 330
24Sea 12526
Pvu I 500 
. Pvu II 529Pvu 12416
BSSHII619 
■ Sac I 657
Bluescript® II KS +/•
2.96 kb
Kpn I 759 
BssH II 792
Pvu 11 977
R e v e r s e  p r i m e r  
5 '  GGAAACAGCT ATG ACCA TG  3 '
Afl 111 1153
MULTIPLE CLONING SITE
T 3  p r i m e r  
5 ‘ AAT T A AC C C T C AC T AA A GG G  3 "
KS P r i m e r  
r C G A G G T C G A C G G T A T C  3 '
ECCÛ109I H i n d i  B s p l O Gl
, Ora I I  ACC I C l a  I EcoRV E c c w l
MET BssH I I  1 3  p r o m o t e r  K p n l  A p a l  Xho I S a i l  H i n d  I I I
S '  g g a a a c a g c t a t g a c c a t g a t t a c g c c a a g c g c g c a a t t a a c c c t c a c t a a a g g g a a c a a a a g c t g g g t a c c g g g c c c c c c c t c g a g g t c g a c g g t a t c g a t a a g c t t g a t a t c g
3 '  C C r T T G T C G A T A C T G G T A C T A A T G C G G T T C G C G C G T T A A T T G G G A G T G A T T T C C C T T G T T T T C G A C C C A T G C G C C G G G G G G G A G C T C C A G C T G C C A T A G C T A T T C G A A C T A T A G C I T A A  
I I I
816 792 759
p - G a l a c t o s i d a s e _ ^
SiiB I Spe  1 Eag I Bs tX I
P s t I  BamHI X b a l  No t  I S a c I I  S a c  I BssH I I
A A T T C C T G C A G C C C G G G G G A T C C A C T A G T T C T A G A G C G G C C G C C AC C GC G G T G GA GC T C C A AT T C G C C C T A T A GT GA G T C G T AT T A C GC G C G C T C A C T G G C C GT C GT T T T A C A A  3 '  
GGACGTCGGGCCCCCTAGGT GA T C A A GA T C T C GC C G G C GG T G G C GC C AC C T C GA G GT T AA G C G GG AT AT C AC T C AG C A T A AT GC G C G C G AG T G a CC GGCAGCAAAAT GT T S '
6 5 7  - * - ' 1  7 7  p r o m o t e r  '
CTAGGT GA T C A A GA T C T C GC  S '  
SK  P r i m e r
619
3 '  C G GG ATATC a C T C A G C a T a a TG S '  3 '  T G A C C GG C a GCAAAATG  S '  
T 7  P r i m e r  H I 3 - 2 0  P r i m e r
Figure 2.4 Restriction map and multiple cloning site of pBluescript SF(-) (Strategene 
Ltd)
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2.2 BASIC METHODS
Throughout the project there were 2 main sources of reference for molecular biology 
techniques :
Molecular Cloning, a Laboratory Manual ; Maniatis et al (1989) - a good source of 
techniques with good theoretical background. 3 volumes.
Promega : Protocols and Applications Guide 2nd ed - less bulky than Maniatis with 
easy to follow protocols, especially for subcloning and deletion protocols.
The composition of all buffers and solutions that were not supplied as part of a kit are 
listed in Appendix 1.
All glassware, plasticware and solutions were autoclaved (Rodwell series 32, 120°C / 
20 mins) before use to destroy nucleases . As DNA has an affinity for glass most of the 
reactions are done in polypropylene tubes.
2.2.1 GEL ELECTROPHORESIS
Due to its negative charge DNA (and RNA) will migrate towards the positive pole of 
an electric field. This property was used to separate and size fragments of DNA by 
running them through a gel cast of l%(w/v) agarose in TAB running buffer. The 
migration rate of the fragment was proportional to the logMW. Gels were run at a 
constant 150mA till the running dye has reached the bottom.
The size of the fragments could then be determined by comparison to known DNA 
markers or ‘ladders’. 2  ladders were commonly used:
)VHindIII - 23.7, 9.4, 6.5, 4.3, 2.3, 2 .0 , 0.56 kb
<DX174/HaeIII - 1.3, 1.0, 0.87, 0.60, 0.31, 0.28, 0.27, 0.23 kb.
Both these markers are combined in Dri-gest III marker fi"om Pharmacia.
All samples were made up with marker dye (10% (w/v) bromophenol blue in 50% 
(w/v) sucrose).
The DNA bands could be visualised by staining with the intercalating dye ethidium 
bromide which fluoresces at 590nm (visible) when excited with UV light (300nm), 
Ethidium bromide was either included in the gel and running buffer (0.5pg/ml) or the 
gel was stained post-run for 20-30 mins followed by a destain in water. Supercoiled 
plasmid could not be run on gels containing ethidium as the dye effects the migration 
rate and gives many bands.
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For a permanent record of the gel a polaroid picture was taken on type 665 
positive/negative film using a polaroid land MP-4 camera (14 sec/f4.5 with orange 
filter).
2.2.2 SOUTHERN BLOTTING OF DNA TO NYLON FILTERS
DNA was transferred to a nylon membrane by Southern Blotting [Southern et al 1975] 
for subsequent analysis of the DNA with cDNA probes, in order to locate homologous 
regions in the recombinants. The gel was depurinated by soaking in HCl (to aid 
transfer of larger fragments), denatured in alkaline and neutralised prior to DNA 
transfer.
Transfer was effected by diffusion. The gel was placed on a wick soaked in 20xSSC 
and the nylon filter placed on top. Filter paper soaked in 2xSSC was placed on this. 
Absorbent towels were placed on top to give the capillary effect and the whole stack 
was compressed by a weight. The transfer was left overnight and the DNA was then 
U.V. bonded to the filter by a 3min exposure. The filter could then be probed with a 
radiolabelled cDNA .(see Figure 2.5).
2.2.3 PURIFICATION OF DNA FRAGMENTS FROM AGAROSE GELS
When preparing fragments for fiirther subcloning or probes there were 2 similar 
protocols for purification; Geneclean and Glassmax, both of which gave good results. 
The procedures were based on the method of Vogelstein and Gillespie [1979] where 
DNA was first separated on an agarose gel and the band excised into a weighed tube. 
2-3 volumes of Nal were added and the agarose melted at 55°C.
Geneclean : The solution was then mixed with a fine suspension of silica particles, 
supplied as "glassmilk",(l pl/pg DNA) and left on ice for 5 min to allow the DNA to 
bind to the silica. The matrix was spun down (lOOOOg/lOsec) and resuspended in ‘New 
Wash’ buffer. This was repeated 3 times and the pellet then resuspended in 10-20pl of 
TE buffer and placed at 55°C for 5 min to elute the DNA. Finally the matrix was 
repelleted and the DNA solution removed for use.
Glassmax : This was essentially the same as Geneclean but the silica was immobilised 
on an filter. The filter was mounted on an insert that fitted onto an eppendorf and this 
allowed the solutions to be passed through the matrix by centrifugation. It was 
marginally quicker than Geneclean and gave comparable yields. The main advantage of 
this procedure over Geneclean was that fragments of DNA greater than lOkb could 
bind to 2 or more glassmilk particles and thus shear during the resuspension steps. This 
was not a problem with Glassmax as the silica particles don’t move relative to each 
other.
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Figure 2.5 Southern Blotting apparatus.
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2.2.4 PURIFICATION OF DNA IN SOLUTION
There were several procedures which required the purification of DNA from an 
aqueous solution containing proteins and other contaminants. This was achieved by 2 
phase extraction using TE saturated Phenol/Chloroform. The aqueous phase was made 
up to a suitable volume and an equal volume of phenol/chloroform was added and 
mixed by vortexing. The aqueous and organic phases were separated by centrifugation 
(2,500g/10mins) and the top (aq.) layer removed, taking care not to disturb the 
interface where some of the protein often precipitated. This was repeated until the 
interface was clear.
DNA could be efficiently precipitated out of aqueous solution by the addition of salt 
and Ethanol. The salt of choice was 7.5M NH4 OAC (since this could be removed later 
by sublimation under vacuum and thus did not interfere with subsequent reactions), 
although 3M NaOAc was also used. The aqueous solution was mixed with 0.5 vols of 
7.5M NH4 OAC and 2 vols ice cold 100% Ethanol. The mixture was placed at -70°C 
for 15 mins (or -20°C overnight), centrifuged (12,000g/15mins), and lyophilised under 
vacuum for 5 mins (Univap centrifugal evaporator. Uniscience Ltd.). Care was taken 
to prevent overdrying of the pellet as this lead to difficulties in resuspension. The pellet 
was then resuspended in a suitable volume of TE. If NaOAc was used a wash with 
70% Ethanol removed some of the salt.
2.2.5 DETERMINATION OF DNA CONCENTRATION AND PURITY.
The concentration of DNA in solution was determined by measurement of the 
absorbance of the solution at 260nm. 1 Absorbance unit at 260nm is equivalent to a 
concentration of 50pg/ml.
The purity of the DNA was determined by scanning the absorbance of the sample from 
200 to 320nm. A symmetrical peak at 260nm point with a ratio of absorbances at 
260/280nm of 1.8 would indicate that the DNA was free from contaminants (Sambrook 
etal\9%9).
If the DNA had been prepared by the Geneclean/Glassmax method residual Nal shifted 
the peak and gave misleading results. In this case the best method of concentration 
measurement was to run an aliquot of the sample on a gel and compare the ethidium 
bromide staining intensity to that of the markers. This also gave an indication of any 
degradation or RNA contamination of the DNA which was not detectable by uv/vis 
scanning.
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2.2.6 DIGESTION AND MAPPING OF DNA WITH RESTRICTION 
ENZYMES
Restriction endonucleases recognise and cut specific sequences (usually 4-8bp) in DNA 
molecules. The recognition sites are usually palindromic and the enzyme will either cut 
both strands at the same base pair to generate blunt ended fragments(e.g. Smal) or in a 
staggered fashion, to give fi-agments with overhanging or ‘sticky’ ends (e.g. EcoRl). 
Each enzyme was supplied with an appropriate buffer which contained varying amount 
of salt. By reference to a buffer chart it was possible to perform double digests with 2 
enzymes in the same buffer.
By using a range of enzymes both singly and in combination it was possible to 
determine the relative position of the enzyme sites in the DNA fragment and thus build 
up a ‘map’. This was facilitated if the fragment was in a vector (plasmid or phage) 
whose sites were known and could therefore be used as reference points.
For most mapping projects I  pg of DNA was cut with 3-5 units of enzyme in a total 
volume of 20pl H2O and buffer. If the digest was for preparative purposes then the 
volumes were increased and the DNA extracted by phenol/chloroform or Geneclean.
2.2.7 ENZYMIC MODIFICATION OF DNA
2.2.7.1 Dephosphorylation
If a plasmid vector had been cut with a single restriction enzyme for subsequence use in 
a ligation reaction it was necessary to prevent self-religation. This was achieved by 
removing the phosphate group fi"om the 5' ends of the linearised plasmid DNA strands 
using calf intestinal alkaline phosphatase (CIAP). The cut vector was incubated with 1 
Unit of enzyme/nmol 5' ends in Ixbuffer (supplied with enzyme), at 37°C for 60 mins. 
The reaction was stopped by the addition of EDTA to a final concentration of ImM 
and the protein removed by extraction with phenol/chloroform.
2.2.7.2 Blunt Ending of Overhanging Ends
It was possible to insert a sticky ended fragment into a blunt ended vector by also 
making the insert blunt ended. This was achieved with the enzyme DNA Polymerase 
(Klenow fragment). The insert was incubated with 3-5U of the enzyme in the presence 
of 2mM dNTPs and Klenow buffer (provided with enzyme) at 37°C for 15 mins. The 
DNA was then extracted as above.
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2.2.8 HYBRIDISATION WITH RADIOLABELLED PROBES
2.2.8.1 cDNA Probes
The probes used to isolate the putative human CYP4A recombinant clones were derived 
from rat CYP4A1 cDNA, isolated and sub-cloned by D. Eamshaw in this laboratory 
[Eamshaw et al, 1987]. The cDNA was 2. Ikb in length and inserted at the EcoRl site 
of the plasmid vector pUC9.
The full length cDNA was excised with EcoRI and used as a probe to screen for full 
length human CYP4A recombinants and was used in the early rounds of screening. In 
the later rounds, when the aim was to concentrate on the 5' end of the gene, only the 
first 600bp of the cDNA (ie the 5' end) was used as a probe. This was prepared by 
cutting the excised cDNA with a second enzyme Bgll which cleaves off the first 600bp 
of the cDNA. This fragment corresponds to the first 5 exons as shown in Figure 2.6.
2.2.8.2 Radiolabelling of DNA Probes
All hybridisations were performed with [^^P] labelled cDNA probes which had been 
prepared using the Multiprime procedure. This involved the incorporation of [^^P] 
dCTP into copies of the probe sequence.
The probe DNA was mixed with a solution of random octamer primers, boiled and then 
cooled slowly. This process melted the two DNA strands apart and allowed the 
random primers to bind. The resulting DNA/primer hybrid was incubated with the 
Klenow fragment of DNA polymerase I in the presence of dNTPs (including 
[32p]dCTP ) which were incorporated into new strands to form a new radiolabelled 
copy of the probe DNA.
The reaction was terminated by passing the reaction mixture through a "NICK" 
(Sepharose exclusion) column which separates the unincorporated nucleotides from the 
probe DNA. This was a necessary process as free radiolabelled dNTPs cause high 
radioactive background in autoradiography due to non-specific binding. The probe is 
then boiled to melt double stranded regions, added to the hybridisation buffer and 
added to the tube(s) containing the filters to be probed.
The Multiprime kit has now been replaced by the Megaprime kit which uses synthetic 
nonamers as primers and requires less template DNA.
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Figure 2.6 Hybridisation probes derived from rat CYP4A1 cDNA
EcoRI sites are derived from synthetic linkers used in the preparation of the cDNA 
library. The cDNA is inserted in pUC9 and numbers correspond to exons.
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2.2.S.3 Hybridisation of Filters
Filters were probed in a hybridisation bottle inside a temperature regulated oven 
(Hybaid Ltd). Non-specific binding sites on the filter were first blocked by incubating 
overnight in pre-hybridisation buffer at 42°C This served to reduce the background on 
the resulting autoradiogram, which was important for plaque screening as positive spots 
were very faint due to the small amounts of DNA transferred.
After the pre-hybridisation step the buffer was removed and hybridisation buffer 
containing the radiolabelled probe added to the tube. Hybridisation was performed 
overnight at 42°C in the oven.
In order to maximise the detection of authentic hybrids following hybridisation, filters 
were washed in dilute solutions of SSC salts and SDS. The stringency of the washes 
depended on the nature of the probe and the target sequences. To some extent the 
appropriate conditions of SSC salt concentration and temperature were determined 
empirically.
The washing conditions used for rat cDNA probe on the human DNA were as follows:
2xSSC / 0 .1% SDS 2x30  mins room temp.
O.lxSSC/0.1% SDS 2x30  mins 55^C
SxSSC room temp.
The filters were then put into an X-ray cassette between 2 sheets of plastic and an X- 
ray film (Kodak X-Omat AR5 high speed film) added. The cassette was then stored at 
-70°C to increase the sharpness of the image and lefi: for a period of time determined by 
the radioactivity of the filters (as determined using a hand held Geiger counter). Plaque 
lift filters usually took a week to expose. Once the exposure was complete the film was 
developed in an automatic film developer (Fuji RGII Medical film Processor).
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2.3 METHODS WITH GENOMIC DNA
2.3.1 Extraction of Genomic DNA From Human Liver Samples
Total genomic DNA was extracted from samples of rat and human liver using a 
modified version of the protocol of Johns et al [1989] which used sodium perchlorate 
instead of phenol as the extraction step.
Ig of liver was homogenised in 9.8ml of TEN buffer (50mM Tris.HCl (pH 7.4), 
ISOmM NaCl, lOOmM EDTA) in a 50ml Falcon using a Polytron (Kinematica GmbH, 
Switzerland). 0.2ml of 10% SDS was added, mixed gently by inversion and then Img 
RNAse A was added and incubated at 37°C for 30 mins. Another 1.5ml of 10% SDS 
was added and the tube heated to 60°C for 1 0  mins to denature the protein. 2.5ml of 
sodium perchlorate was added immediately, mixed by inversion and then 14ml (equal 
vol.) of Chloroform:isoamyl alcohol (24:1 (v/v)) was added. The tube was rocked 
gently in a fume hood for 30 mins. The 2 phases were separated by centrifugation 
6,000g/15 mins and the upper aqueous phase transferred to a new tube. 2  vols of ice 
cold 100% Ethanol were carefully poured down the side of the tube and the DNA 
could be seen precipitating at the interface. This was removed by twirling a sealed long 
form Pasteur pipette and spooling the long translucent DNA strands round it. The 
DNA was drained of excess ethanol by blotting against the side of the tube and put into 
5ml of TE. The spooling was repeated until the phases have completely mixed and the 
DNA was allowed to dissolve at 4°C for 30 mins. 0.5ml 3M NaoAc was added and 
10ml of ice cold 100% Ethanol was gently added on top and the spooling process 
repeated. The spooled DNA was put into 1ml 70% Ethanol and pelleted gently 
(4000g/lmin). The pellet was rewashed with 70% Ethanol spun down and air dried. 
The pellet was then resuspended in 1ml of TE at 4°C overnight.
2.3.2 Digestion Of Genomic DNA
Genomic DNA was digested in the same manner as other DNA but care was taken to 
ensure complete mixing as the solution is very viscous. Half the required amount of 
enzyme was added and incubated at 37°C for 4-6 hours. The digest was then mixed by 
pipetting using a 1ml tip with the end cut off to prevent shearing of the DNA. The 
remainder of the enzyme was then added and incubated at 37°C overnight. A small 
sample of the digest was electrophoresed to check the efficiency of the digest. If 
necessary more enzyme was added and the incubation repeated. The DNA was then 
electrophoresed on an agarose gel and Southern blotted as before.
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2.4 METHODS WITH BACTERIOPHAGE
2.4.1 Titration of a Phage library
To determine the phage titre of a library, 10 fold serial dilutions (to 10"^) of the library 
were made in SM buffer and 10|il of each dilution was incubated, in duplicate, with 
ibOul of LE392 cells (from fresh overnight culture in LB + MgS0 4 ) at 37°C for 
30mins. This mix was added to 3ml of top agarose and poured onto L Agar + MgSO^ 
plates (previously prewarmed to 37°C) and once the agar had set the plates were 
inverted and incubated at 37°C overnight. During the night the cells formed a 'lawn' on 
the top agarose spotted with clear areas called plaques, formed by bacteriophage lysing 
the cells and spreading radially through the layer. The number of plaques/plate were 
counted and by taking into account the dilution a titre of plaque forming units/ml 
(pfu/ml) was calculated.
2.4.2 Library Screening By Plaque Purification
The library used for the isolation of the human clones was a human placental Genomic 
Libraiy in the phage vector EMBL3a, supplied by Clonetech Ltd. Genomic DNA had 
been partially digested with Sau3A and inserted into the BamHl site of the 
bacteriophage. Insert sizes of approximately 14kb were selected by gel electrophoresis 
and packaged. The library titre was 1012 pfu/ml. Calculations indicated that the 
library contained at least 1 0 ^ different phage constructs.
The library was screened using the standard procedure. For the initial round of 
screening large 20cm x 20cm plates were poured using L Agar with lOmM MgS0 4 . A 
sample of the Phage library was used to inoculate an overnight culture of LE392 cells. 
The resulting culture was added to 50 ml Top Agarose and poured over the agar plates 
(a total of 5 plates were used). Once the agar had set the plates were inverted and 
incubated at 37°C overnight.
The plates were incubated at 4°C for Ihr and a nylon Hybond N membrane 
(Amersham) was laid onto the surface of the plate and its alignment marked. Phage 
from each of the plaques bound to the membrane and thus a mirror-image map was 
obtained. The filters were placed phage-side up onto Watmann 3MM filters soaked in 
O.IM NaOH (1 min) to rupture the phage and release the DNA, 1.5M NaCl (1 min) to 
bind the DNA to the filter, and 0.2M Tris.HCl + 2 x SSPE (5 min) to neutralise the 
filters. The filters were then air dried and the DNA fixed by UV crosslinking for 3 min.
The filter was then incubated with a radiolabelled cDNA probe. Positive plaques were 
identified as dark spots on the autoradiograms and excised from the top agarose into 
phage buffer where the phage migrated into solution.
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This screening procedure was then repeated using smaller (90mm) petri dishes of L 
Agar and the diluted phage from the initial screen. This cycle was repeated until all the 
plaques are positive for the probe, usually on the 4th or 5th round of screening, (see 
Figure 2.7).
2.4.3 Preparation of Phage DNA
Once positive recombinant phage had been isolated by plaque purification and a 
homogeneous solution obtained then DNA was prepared from phage cultures. The 
DNA preparation used was a liquid lysate method.
The first step was to prepare a solution containing a high titre of the phage (primary 
lysate). An aliquot of the phage buffer from the final round of screening was used to 
infect a small overnight culture of LE392 cells. Adsorbtion was for 30 mins at 32°C. 
The cells are then grown up overnight at 37°C in LB medium with 10 mM MgS04 to 
allow the phage multiplication and lysis of all the cells.
The resulting solution was treated with a few drops of CHCI3  to kill any viable LE392 
cells and then centrifuged at 4,000 g to pellet the cell debris. The resulting cleared 
lysate was used as the primary lysate for the DNA extraction procedure.
An aliquot of the primary lysate was used to infect 10 ml of an overnight .culture of 
LE392 cells. These were incubated at 37°C for 4-6hrs to establish infection. 
Simultaneously 500ml of LB medium was inoculated with 10ml of LE392 (overnight 
culture) and grown at 37®C. The 2 cultures were then combined and grown overnight 
at37°C.
Any viable cells were lysed by shaking with a few drops of CHCI3  and the debris 
centrifuged at 4,000 g. The cleared solution was treated with DNAase I (lOmg/1) to 
digest the bacterial DNA The phage DNA was not digested as it is protected by the 
phage protein coat. The phage coat was then broken open with 150ml of 0.3M Tris 
HCl / 0.15M EDTA / 1.5% SDS and phage protein, bacterial protein and digested 
bacterial DNA precipitated by the addition of 110ml 8 M Ko Ac. The mixture was 
incubated on ice for 30 mins. The precipitate was pelleted by centrifugation 18,000 g 
for 30 mins and the supernatant then incubated with 170ml isopropanol to precipitate 
the phage DNA which was then pelleted by centrifugation (18,000 g for 30 mins).
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The pellet was resuspended in sterile distilled water and treated with RNAase A 
(50mg/l) to digest any RNA contamination and with Proteinase K (200mg/l) to remove 
residual protein (including the RNAase). The mixture was extracted with TE saturated 
Phenol/CHCls and the aqueous phase removed. The phage DNA was precipitated 
from this by adding 0.1 vols 3M NaoAc and 2 vols 95% Ethanol at -70°C. The DNA 
was then further purified by reprecipitating with 0.1 vols NH4 OAC and 2 vols 100% 
Ethanol. The pellet was dried in a Univap and resuspended in 200pl of TE buffer 
ready for use.
2.5 METHODS WITH PLASMroS
2.5.1 Ligations
The yield of DNA from a phage preparation was small and prone to degradation. It 
was therefore desirable to insert the genomic DNA fragments of interest into a bacterial 
plasmid vector as soon as possible. This also had the advantages of a much higher yield 
from plasmid DNA preparation and the ability to sequence the insert which was not as 
easy while in phage.
The plasmid chosen for subcloning was pGEM 7zf(+) (Promega). This is also an 
expression vector and so could be used in later studies. The vector carries the 
Ampicillin resistance gene (amp^) and the multiple cloning site is located in the lac z 
gene. Each reaction contained lOOng of cut plasmid DNA (Ipl), 2\x\ of 5x buffer 
(supplied with ligase), Ipl (lOU) T4 DNA ligase and insert DNA in a final volume of 
1 Opl.Two methods were used for the ligations:
Shotgun Ligations : The phage inserts were sub-cloned using this technique which has 
a good success rate in our hands. The plasmid and phage were digested overnight with 
the same enzyme and the plasmid was treated with CIAP to prevent self-ligation. The 
resulting fragments were ligated together using T4 DNA ligase and the reactions were 
performed with 1:1 and 1:3 ratios of plasmid to inserts. The inserts^ ligated into the 
plasmid while the phage arms remained behind as they only had 1 end compatable with 
the cut vector and so do not form viable plasmids. I
Directed Ligations : For more difficult inserts the insert was cleaned up and ligated in 
the 1:1 and 1:3 ratio as before. This method was used for blunt ended inserts and 
inserts with different sites at each end.
Various controls were also performed : cell viability (no plasmid), efficiency of 
transfection (uncut plasmid), vector digestion (cut plasmid) and vector 
dephosphorylation (cut plasmid + ligase). The ligation reactions were diluted 1:10 in
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TE and 20|il of each (containing 20ng vector DNA) transfected into a competent cell 
line such as JM109 or TBl. The remaining ligation mix was stored at -20°C.
2.5.2 Preparation of Competent Cells
Bacteria (JM109 or TBl) were streaked out onto M9 plates containing Thiamine HCl 
and grown up overnight. A single colony was picked into 25ml of LB medium and 
grown up overnight at 37°C with vigorous shaking. 5ml of this culture was used to 
inoculate 500ml LB and the culture grown up until the absorbance at 600nm was 
between 0.45-0.55. The culture was chilled on ice for 2 hours and the cells collected 
by centrifugation at 2,500g/20mins/4°C. The cells were then resuspended in 2 0 ml ice 
cold trituration buffer, made up a final volume of 500ml and incubated on ice for 45 
mins. The cells were pelleted at l,800g/10mins/4°C and resuspended gently in 50ml ice 
cold tituration buffer. The flask was stirred and 11.5ml of 80% glycerol was added 
dropwise to a final concentration of 15% (v/v) and the cells frozen on dry-ice in 1 ml 
aliquots. The cells were stored at -70°C until use.
2.5.3 Transfection of Recombinant Plasmids Into Competent Cells
Competent cells were thawed on ice and 200pl aliquots put into 4ml Greiner plastic 
tubes. 3 pi DMSO and 20pl of the ligation or control was added to each and the cells 
were left on ice for 30mins. The cells were heat-shocked (42°C/2mins) and then cooled 
on ice for 5 mins. 2ml of LB was added and the culture grown up at 37°C for Ihr in a 
shaking incubator. 100 and 200ml aliquots were then spread onto X-Gal plates and 
grown up overnight at 37°C. The remaining transfected cells were stored at 4°C. If 
there were very few colonies on the plates the remaining transfected cells were 
concentrated by centrifiigation (4,000g/5mins) and then resuspended in 300ml of LB 
and plated out as before.
2.5.4 Screening of Recombinants
It was important to ensure that the colonies contained plasmids which did contain the 
expected inserts and were not artefacts of the cloning process. This was done by the 
technique of blue/white screening, using specially poured agar plates containing 
Ampicillin, IPTG (an inducer of the lac z gene), and X-Gal (a substrate which is broken
down to a blue dye by the lac z gene product), on which the newly transformed cells
were grown. This screening identified 3 groups :
a) cells with no plasmid did not grow as they lacked the amp^ gene.
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b) cells containing a plasmid with no insert had a functioning lac z gene which was 
induced by the IPTG to produce 3-galactosidase to break down the X-Gal causing the 
colonies to appear blue.
c) cells containing a plasmid with an insert had a defective lac z gene and so did not 
metabolise X-Gal causing the colonies to remain white.
The resultant white colonies were picked and streaked out on more X-Gal plates to 
confirm they were white and then lysed or 'cracked' to check the insert size.
2.5.5 Secondary Screening - ’Cracking* Procedure.
'Cracking' is a high throughput lysis method to screen for plasmids with inserts. A loop 
of restreaked colony was resuspended in 50pl of lOmM EDTA and 50pl of cracking 
buffer was added. The tube was incubated at 75°C for 30mins and then cooled on ice.
1.5 pi 4M KCl and 3 pi DNA running dye were added and the tube incubated on ice for 
lOmins. The genomic DNA, RNA and proteins were precipitated and spun down 
(14,000g/5 mins) and the supernatant loaded directly onto a 0.7% agarose gel. Plasmid 
without insert was run as a marker and any plasmid with an insert ran slower in 
comparison. The restreak from such a sample was used as a source for further plasmid 
preparations.
2.5.6 Plasmid DNA Preparations
To do any extensive work on the plasmid DNAs it was necessary to prepare larger 
quantities of DNA so that restriction enzyme digests and sequencing reactions could be 
performed. These processes both required clean and complete plasmid DNA and two 
kit methods were utilised for this.
a)Qiagen This was the method of choice and typically yielded l-2pg of clean plasmid 
per ml of original culture. The columns came in two sizes; the mini prep handled 10 - 
15ml of culture and the midi prep 100 -150ml of culture. The protocol for the mini (tip 
2 0  ) column is described below (buffer content listed in appendixl).
The columns and buffers come in a kit and the protocol is simple. The colonies which 
appeared to contain plasmids with inserts on the cracking gels were grown up overnight 
in 20ml LB + Amp and in the morning cells were pelleted by centrifugation. The cells 
were resuspended in 300pl Buffer PI and then the cells were lysed with 300pl Buffer 
P2. The debris was precipitated with 300pl Buffer P3 and centrifuged down.
The supernatant was loaded onto the affinity column which had been equilibrated with 
1ml QBT. The column was then washed through with 4ml buffer QC to remove RNAs
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and small nucleotides and then the clean plasmid DNA was eluted with buffer QF and 
precipitated with 0.8 vols of propan-2-ol and pelleted 14,000g/15mins/RT.
The DNA was further purified by Ethanol precipitation and then dried down in a univap 
to remove the salt. Once resuspended the DNA was used for sequencing and mapping. 
The midi preps (tip 100 ) were a scaled up version using 150ml original culture.
b) Magic Mini-Preps ; This kit is a similar system to Qiagen. The overnight cultures 
are treated with 3 buffers (resuspension, lysis and precipitation, 200pl of each) as with 
Qiagen and the precipitate spun down. The supernatant was mixed with the ion 
exchange resin and loaded onto a spin-column containing a 0.22pm filter. The column 
was washed with 2ml of wash buffer to remove the contaminants and then the DNA 
was eluted with warm (65-75°C) TE or H2 O.
This method had two advantages over Qiagen. Firstly, with the aid of a vacuum 
manifold, it was possible to obtain clean plasmid DNA from 20 samples in 30 mins 
compared with 3-4 hrs with Qiagen. Secondly there was no salt in the elution buffer 
and this was significant in the preparation of template for Taq Cycle sequencing (see 
section 2.6.2). The disadvantage was that the elution volume had to be 50pl and this 
lead to problems with low DNA concentration. This was overcome by elution in water 
and then lyophylisation to achieve the desired concentration.
Restriction enzyme digest with the original insert and vector preparation enzyme(s) 
displayed the size of the inserted DNA in the plasmid. This was often used as a further 
round of screening as some of the inserts were of a size different to that of DNA 
fragments prepared from the recombinant phage. This was mainly due to artefactual 
recombinations of inserts and plasmids and were disregarded at this stage.
The plasmids which contained DNA inserts of the size predicted by the recombinant 
phage maps were then grown up in midi preps so there was enough DNA to do 
extensive mapping. Mapping was much easier in plasmids as the circular nature of the 
DNA allowed more accurate determination of the enzyme site positions as the sizes of 
digested fragments were much smaller. Mapping also showed the orientation of the 
insert in the plasmid which was important for the sequencing strategy.
2.5.7 Storage of Cells Containing Plasmid
The master plates on which the clones were restreaked were used as the source of cells 
in the short term but were prone to contamination and loss of viability. This was a 
particular problem with the cells grown on X-Gal plates which had poor viability after 
long periods of storage. There were three methods used for the storage of the cells:
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Liquid cultures : These were used for period of 3-5 days and stored at 4°C. These 
were useful for inoculating large cultures for plasmid preps.
Plate cultures : A loop of liquid culture was streaked onto an L Agar Amp plate and 
grown up overnight. The plate was sealed with plastic tape and stored at 4°C and cells 
were viable for up to 6  months. It was possible to pick a single colony and use this as a 
source for future work.
Glycerol stocks : For long term storage and archiving the cells were frozen in glycerol 
(to prevent rupture by ice crystals). A single colony from a streak plate was used to 
inoculate 2ml of LB + Amp and grown up overnight. The culture was divided into 
eppendorfs and sterile 80% Glycerol added to a final conc. of 15%. The tubes were 
vortexed, frozen at -20°C for 30mins, revortexed and stored at -70°C. The cells were 
viable in this form for 2-3 years
2.6 DNA SEQUENCING
2.6.1 Introduction
Once a map of the recombinant DNA clone had been determined by restriction mapping 
the actual nucleotide sequence was determined. This was performed by two methods; 
firstly manually using the Sequenase System and secondly using an ABI 3 73A 
automatic sequencer with dye labelled primers.
The sequencing reaction was a modified version of the Sanger Dideoxy Chain 
Termination system [Sanger et al\ 1977] as described by Chen and Seeburg [1985]. 
DNA polymerase was used to copy a single stranded template using synthetic, 
complementary oligonucleotides as primers and dNTPs as a source for the second 
strand. By using [^^S] labelled dATP in the reaction mixture the resulting strand was 
labelled. Dideoxy nucleotides are used to produce premature termination in the nascent 
strands and the resulting terminated fragments can be separated by electrophoresis in 
polyacrylamide gels.
In this work commercially available primers were utilised which bound to specific sites 
outside the Multiple cloning sites of the plasmid (the system was designed to work on 
the M l3 bacteriophage vector but as most plasmids have M l3 derived regions it 
worked as well on single stranded plasmids) See Figure 2.8. As the Klenow addition 
works 5' to 3' then the primers were directional depending on which strand they bind to. 
Primers binding the top strand to the 5' end of the multiple cloning site were designated 
as Forward or Universal while those that bind the bottom strand to the 3' end of the 
multiple cloning site were designated as reverse. In pGEM the M l3 universal and 
reverse primers lay 50 bases either side of the multiple cloning site which cut down the
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Figure 2.8 Arrangement of sequencing primer sites in pGEM 7zf(+)
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effective range of the sequencing. The pGEM7 zf(+) vector had the T7 and SP6
promoter sites immediately outside the multiple cloning site and these were used 
instead.(the sequences of the primers are listed in Appendix 1).
2.6.2 ’Manual’ Sequencing Using the Dideoxy Sequencing Using the Sequenase 
System.
The 'manual' sequencing was performed using the Sequenase system (US Biochem. 
Inc) which was capable of reading 300 - 350 bp from the primer. The system used a 
genetically engineered version of bacteriophage T7 DNA polymerase - Sequenase and 
was supplied in a kit with all the appropriate buffers.
2.6.2.1 Sequencing Reaction
The sequencing system utilised the properties of (2',3') dideoxy nucleotides (ddNTPs) 
which were identical to their (2') deoxy analogues but had an H instead of an OH in the 
3' position. This meant that the ddNTP was not capable of polymerising to another 
nucleotide in the 3' direction and so the addition of a ddNTP to a growing chain 
terminates it.
The first step of the sequencing was to melt the plasmid into single stranded DNA. 5pg 
of DNA was made up in 16|il of H2 O and 2\i\ 0.2M NaOH and 2pl 0.2mM EDTA. 
The plasmid was then neutralised with 2pl 2M NH4 0 AC and then Ethanol precipitated. 
Once the DNA had been dried down it was resuspended in the sequencing buffer and 
the primer added. The mixture was heated to 65°C and cooled slowly to allow the 
primer to anneal to the DNA.
The primer/DNA mix was incubated with Sequenase in the presence of dNTPs 
including p^S] dATP. p^S] was used in preference to p^P] as the latter was a 
stronger emitter which lead to poorer resolution of the individual bands although on 
another isotope p^P] has recently become available with the containment properties 
and resolution of p^S] but the signal strength of P^P]. After 5 mins the incubation mix 
was split between 4 tubes, each containing a different ddNTP as well as more dNTPs. 
The polymerisation continued as before but each time the Sequenase incorporated a 
ddNTP into the chain the polymerisation stopped. It was statistically probable that 
there was a terminated chain for each of the bases to which the ddNTP is an analogue. 
After another 5 mins the reactions were terminated by the addition of 4pl stop solution 
containing EDTA and a running dye.
There was an option in the protocol to use 'extension mixes' which allowed reading of 
the sequence fiirther from the primer. This involved the addition to various ratios of 
the extension mix to the termination tubes (see Sequenase protocol for details).
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2.6.2.2 Gel Preparation, Electrophoresis and Processing
The apparatus used in Surrey was a home-made version of the BRL vertical gel systems 
and accommodated 60x20cm glass plates. The plates were cleaned with Decon and hot 
water, rinsed with distilled water, 70% Ethanol and then acetone. After every 5 runs 
each plate was coated on 1 side with 1 0 ml dimethyl dichlorosylane to prevent the gel 
sticking to the plates. 0.4mm side spacers were placed along each side and the edges 
taped up with sealing tape (Gibco).
31.Sg of urea was dissolved in 11.25ml 40% acrylamide stock (acrylamide:bis 
aciylamide 19:1) and 10ml lOxTBE and then made up to 75ml with dH20 (final con 
6 % (w/v) polyacrylamide gel). This was polymerised with the addition of 420pl 10% 
ammonium persulphate and 75pl TEMED and poured between the taped plates with a 
50ml syringe. The flat side of a sharks-tooth comb was placed into the top of the gel to 
form the well, the gel clamps attached and the gel allowed to set for at least 4hrs or 
stored overnight with the top covered with wet tissues and cling film.
Prior to the electrophoresis of the samples the gel was clamped into the apparatus and 
the top and bottom tanks filled with IxTBE. The well was flushed out and the sharks- 
tooth comb reversed and re-inserted until the teeth just penetrated the top of the gel. 
The gel was pre-run for 30mins at 50W constant power. The samples were heated to 
75°C for 2 mins prior to loading and then 3pi fi*om each tube (G,C,A,T) were loaded 
with a drawn out Gilson tip. The gel was run for 3 hrs (short gel) or 6 hrs (long gel) at 
50W (9 and 12hrs for extension mixes).
After the run the tape was removed fi-om the plates and they were carefully separated. 
The plate to which the gel had stuck was carefully immersed in an solution of 
Methanol:acetic acid:H20 (1:1:8) to fix the gel and then rinsed in water to remove the 
fix solution and the urea. The gel was then transferred to wet 3MM filter papers and 
dried at 80°C for Ihr in a slab gel drier (model 4823, Biorad). The gel was then placed 
into an autoradiography cassette and the signal strength determined with a hand held 
counter. The autoradiograph was then exposed for an appropriate length of time at 
room temp, and developed as before.
2.6.2.3 Alternative Manual Methods
The system described above was very effective for reading up to 200 nucleotides from 
one run. By split loading a gel (loading the same sample after a time delay onto the 
same gel) it was possible to get 350bp of sequence but as the gel could only run six 
samples at a time this was 1/3 of the capacity of the gel. The main shortfall of the 
system was that the bands were not evenly spaced down the gel making it difficult to
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resolve the top bands. The ideal situation would be that the band were all spaced the 
same and therefore more bases could be read over the same length. This was achieved 
in 2  ways:
Wedge Spacers : These were specially designed spacers which widened from 0.4mm to 
1 .2mm over the 60cm length. Since the rate of migration of the DNA down the gel is a 
function of the thickness of the gel, the wedge served to slow the DNA as it 
approached the bottom of the gel and so increased the number of bases over the length 
of the gel. The main problems with this system was that the gel was more difficult to 
pour and the thick part of the gel took significantly longer to dry completely (up to 4 
hrs).
Buffer Gradient Gels : Another factor that determined the migration rate of the DNA 
was the buffer concentration. It was possible to achieve the same affect as the wedge 
spacers by pouring a gradient gel using standard spacers, thus eliminating the drying 
problems. Two 6 % acrylamide stocks were made one containing 0.5 xTBE (soln A) 
and the other with 5x TBE and 50mg bromophenol blue (soln B). The plates were 
taped up as before and 4 conical flasks (3x25ml and Ix 250ml) were labelled 1 to 4. 
The following mixes were set up:
Flask 1 : 6 ml of B
Flask 2 : 4ml of B and 2ml of A
Flask 3 : 2ml of B and 4ml of A
Flask 4 : 70ml of A
Flask 1 was polymerised with ; 1 1  pi 25% APS andj 11 pi TEMED and poured directly 
into the plates and allowed to settle. The same was repeated for flasks 2 and 3, care 
being taken not to disturb the layer below. Finally flask 4 was polymerised with 150pl 
APS and 150pl TEMED and poured into the top and the plates clamped as before. 
The gel was then used in the same way as the standard system (this time using the BRL 
40x40cm plate system) and 250bp could be read off 1 track.
2.6.3 Automatic dideoxy sequencing using dye labelled primers.
The use of fluorescent dyes to label the primers used in the sequencing reaction allowed 
for the rapid automation of the protocol and by using a different dye for each primer it 
was possible to multiplex the samples; i.e. run all 4 reactions in the same lane. The 
sequencing machine used was the ABI 373A (sequencer ver 1.8, analysis program 1.2)
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and the work was performed at the Glaxo Institute for Molecular Biology, Geneva, 
Switzerland.
There was a choice of using dye-primers or dye-terminators in the system and it was 
decided to use primers as these gave a better sequencing range as well as being a 
cheaper alternative. The dye primers used are shown in Table 2.2.
The F AM and JOE primers were floresceine based while the TAMRA and ROX were 
rhodium based. The signals from the latter pair were not as strong and it was therefore 
necessary to double up the reagents in the G and T reactions so that the final signal 
strengths are comparable.
2.6.2.1 Sequencing Reaction
The sequencing protocol was also radically different to the one previously used (ie the 
Sequenase di-deoxy system) and was based around Amplitaq polymerase in a process 
known as taq-cycle sequencing. Rather than a separate elongation and termination step 
both reactions were performed simultaneously using a PCR-like cycling which allows 
for an amplification effect. The reaction was performed over 35 cycles and so it was 
possible to get multiple copies from each plasmid which meant that less template DNA 
was required when compared to the Sequenase system (1-2 cf. 3-5pg).
The protocol for the reactions is given below. If several samples were to be sequenced 
with the same primer it was better to mix the reagents in bulk first and then add them to 
the plate. The protocol below is for 24 samples sequenced with the same primer 
though enough reagent for 25 reactions was made up to allow for pipetting 
inaccuracies. For the reasons listed above the volumes were doubled in the G and T 
tubes.
4 eppendorfs were labelled 'G, ‘C, 'A' and'T' and into each was put 25 pi d/ddNTP mix, 
25pi Dye primer, 25pi 5X cycle sequencing buffer 12.5pi Amplitaq (8 u/ml) was 
Diluted in 137.5pl H2 O and 25pl of this mix added to each of the tubes.
A 96 well U-bottomed microtitre plate ( Falcon 3911 MicroTest III Flexible assay 
plate) was divide up into the 4 lanes (order unimportant) and into the bottom of each 
well was pippetted 4pl (or 8 pl) of the mix. Ipl (x2 for G & T) of DNA template was 
pipetted on the side of each well and the contents mixed by spinning 1 0 0 0  rpm for 2 . 
mins (Beckman J6 B with swing-out plate carrier).
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d/ddNTP DYE NAME EMMISSION X (nm)
A FAM 540
C JOE 560
G TAMRA 580
T ROX 610
Table 2.2 Dyes used in Automatic sequencing.
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A drop of mineral oil (Sigma) was applied to each of the wells to prevent evaporation 
of the sample during cycling and covered with a lid. The plate was put onto thermal 
reactor (PTC 100 MJ Research Inc) and program 'TC-373' selected which had the 
following profile:
15 cycles of 95°C/30 secs, 55°C/30 secs, 70°C/1 min.
20 cycles of 95°C/30 secs, 70°C/1 min.
(if running overnight then final step 4°C/16 hrs).
After run had finished the plate was covered in foil (the dyes are light sensitive) and 
stored at 4°C until required.
The 4 reactions for each template were pooled into a single tube and centrifuged briefly 
to separate the 2  layers (aq and oil). The bottom, aqueous layer was carefully removed 
to a fresh microcentrifuge tube and care was taken not to transfer any oil. 5pi of 3M 
NaoAc and 80pl 100% Ethanol were added and the tubes spun at 15,000 rpm for 20 
mins at room temperature.
The pellet was washed with 250pl of 70% Ethanol and re-spun for 10 mins. The 
supernatant was removed and dried under vacuum for 4-5 mins (care was taken not to 
dry the pellet completely as this hindered resuspension). The pellets could then be 
stored in this state at -20°C until ready to electrophorese on a gel.
2 6 3 2 Gel Preparation
As the detection system for the automatic sequencing relied on accurate laser optics the 
glass plates between which the gel was poured had to be fi'ee of optical imperfections 
and thoroughly cleaned before use. Lint free lens tissue was be used for this purpose 
The protocol for the gel preparation is as follows:
The acrylamide stock (7%) was prepared in advance and could be stored up to 3 days 
at 4°C. If more than 1 gel was to be run in this period it was made up in bulk. For 4 
gels (400ml total) 184g Urea was dissolved in 70ml 40% acrylamide:bis acrylamide 
(19:1 (v/v)) and 130ml water. Once the solution cleared (could be facilitated by 
heating to 37°C) Ig of Amberlite deionising resin was added and left mixing for Ihr. 
The mix was then filtered (Millipore 0.22mm ), 40ml lOx TBE added and the vol made 
up to 400ml with sterile water.
Both plates were cleaned with Alcanox powder (a non-abrasive detergent which did not 
smear and therefore did not leave residues that would affect the optical properties of
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the plates), and rinsed in distilled water. The plates were taped up with side spacers 
(cut section at the top).
100ml 7% acrylamide stock was polymerised with 140pl 25% APS and 60pl TEMED 
and poured into the plates avoiding the formation of bubbles. The well former was 
inserted and the edges clamped with bulldog clips (care was taken not to scratch the 
read window).The plates were left 2  hours at room temperature for the gel to set.
Once the gel had set both plates were cleaned with Alcanox to remove any acrylamide 
residue that may have leaked during the pouring. The tape was removed and the slot 
wash out with distilled water,
2.6.3.3 Automated sequencer set-up
As the sequencer required a large amount of computer memory to run the programmes 
and to store the sequencing data it was necessary to select only the essential operating 
systems and this was done via the INIT picker function on the Mac 'control panel' 
menu. This freed up the memory.
The gel was put into the machine and the pre-run/plate check option was selected on 
the sequencer's control panel. This checked that there were no optical imperfections in 
the gel (caused by bubbles, scratches or smears). If a problem was detected it was 
cleaned off or the lane was left empty. The top tank was then positioned and the gel 
clamped into place using a cross piece with the lanes marked on it for easy 
identification. The sharks tooth comb was then inserted and the buffer tanks filled with 
IX TBE. The wells were washed out and the bottom of the gel cleared of any bubbles 
that may have become trapped there. The Gel was then pre-run for at least 45 mins 
with the scanner switched off.
The DNA pellet was re dissolved in 4pl of deionised fbrmamide/5OmM EDTA (pH 8.0) 
5:1 (v/v) and shaken for Ihr to ensure complete resuspension.(samples can be stored at 
-70°C at this point) Immediately prior to loading the samples were heated to 90°C for 2 
mins to denature the DNA then loaded onto the pre-run gel. To allow the detector to 
distinguish the lanes, the odd numbered lanes were loaded first, the gel run for 5 mins, 
the wells flushed out, and then the even numbered lanes were loaded. The gel was run 
at a constant 30W (approx. 1400V, 30mA depending on gel) for 12hrs with the data 
collection package open on the Mac program. Once the run was complete the 
sequences were analysed automatically. If there is a problem with the lane assignment 
it was necessary to retrack and re-analyse the lane. Once the sequences had been 
analysed they were transferred to the mainfi’ame computer system where they were 
assembled and further analysed.
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2.7 LONG RANGE DNA SEQUENCING
The sequencing methods described above are very effective but had a maximum 
accurate range of 350 - 400 bp, after which the bands become difficult to resolve or the 
signal is too weak. For inserts of greater than about 600bp this is obviously a limitation 
and it is a usual requirement that a sequence should be read completely on both strands 
before it can be published. There are three ways of overcoming this problem:
a) Oligonucleotides can be synthesised corresponding to regions found near the end of 
the sequence read fi’om the conventional primers. These can then be used as primers 
for the sequencing of the next 300 bases. The disadvantages of this system is that each 
oligonucleotide will have its own annealing temperature which has to be determined for 
each one. Also a new oligonucleotide has to be made for each 300bp and this can add 
up to a lot of oligonucleotides required to sequence an insert of any significant length.
b) The insert can be shortened using restriction enzyme sites near the end of the known 
sequence to excise the part already sequenced and then re-ligating the shortened 
plasmid. This is not really practical as there are not always suitable enzyme sites to do 
this and it requires the re-ligation process to be performed every 300 bases.
c) The insert can be shortened with an exonuclease from one end while it is still 
attached to the plasmid at the other. This is a procedure known as nested deletions and 
has the advantage that the plasmid can be easily recircularised without the need to do re 
screening. This is the method of choice and is performed using the Erase-A-Base 
deletion kit (Promega Ltd).
2.7.1 ERASE -A BASE NESTED DELETION SYSTEM
The Erase-a-Base system is based around the exonuclease Exo III which digests DNA 
single-strandedly in the 3' to 5' direction. The enzyme will digest DNA that has be cut 
with a restriction enzyme which leaves a 5' overhanging or blunt sticky end but it will 
not digest from a 3' overhang. This allows the direction of the digestion to be 
controlled. The reaction is temperature dependant (90bp/min at 25°C rising 25bp / min 
/°C) and so the rate of the digestion can also be controlled. ( See Figure 2.9).
The protocol described below uses a microtitre plate on a thermal cycler for the 
incubations as it is easier to control the temp, changes. The protocol is just as 
effective using tubes and water baths. All buffers and mixes are listed in the Promega 
protocol.
20pg of plasmid was cut with 2 restriction enzymes; a 3' overhanger closest to the 
primer site to protect it and a 5' overhanger or blunt ender close or just inside the insert
65
I
§
600 -
c5 500
CL
400 -
I 300 -
200 -
.D) 100
»45°C
{600bp/min)
»37°C
(450bp/min)
(25bp/min)
'30“C
(210bp/min)
'25°C
(90bp/min)
22°C
(80bp/min)
10 20 30 40
Temperature (°C)
50
Figure 2.9 Relationship between temperature and rate of deletion for the ExoIII 
deletion reaction (taken from Promega Erase-a-base protocol).
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from which the Exoin digests. If there were no suitable 3' overhangers near the primer 
then a 5' overhanger could be used and the resultant sticky end filled in with a- 
phosphorothioate dNTPs (sulphur containing analogues of the normal dNTPs which are 
resistant to Exo HI digestion) See Table 2.3.
Because the ExoIII will digest any 5’ overhangs it will also work on nicked DNA and 
give deletions in the wrong place. The Plasmid was therefore prepared fresh using the 
Qiagen midi protocol and was used directly as freezing can cause the nicks.
The double cut DNA was extracted from the digest using the standard Phenol/CHCl] 
and ethanol method. The pellet was resuspended in 60pl of dH20 and 6 pl of this run 
on a 1% agarose gel to check cutting and resuspension. 6 pl of lOx ExoIII buffer was 
added to the remaining 54pl of DNA and the tube is incubated at the selected deletion 
temperature (waterbath or heating block).
A 96 well microtitre plate was marked up with the number of timepoints required (each 
reaction can delete 24 timepoints) and into each well 7.5pl of SI nuclease mix was 
added. This was placed on the PCR machine which had been precooled to 4°C.
Once the DNA tube has equilibrated at the reaction temp a 2.5pl aliquot was taken and 
mixed in the first well of the plate. This is the to time point and is a control for the 
DNA prior to the addition of the enzyme. If the separation between the 2 restriction 
enzymes used for cutting is high this to sample is a good start point for the sequencing.
2.5pi of ExoIII (150u/pl ) was then added to the DNA tube, mixed by pipetting and 
the timer started. After 30secs the tube was mixed by pipetting and a 2.5pl aliquot 
transferred to the next well on the plate and the contents mixed thoroughly. This 
process was repeated until the required number of time-points had been taken (up to a 
maximum of 24). The SI mix contains ZnS0 4  which stops the ExoIII from further 
deletion. The plate was then removed to RT where it is incubated for 30mins. This 
allows the SI nuclease to digest away the resultant single strand left after the Exo 
digestion and thus blunt end the digested end. The SI was stopped by the addition of 
Ipl stop solution (TE), sealing the plate (to stop cross-mixing by evaporation) and 
heating it to 70°C (PCR).
The plate was spun down to ensure none of the reactions were lost through 
evaporation and 2pl aliquots from each were run on a 1% agarose gel containing EtBr 
(for a quicker result). As well as the marker ladder a linearised sample of the original 
plasmid was run at 1 side of the deletion series and linearised pGEM at the other. This 
gel shows the extent of the deletion in each timepoint and can also detect any problems 
in the original digests.
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If the reaction worked correctly then a single band should be present in each lane, 
arranged in a descending series. By comparison to the pGEM marker it was possible to 
reject the clones that had deleted all the insert and into the vector thus cutting down the 
number of clones processed. If the 3' cutter has failed to work then the deletion would 
go both ways from the 5' site and the bands descend twice as fast as expected. In this 
case the clones was abandoned as the primer site will have been deleted. If the 5' cutter 
failed to work there was a band the same size as the original parent (plasmid + insert) 
and this did not descend across the time points. If these bands occurred along with the 
correct deletions it was possible to screen these out by back selection before the 
ligation stage.
The plate was replaced on the PCR (37°C) and allowed to equilibrate. The 3' overhang 
close to the plasmid was blunt ended by the addition of Ipl Klenow mix, incubation for 
3 mins followed by the addition of Ipl dNTPs. After a fiirther 5' at 37°C the plate was 
removed to RT, 40pl Ligase mix added and the reaction left for Ihr.
If an undeleted band did show on the gel, 20pl of each sample was digested with an 
enzyme that cuts between the 2 original enzymes. The deleted plasmids lacked this site 
and so remained circular while the parent was linearised and thus would not be viable 
for transfection. This was especially useful for the first few time points that were close 
to the parent size. The reaction is sumarised in Figure 2.10 .
20pl of the ligation/digest was transfected into 20pl competent cells, plated out onto L 
Agar/Amp (50pg/ml) plates and grown up overnight. The following day 4 colonies 
from each plate were restreaked onto 4 master plates and grown up overnight to give a 
working stock of the plasmid. The clones were cracked as before, using uncut parent 
and pGEM as the top and bottom markers. Any clones within the range are picked into 
20ml LB/Amp and grown up overnight.
These plasmids were then sequenced as before using the primer to the site that had 
been protected. It was possible to sequence large inserts in this fashion and by 
selecting restriction enzymes at the other end of the multiple cloning site it was possible 
to repeat the process for the reverse strand.
If there were no suitable enzymes at the other ends of the multiple cloning site and the 
insert had the same restriction site at both ends, the insert was ’flipped'. 5pg of the 
plasmid was digested with the insertion enzyme and the DNA extracted with 
Phenol/CHCls. The insert and vector were then religated and retransfected into 
competent cells, and the resulting plasmid digested with an enzyme which cuts 
asymmetrically in the insert thus giving an indication of the orientation. Theoretically
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Figure 2.10 Summary of Erase-a-Base protocol (Taken from Promega Handbook).
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the plasmids with inserts should have an even distribution of orientations and the 
desired flip could be selected.
2.8 SEQUENCE ANALYSIS
The analysis of the sequence data was too complex to be done by eye or on paper and a 
sequence analysis package was required. The manual sequencing performed at Surrey 
was analysed on the Microgenie package (Beckman Ltd) run on a PC. The automated 
sequencing data was analysed on the GCG package [Dervereux et al 1984] run on a 
VAX mainframe. Both systems are described here.
2.8.1 Microgenie
The DNA clones were sequenced 3 or 4 times until a consensus of the sequence was 
determined. This was then entered onto the Microgenie analysis program. This was a 
versatile system which allowed comparison of sequences and the location of sites within 
them. The program could also determine the protein sequence coded for by the 
consensus and thus indicate any sites of interest such as start and stop codons.
Once the consensus sequences had been determined they were sent, via a modem link, 
to the central sequence database at Daresbury where they were compared to the EMBL 
and GENBANK databases which contain all the published sequences reported world­
wide. Via this link it was also possible to search and retrieve sequences from the 
database to use on the Microgenie software package. The main problem was that the 
link to Daresbury was via 3 other computers and so the results took up to a week to 
return.
2.8.2 GCG Package
This was used in Geneva and had several advantages over the Microgenie system. 
Firstly the sequencer was networked to the system so the sequences generated could be 
transferred directly. The analysis packages gave greater freedom due to the increased 
memory size of the system and several comparisons and searches could be run 
simultaneously thus speeding up the work. The main advantage was that the package 
contained the same databases as Daresbury and so direct interaction was possible thus 
speeding up the searches.
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CHAPTER 3
CHARACTERISATION OF HUMAN CYP4A CLONES HG6
AND HG19
CHAPTER 3 CHARACTERISATION OF HUMAN CYP4A CLONES 
HG6 AND HG19
3.1 INTRODUCTION
The experimental work described in this chapter is an extension of the work started by 
Dr. C McGeoch in this laboratory. A human genomic library contained in the X 
Charon 3a vector was screened using the rat CYP4A1 cDNA probe. One positive 
recombinant clone was obtained from this library which yielded 2 BamHI fragments 
which were detected by the probe. These were designated HG6 (2.7kb) and HG19 
(1.4kb) and subcloned into the plasmid vector pUC9.
In order to proceed further it was necessary for me to characterise these DNA 
fragments and answer the following questions :
a) Were the DNA fragments truly related to the rat CYP4A1 cDNA sequence?
b) Did these genomic DNA sequences contain part of the 5' non coding region 
of the human CYP4A gene othologues?
c) How much sequence similarity existed between the human and rat genes?
d)Was the DNA sequence more similar to rat CYP4A1, CYP4A2 or CYP4A31
e) How many related genes were present in the human genome and was it 
possible to detect any restriction fragment length polymorphisms in a small population?
3.2 CHARACTERISATION OF THE HG6 AND HG19 CLONES BY 
SOUTHERN BLOTTING
3.2.1 PLASMH) PREPARATION AND DIGESTION
HG6 and HG19 plasmid DNA was prepared by Qiagen tip 100 preparations (section 
2.5.6) and the DNA concentration determined by absorbance at 260nm (section 2.2.5). 
Both of the clones had been inserted into the BamHI sites of the pUC9 plasmid vector 
and this enzyme was therefore used to release them again.
On digestion with the BamHI it became apparent that while the 1.4kb HG19 DNA 
insert was easily resolved from the 2.7 kb pUC9 DNA band on the agarose gel, the 
HG6 and pUC DNA bands co-migrated at a fragment size of 2.7kb. This was a 
problem as a pure 2.7kb HG6 insert fragment was needed for further mapping work. 
It was therefore necessary to find an enzyme which could cut the plasmid vector
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further but not digest the insert. Several enzymes were examined and Pvul was 
selected since it was active in the same buffer as BamHI. Pvul cut the pUC9 vector 
DNA into 2 fragments of 1.8 and 0.9kb which electrophoresed separately from the 
HG6 band.
3.2.2 SOUTHERN BLOTS OF HG6 AND HG19
In order to determine the location of the DNA sequences in HG6 and HG19 in relation 
to that of the rat CYP4A1 cDNA, Southern blot experiments were performed on 
BamHI or BamHI + Pvul cut DNA using a radiolabelled CYP4A1 cDNA probe. As 
HG6 and HG19 had been isolated following library screening with the full length 2.1 kb 
rat CYP4A1 cDNA probe it was expected that both of the human DNA fragments 
would contain sequences similar to the coding regions of the rat gene. To determine 
whether the human DNA fragments were from the 5' or 3' ends of the gene a second 
cDNA probe corresponding to the first 600bp of the rat cDNA was used. If the 
fragments were from the 5' end of the gene, they would hybridise to both cDNA 
probes while 3' located DNA fragments would only hybridise to the full length 2.1kb 
rat cDNA probe.
500ng of each of the 2.1 kb and 600bp probes were labelled separately with [^^P]dATP 
using the Multiprime process and the filters were hybridised as described previously 
(section 2.2.8.3). The filters were washed to high stringency (O.lxSSC / 0.1%SDS / 
55°C) and exposed to autoradiography for 48hrs.
The resultant autoradiograph (figure 3.2) showed two important features. First both 
of the probes had some contamination with pUC (the vector in which the probe is 
inserted) although this did not effect the results of the experiment. Secondly neither 
the HG6 or the HG19 inserts hybridised to the 600bp (5' specific) probe. The filter 
probed with the full length 2.1 cDNA shows a 2.7kb band in lane 4 and a 1.4kb band in 
lane 7 which were absent from the filter probed with the 600bp probe. This indicated 
that the clones originate from the region of the human CYP4A gene which does not 
hybridise to the 600bp probe.
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LANE DNA ENZYME(S) PREDICTED BAND 
SIZES (Kb)
1 X Marker Hindm see section (2.2.1)
2 empty
3 HG6 BamHI 2.7 (x2)
4 HG6 BamHI + Pvul 2.7, 1.6+1.1
5 pUC9 BamHI + Pvul 1.6+ 1.1
6 empty
7 HG19 BamHI 2.7+ 1.4
8 empty
9 X Marker Hindm see section (2.2.1)
Table 3.1 Southern blot analysis of HG6 and HG19. Lane contents of the gel in 
Figure 3.1.
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23.7Kb
9.7
6.7
4.3
2.3 
2.0
Figure 3.1 Agarose gel of HG6 and HG19 digests (as described in Table 3.1) stained 
with ethidium bromide.
+
5 4 3 5 4 3
2  7  k b
I  7  k b
6 0 0  b p 2  1 k b
Figure 3.2 Autoradiographs of Southern blots of HG6 and HG19 probed with the 
2.1kb and 600bp CYP4A1 cDNA probes. Lane numbers correspond to those in Table 
3.1.
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3.3 MAPPING OF THE HG6 AND HG19 CLONES WITH RESTRICTION 
ENZYMES
3.3.1 RESTRICTION ENZYME DIGESTS
The restriction enzymes used were selected from the known map of pUC9 and its 
multiple cloning site. The enzymes were used singly and in double digests in all the 
possible combinations. If the optimum buffers did not match the buffer chart was used 
to determine the most efficient compromise. All DNA digests were electrophoresed 
on 1% agarose gels and digested \  phage and 0X174 markers used to determine the 
band sizes. The enzymes used and their resulting restriction fragment patterns are 
shown in table 3.2. In each case 5pg of DNA was digested overnight at 37°C. An 
example of a mapping gel is shown in Figure 3.3.
3.3.2 DERIVATION OF RESTRICTION ENZYME MAPS
Using scale drawing it was possible to build up a map of the sites within the insert. 
Because the sites in the vector are known, additional DNA bands resulted from cutting 
sites within the insert. The main problem with this approach was that the accurate 
sizes of the bands were sometimes difficult to determine, especially for the larger 
fragments since the migration rate was a logarithmic fiinction of size and so the 
resolution was less clear at the top of the gel. Where the fragments had been 
accurately sized then the total of the fragment sizes were close to the size of the linear 
recombinant plasmid.
The resulting maps are shown in figure 3.4. The positions of the restriction sites are 
accurate to within lOObp and this was considered to be as accurate as required before 
the fragments were sequenced. Haell was not mapped in HG6 as the banding pattern 
was too complex to accurately locate the sites.
A comparison of these maps to published data on the rat CYP4A1 and 4A2 genes 
[Kimura et al; 1989a] did not give any real indication of the relative position of HG6 
and HG19. This was as expected as sites are not often conserved between species and 
many of the sites in the inserts probably corresponded to positions in introns which 
have an even lower conservation rate. HG6 and HG19 were therefore prepared for 
sequence analysis to determine directly the relationship between rat and human CYP4A 
genes.
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ENZYME(S) BUFFER
(ReacT)
HG6 BANDING PATTERN (kb) HG19 BANDING PATTERN 
(kb)
BamHI 3 2.7 2 .7+  1.4
BamHI +PvuI 3 2.7,1.69 + 0.98 1.69, 1.4 + 0.98
EcoRI 3 3.0 + 2.45 3.3 + 1.05
Haell 2 3.0, (2.4), 2.0 +0.4 2.1, 1.3, 0.57 + 0.35
Hindm 2 3.6 + 1.3 4.2
Ncol 3 3.25, 1.55 + 0.7 4.2
Avan 2 2.7, 1.6, 0.79 + 0.23 2.5, 1.2, 0.42 + 0.23
EcoRI + BamHI 3 2.7, 2.35 + 0.37 3.0, 1.05 + 0.39
EcoRI + Hindm 4 2.8, 1.6, 0.79 + 0.38 2.7, 1.05 + 0.42
EcoRI + Haell 3 2.35, 2.0, 0.64 + 0.38 2.1, 1.05, 0.57 + 0.39
EcoRI + NcoI 3 2.9, 1.4, 0.68, 0.48 + 0.26 3.3, 1.0 + 0.13
EcoRI + Avail 2 /3 1.85, 1.09, 0.88, 0.76, 0.5.+ 0.3 2.0, 1.1,0.46, 0.38 + 0.23
BamHI + Hindm 3 2.7, 1.55 + 1.2 2 .7+  1.4
BamHI + Haell 3 2.7,1.9,0.4,0.3 + 0.2 1.9, 1.15, 0.39, 0.32 + 0.27
BamHI + Ncol 3 2.7, 1.5 + 0.68 2.7.+.1.4
BamHI + Avail I 1.45, 1.35, 1.05, 0.76 + 0.54 1.55, 91.27), 1.08, 0.78, 0.6, 
0.47 + 0.27
Haell + Hindm 2 1.9, 1.7, 1.2 + 0.42 2.0, 1.3,0.39, 0.33 +0.27
Haell + Ncol 3 1.9,1.5, 0.68, 0.6, 0.43 + 0.42 2.3, 2.0, 1.15, 0.6, 0.41,0.25
HaeH + Avail 2 1.55, 0.87, 0.84, 0.76,0.68 +0.42 0.875, 0.8, 0.56, 0.51, 0.50, 0.39, 
0.29 + 0.24
Hindin+ Ncol 3 3.0, 0.86, 0.68, 0.66 + 0.37 2 .7 + 1 .6
Hindlll+ Avail 2 1.55, 1.4, 1.2, 0.76 + 0.51 1.45, 1.15, 0.8, 0.47 + 0.23
NcoI+ Avan 2 /3 1.7,1.3,1.0, 0.54 + 0.25 2.15, 1.05, 0.46 + 0.23
Table 3.2 restriction fragments obtained from HG6 and HG19 DNA. Buffer column 
refers to BRL buffers. Figures in brackets indicate partial digestion products.
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12 11 1 0 9 7 6 5 4 3 2
4.3kb
2.3
2.0
1.35
1.07
0.87
0.6
0.31
LANE ENZYME / MARKER
2 BamHI +HindIII
3 BamHI +HaeII
4 BamHI +NcoI
5 BamHI + Avail
6 Haell +NcoI
7 Haell +HndIII
9 Haell +AvaII
10 Hindlll + Ncol
11 Hindlll + Avail
12 Ncol + Avail
Figure 3.3 Restriction enzyme mapping gel of HG6. Lanes are as indicated in the 
table. Lanes 1 ,8  13 contain a mixture of X and 0X174 markers. (For reasons of 
clarity the bands above 4.3kb and below 0.3 Ikb are unlabelled.).
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HG_6
Eco Nog
Bam Nco A va Nco A va Hind
2.7 kb
HG 19
Bam
Ava Ava Eco Mae Bam
1.4 kb
Figure 3.4 Deduced maps of HG6 and HG19 inserts from the restriction fragment data 
(Table 3.3).
(Bam = BamHI, Eco = EcoRI, Ava = Avail, Hae = Haell, Nco = Ncol, Hind = Hindlll)
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3.4 PARTIAL DNA SEQUENCING OF HG6 AND HG19
3.4.1 STRATEGY
The HG6 and HG19 clones had both been inserted into the multiple cloning site of 
pUC9 and so could be sequenced with the Ml 3 universal and reverse primers supplied 
as part of the Sequenase sequencing kit. As discussed previously (section 2.6.1) this 
system was effective for sequencing 300-350bp from the primers without the need for 
extra oligonucleotide primers or deletion techniques. It was decided that this would 
give sufficient sequence data for a comparison to be made against the other published 
CYP4A genes and thus give some positional information for HG6 and HGl 9.
At the time that this work was performed there were 8 published CYP4A sequences. 
The gene sequences for CYP4A1 and 4A2 [Kimura et al  ^ 1989a] and the cDNA 
sequences for CYP4A3 [Kimura et al, 1989b), CYP4A4 [Matsubara et al, 1987], 
CYP4A5-7 [Johnson et al, 1990] and CYP4A8 [Stromstedt et al, 1990] were obtained 
from the Daresbury-EMBL database and downloaded onto our Microgenie system. 
They were then be compared directly with the sequences obtained from HG6 and 
HGl 9.
3.4.2 DNA SEQUENCING OF HG6 AND HG19
The 2 clones were sequenced as described (section 2.6.1) using p^S] dATP and the 
Sequenase system. The clones were sequenced three times with each primer and the 
resulting sequencing gels were read by two different people to check for reading 
errors. The individual sequences were then typed into the Microgenie database and 
consensus sequences generated for each strand. This was achieved by comparing all 
the sequence data from the same clone and primer and checking any differences back 
to the original autoradiographs. The consensus for HG6 sequenced using the universal 
primer was designated HG6UC and that with the reverse primer designated HG6RC. 
HG19UC and HG19RC were the corresponding consensus sequences for HGl9.
As the HG6 and HGl 9 inserts have the same BamHI site at each end it was not 
possible to determine the orientation of the sequences in relation to the original gene. 
Also the reverse primer read the sequence on the opposite strand to the universal and 
so one of the sequences for each of the clones was reversed and in the anti-sense 
direction. It was therefore necessary to generate the complimentary strand for each of 
the consensus sequences for use in the analysis work. This was done using the 
‘Transform’ option in the ENTER section of the program. The transformed sequences 
were designated HG6UCT, HG6RCT, HG19UCT and HG19RCT respectively. These 
sequences were used in the comparison programs.
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3.4.3 ANALYSIS OF HG6 AND HG19 PARTIAL SEQUENCES
3.4.3.1 Restriction sites
The consensus sequences were analysed for restriction sites using the ‘sites’ option in 
the ANALYSIS section of the Microgenie program. Figure 3.5a-d shows the GCG 
version of this data. In the HG19UC sequence the Ncol site predicted by the mapping 
could be seen 20 bases from the BamHI site at the 5' end of the insert. No additional 
sites for the enzymes used in the mapping were detected in the sequences confirming 
the results of the digestion experiments.
3.4.3.2 Matrix comparison of HG6 and HG19 to C YP4A1  and 4A 2
The four consensus sequences and their transformed strands were compared to the 
gene sequences of CYP4A1 and 4A2 using a graded series of tests. To obtained a 
crude location for the consensus sequences the ‘Matrix’ option was used. This was an 
algorithm which compared two sequences and plotted matches with the query 
sequence on the Y axis and the target sequence on the x axis. The parameters that 
decided a match could be pre-determined and a continuous line indicates a region of 
good homology. The results are shown in Figure 3.6a-h. From this data the following 
initial conclusions were drawn:
a)HG6 and HGl9 had significant DNA sequence similarity to CYP4A1 and 4A2 
and should therefore be analysed further.
b) Because HG19RC and HG19UCT both showed similarity with the CYP4A1 
and 4A2 genes the insert must have been reversed in the vector relative to the 5'- 
3'orientation of the gene in human DNA. No comparable homology was detected for 
the HG19RCT and HG19UC sequences when compared under the same conditions 
(data not shown). The same conclusion was made for the HG6 clone as HG6UCT and 
HG6RC showed good similarity while HG6UC and HG6RCT did not (data not 
shown).
c) From the areas of similarity HGl 9 originated from a region of the human 
gene closer to the 5' end than HG6. Also the start of HGl 9 was outside the region 
hybridised by the 600bp rat CYP4A1 cDNA probe thus confirming the results obtained 
by Southern blotting.
d) The HG6 fragment probably contained the exon sequence for the haem- 
binding region which encodes a highly conserved cysteine residue as it shows sequence 
similarity to the corresponding region in the CYP4A1 gene.
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Figure 3.5a Sequence of HG6UC showing enzyme sites (BamHI insertion site 
underlined).
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Figure 3.5b Sequence of HG6RC showing enzyme sites (BamHI insertion site 
underlined).
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Figure 3.5c Sequence of HG19UC showing enzyme sites (BamHI insertion site and 
Ncol site underlined)
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Figure 3.5d Sequence of HG19RC showing enzyme sites (BamHI insertion site 
underlined)
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Figure 3.6 e-h Matrix plots of HG6RC and HG6UCT vs CYP4A1 and 4A2
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The consensus sequences were then compared at a nucleotide level for the best 
alignment between them and the rat genes. The computer automatically inserted gaps 
to make the alignments better. The sequences were aligned and a score of 
matches/length calculated and the results displayed as a visual comparison, Figure 
3.7a-h.
The overall similarity (intron and exon) indicates that the human gene fragments were 
more similar to CYP4A1 (61%) than to CYP4A2 (54%). This greater similarity is bom 
out by the alignment data. For HG6 and HG19 to correctly align to CYP4A2 they 
would have to overlap by 50bp while for CYP4A1 they would be separated by 5 bases, 
complimenting the homology data. This is shown in Figure 3.8. However a better 
comparison of the genes came from the exon to exon similarity when the exonic 
regions were identified.
Using the published sequences of CYP4A1 and CYP4A2 as a guide exons 8 to 12 
were identified. HG19RC contains the 3' end of exon 8 and the whole of exon 9; 
HG19UCT contains the whole of exon 10; HG6RC contains exon 11 and HG6UCT 
contains most of exon 12 (except the last 30 bp) The exons are marked as boxes on 
Figures 3.7 a-f.
3.4.3.4 Deduced amino acid sequence similarities between exons in HG6 and 
HG19 and other members of the CYP4A family
Having identified the exonic sequences of the human gene fragments these were 
translated into the amino acid code. This was a better format for comparison as it 
accounted for degeneracy in the nucleotide sequence that did not effect the final 
polypeptide sequence. Using the deduced amino acid sequence it was also possible to 
compare HG6 and HG19 with members of the CYP4A family whose cDNA sequences 
were published, CYP4A3-8^ and therefore to species other than rat.
As expected the amino acid sequence was well conserved around the haem-iron 
liganding cysteine residue in exon 12 (Figure 3.9). The amino acid similarities for the 
other exons are summarised in table 3.4. The intronic (nucleotide) sequences of 
CYP4A1 and 4A2 were also compared with the human intronic sequences to determine 
similarity in regions that are less conserved across species. (This data is shown in 
Table 3.4). Further analysis of these sequences is discussed in Chapter 6.
8 8
Length: 248, Gaps: 5, Percent Similarity: 73.516 Percent Identity: 65.297
1 . . . 6CAGGTCGACGGATCCTCTATACTCT6GCCACACACCCCAAGCATCA 47
I I I  II III II III I! II11 I! II II II I! 11 I I II E X O N  8
8 1 9 0  AGTGGAGTCTCCTGGATCTTCTATGCTCTGGCCACACACCCTGAGCACCA 8 2 3 9  
48  XGXGAGGXXCXG.XAGGAGATCCACAGCCTCCTGGGTGATGGAGCCTCCA 96
: : II : :  I: 1 : 1 1  I I I II II I I I I I I I  I I I I I I I I I I I E X O N  8 
8 2 4 0  ACAAAGATGCAGAGAGGAAGTTCAGAGTGTCCTGGGGGATGGGTCCTCCA 8 2 8 9
97  TCACCTGGTGAGTGATGGGCTCAAAAGATGGGGTTCCCTGCCTTCTCCAC 1 4 6
I I I I I I I I  I! I I I II I I I  E X O N  8
8 2 9 0  TTACCTGGTAAGAGTTCAAGTAGAA GTGCCC 8 3 2 0
1 4 7  XXXXXCCCCTGGTCTXCCCAXXCCTTXCTGGTXTTCAGGATGGA.ATTGT 1 9 5  
: : : : : |  I I I I I : I ::  II : | l l  : |  II I I I I I I I
8 3 2 1  TTATTCTTTGGGTCTCC.. .AGTCTACCTGACCTCCACATTGGACTTTAT 8 3 6 7
1 9 6  TTCCCGAACCACCTGGCCCAGATXCCCTACXCCACCTATGTGCACCA. 2 4 2
I I I I I I I I I I I I  l l l l l l : | | | | l | : | | | | |  Mi l l  I II E X O N  9
8 3 6 8  TTCAGGGATCACCTGGACCAGATTCCCTACACCACC.ATGTGTATCAA 8 4 1 4
a) Alignment of HG19RC to CYP4A1
Length: 253, Gaps: 4, Percent Similarity: 71.622, Percent Identity: 63.514
1 ......................GCAGGTCGACGGATCCTCTATACTCTGGCCACACACCCCAAG 42
I I  I I I  Mi l l  1111111111 11111 M E X O N  8
7 2 6 4  CAGCCAGTGGAATCTCCTGGGTTTTCTATGCTCTGGCCACCCACCCTGAG 7 3 1 3  
43  CATCAXGXGAGGXXCXG.XAGGAGATCCACAGCCTCCTGGGTGATGGAGC 91
II i i : | : l l l  : : | : |  M U M  I II III I I I I I I I I I I I I I I E X O N  8
7 3 1 4  CACCAAGAGAGATGCAGAGAGGAGGTGCAGAGCATTCTGGGTGATGGAAC 7 3 6 3  
92  CTCCATCACCTGGTGAGTGATGGGCTCAAAAGATGGGGTTCCCTGCCTTC 1 4 1
T m I I I I  I I I I I I I  I I I I  I E X O N  8
7 3 6 4  CTCTGTCACATGGTGAG....................... ..  . AACCATTCATCTGTCTTCTT 7 4 0 0
1 4 2  TCCACXXXXXCCCCTGGTCTXCCCAXXCCTTXCTG.GTXTTCAGGATGGA 1 9 0
: : : : : | |  I I I I I I I : I I I I : : I : II I : I I I II I I I I I I
7 4 0 1  AAAGGAGAGACCTCTGGTCTGCCCAGATTTGTGTGACTCTTCAGGATGGA 7 4 5 0  
1 9 1  .ATTGTTTCCCGAACCACCTGGCCCAGATXCCCTACXCCACCTATGTGCA 2 3 9
II I I I I I II II II II I 111111: 11 II I: II II II II II II I E X O N  9
7 4 5 1  CTTTATTTCAGGGACCACCTGGACCAGATGCCTTACACCACCTATGTGCA 7 4 9 6
b) Alignment of HG19RC to CYP4A2
Figure 3.7a-b Alignment of HG19RC to CYP4A1 and CYP4A2 . The position of 
exons 8 and 9 are underlined.
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Length: 301, Gaps: 2, Percent Similarity: 61.724 Percent Identity: 61.724
1 . GGAAGTAGGCTTTTGGGC. . . CTTCTTTTGTGCTGCTGGCTGAAGTACC 46  
II I I I I I I I  I I I  I I I I I I I I I I I I I I 
1 0 7 7 0  GCACCCTAACCTCTTGTGCAAACGTATCATTCCCTGCTGTCTCAGGAACC 1 0 8 1 9
47  AGG..CCACCCCATGCA7VATGATTGGTCTTCTCTCTGTTTCCAACCTGCA 94  
I I  III II I I  I I I I I I I I I I I I I I I I I
1 0 8 2 0  AAGGAGTCACCCCTGGGTGTAACCCATCTTCTCTCACATTTCTATCTGCC 1 0 8 6 9
9 5  CCACAGGTATCATGGTCCACCTCTCCATTTATGGCCTTCACCACAACCCA 14 4
I I I I I I I I I I I rn I I I I Ml  I I I I I I I II I I I I I I I I I I I E X O N IC
1 0 8 7 0  CCACAGGTATCCAAGTCACACTCTCCATTTATGGTCTCCACCACAACCCG 1 0 9 1 9  
1 4 5  AAACTCTGGCCCAACCCAGAGGTATGTGGTCCTTGAGAGGAGGAAATGAG 19 4
M I I I I I I I I I I I I I I I I I I I M l I II II I I I I E X O N IC
1 0 9 2 0 AAGGTGTGGCCAAACCCAGAGGTAGGAGGTTCCCCCAAGGAGGGCAGAGG 1 0 9 6 9
1 9 5 GTGATCCCTCAAGACCAATACCTTCTCCTGCTTCCACCTCTGGGAGTCCT
I I I I I I I  I I I I I I I  II II 1 1 1 1 1 1 1 1 1 1 1
2 4 4
1 0 9 7 0
I I I I I I I  I I I I I I I  II II 1 1 1 1 1 1 1 1 1 1 1 
AGTTGGTCTCAAGATCAATACCACCTATTGTCCCCACCTCTAGGCACATT 1 1 0 1 9
2 4 5 GTCCCCCATGGGTGGCAAGTAGGTGCTGGATCCCCGGGAATTCACT. . . .  
l i l t  1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 i l l
2 9 0
1 1 0 2 0
1 1 1 1 II II 1 1 1 1 1 1 1 1 1 II I I II 1 
GTCCATTGTGAGTTGCAAGCAAGGGTTTGACCTCTATCTATCCTGACTGA 1 1 0 6 9
c) Alignment of HG19UCT to CYP4A1
Length: 295, Gaps: 2, Percent Similarity: 51.748 Percent Identity: 51.748
1 GGAAGTAGGCTTTTGGGCCTTCTTTTGTGCTGCTGGCTGAAGTACCAGGC 50
I I I I  I I I I I I I I I I I I I I I III
9 4 8 0  ATAGTTGGGTCCTCGGGTAGTTCAATGTCCAATTTTCTGAGGAACCTCCA 9 5 2 9
51  CACCCCATGCAAATGATTGGTCTTCTCTC. . . TGTTTCCAACCTGCACCA 97  
II I I I I I I II I I I I I I I III I III 
9 5 3 0  GACTGATTTGACTTAATTATGTTTTACTCCATGTTTTCTCCCCTCCCCCA 9 5 7 9
98 CAGGTATCATGGTCCACCTCTCCATTTATGGCCTTCACCAÇAACCCAAAA 14 7
I I III M II Til n  MM I I I I  I I I I  I II I I I I I I I  E X O N IC
9 5 8 0  CAGGTATCAGAGTCACAATTTTAATTTATGGTCTTCATCATAACCCAAGT 9 6 2 9  
1 4 8  CTCTG6CCCAACCCAGAGGTATGTGGTCCTTGAGAGGAGGAAATGAGGTG 19 7
I I I I I  I I I I I I I  I I I I I I I  III I II I I I II E X O N  1C
9 6 3 0  TACTGGCCAAACCCAAAGGTATGAAAGCCTGGGGAAGAGTGAAGACTCAC 9 6 7 9
1 9 8  ATCCCTCAAGACCAATACCTTCTCCTGCTTCCACCTCTGGGA..GTCCTG 2 4 5  
I I  I I I I II I I I I I I I I I
9 6 8 0  TCAGTTGCAACTTTAAGCATTCTGTATTCTTTTGCGTTGGAAATGGGCTT 9 7 2 9  
2 4 6  TCCCCCATGGGTGGCAAGTAGGTGCTGGATCCCCGGGAATTCACT 2 9 0
I I I I I II II I I I II I I I  II
9 7 3 0  GACTCCATCCATGCTGGCCCTGTGCTCTCTCTGCAGGTGTT  9 7 7 0
d) Alignment of HG19UCT to CYP4A2
Figure 3.7c-d Alignment of HG19UCT to CYP4A1 and CYP4A2 showing the position 
of exon 10 (underlined).
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Length: 258, Gaps: 3, Percent Similarity: 67.511 Percent Identity: 63.713
1 ..................... AAGCTTXXTGCAGGTCGACGGATCCTTAACTATCCTGGCTCT 42
I I : :  I I I  I I I  I I I I I I I I I I
1 1 0 2 0  GTCCATTGTGAGTTGCAAGCAAGGGTTTGACCTCTATCTATCCTGACTGA 1 1 0 6 9
4 3  GGTGC. . TCTCTCTGCAGGTGTTTGACCCTTCCCGTTTTGCACCGGGXXC 90
I I I I I I I I I I I I I I I I I I I I  I I I I I I I I  I I I I  I I I I I I I : :  I E X O N  1 1
1 1 0 7 0  AGTGCTGTCTCCCTGCAGGTGTTTGACCCTTCCAGGTTTGCACCAGACTC 1 1 1 1 9
91  TGCTCAACXCAGCCAGXCTTTCCTGCCCTTCTCAGGAGGATCAXGGTGAG 1 4 0
I I I 1 1 : 1 1 1 1 1 1  :  I I I I I I I I I I I I I I I I I I I I I I I :  I I I I I I E X O N  1 1
1 1 1 2 0  TCCCCGACACAGCCACTCATTCCTGCCCTTCTCA6GAGGAGCGAGGTGAG 1 1 1 6 9  
1 4 1  ACXTCCTGTGTGGTAATTCGAATAGAGGAATGAGGGAAGTCTCCGGTCAA 1 9 0
I :  I I I I I I I I I  I I I I  I I I  I I  I I
1 1 1 7 0  ATAGCCTGTG................TATGATGATTGATATACTGTAAAGATCTTTGCAG 1 1 2 1 3
1 9 1  CCCTCTGCACTTTGTAGCCTGATGTTCATATGTGGCATCTTCAGGTGTGC 2 4 0  
I I I  I I I  I I  I I I I I I I I I I I I I I I I I I I I  I
1 1 2 1 4  CATTC CTTGGTTTTATCTCATGCATATATGGCATCTTCGGGTATAT 1 1 2 5 9
2 4 1  TCTTAXA. 2 4 7
I I I :
1 1 2 6 0  CCTGATTG 1 1 2 6 7
e) Alignment of HG6RC to CYP4A1
Length: 257, Gaps: 3 Percent Similarity: 64.732 Percent Identity: 61.161
1  AAGCTTXXTGCAGGTCGACGGATCCTTAACTATCCTGGCTC 41
: :  I I I I I I  I I I I I  m i l  I
9 7 0 0  TCTGTATTCTTTTGCGTTGGAAATGGGCTTGACTCCATCCATGCTGGCCC 9 7 4 9  
42  TGGTGCTCTCTCTGCAGGTGTTTGACCCTTCCCGTTTTGCACCGGGXXCT 91
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I  m  I I I I I :  :  I I E X O N  1 1
9 7 5 0  T . GTGCTCTCTCTGCAGGTGTTTGACCCCTCTAGATTCTCACCAGATTCT 9 7 9 8  
92  GCTCAACXCAGCCAGXCTTTCCTGCCCTTCTCAGGAGGATCAXGGTGAGA 1 4 1
T i l  I :  I I I I I :  I I I I I I I I I I I I I I I I I I  I I I I :  I I I I I E X O N  1 1
9 7 9 9  CCTCGCCATAGCCATGCTTATCTGCCATTCTCAGGAGGAGCAAGGTGATG 9 8 4 8  
1 4 2  CXTCCTGTGTGGTAATTCGAATAGAGGAATGAGGGAAGTCTCCGGTCÀAC 1 9 1
:  I I I I  I I I I I I I I I I I I I  I I I
9 8 4 9  GGAAAGGGTTGG AGGGAAAGGATGGAGGGTTGCCACATATTAAT 9 8 9 2
1 9 2  CCTCTGCACTT. TGTAGCCTGATGTTCATATGTGGCATCTTCAGGTGTGC 2 4 0
I I I  I I I I I I I  I I I I I I I I I I I I  I I I
9 8 9 3  ATTCTATATTTCTGATTGCTTATGTCCCTATGTGGTCACTT.......................  9 9 3 3
f) Alignment of HG6RC to CYP4A2
Figure 3.7e-f Alignment of HG6RC to CYP4A1 and CYP4A2 showing the position of 
exon 11 (underlined).
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Length: 275, Gaps: 4, Percent Similarity: 58.824 Percent Identity: 57.255
1
1 1 1 f 1 1 • 1 I f  I I I  I I
39
1 3 9 0 0
1 1 M 11 «1 I I  1 II I I  
TGAGGCTATGTCAAAAAGTCAGGAGAGCCAAGTAGGCATGACCCGTCATC 1 3 9 4 9
40 GGACACATGAGGTTGGGXACTGAATGXTCAGCTCAGGGCTGGGGTCAGGG
1 l i l t  I I  * 1 * 1  t i l l !  1 I I  I I I
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1 3 9 5 0
1 I I I  1 II • 1 >1 I I I  1 1 1 II I I I  
TCAGCCATTAAACTGAACCTGTGACAGTAGGCCCTGAGTGTTGTTCTGGG 1 3 9 9 9
90 GCCAAAACCTGCTCAGATCAGAATGGGGCCTGAGGACACTTCTCAATTCA 
1 1 i M 1 1 1 M 1 1 M 1 M l  
ATCCTTCACGGGTCAGCCCTTAAAACAG. GTAAGAAGCTAATGAGTTTTA
1 3 9
1 4 0 0 0 1 4 0 4 8
1 4 0 TTATCTCCACCTGGGCCAGGAACTGCATCGGGAAACAATTTGCCATGAAC 1 8 9
I I  I I  I I I I  I I I I I I I 1 1  I I I I I I I I 1 1  I I I I I I I I I I I I E X O N  1 2
1 4 0 4 9  TTTTCCCTTTCTGACCCAGGAACTGCATTGGGAAACAATTTGCTATGAGT 1 4 0 9 8
1 9 0  GAGCTGAAGGTGA.. . CGGCCCTGACC. . . CCXCGCTTTGAGCTGCTGCC 2 3 3
I I I  I I 1 1  1 1 1  1 1  1 1 1 1 1 1 1 I I I  I :  I I I I I I I  M  1 1  1 1  I 1 1  E X O N  1 2
1 4 0 9 9  GAGATGAAGGTGATTGTGGCCCTGACCCTGCTCCGCTTTGAiGCTACTGCC 1 4 1 4 8  
2 3 4  TGATCCCACCAGGATCCCCGGAA. .  2 5 6
1 1 1 1 1 1 1 1 1 1  I 1 1 1 1 1  E X O N  1 2
1 4 1 4 9  AGATCCCACCAAGGTCCCCATCCCC 1 4 1 7 3
g) Alignment of HG6UCT to CYP4A1
Length: 281, Gaps: 3, Percent Similarity: 65.625 Percent Identity: 64.063
1 . . . GGGGTAGAAGTGTCXATGGGCTGTAT GTGTGCAGGGGCTGGA 42
I I I  I I  I :  I I I I I I I I  I I  I I I I I
1 2 1 4 0  CAAGGGAATGATTTAGGCATGTGGTCTATAAATAAAATGATTAGGCTGAT 1 2 1 8 9
43  CACATGAGGTTGGGXACTGAATGXTCAGCTCAGGGCTGGGGTCAGGGGCC 92
I I I  I I I I :  I :  I I I I I I I I I  I I I  I I I
1 2 1 9 0  ACCATCGCGGGGGGGAACCCTGATGCCCCACAGGACTGAGGTTAAAGGAT 1 2 2 3 9
93  AAAACCTGCTCAGATCAGAATGGGGCCTGAGGACACTTCTCAATTCATTA 1 4 2  
I I  I I  I I I  I I I I I I I I I I I I I I I I 
1 2 2 4 0  CAATACTCACCGTACCCAGAGCAAGTCTCAGGCCACATCTTACGTATGTG 1 2 2 8 9
1 4 3  TCTCCACCTGGGCCAGGAACTGCATCGGGAAACAATTTGCCATQAACGAG 1 9 2
11 I i Ml I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I III EXON 12
1 2 2 9 0  TCCCTGCTTGGTTCAGGAACTGCATTGGGAAACAATTTGCCATGAATGAG 1 2 3 3 9
1 9 3  CTGAAGGTGAC.. .GGCCCTGACC.. . CCXCGCTTTGAGCTGCTGCCTGA 2 3 6
I I I 11 I I I I I I I I I I I I I I I I : I I I I I I I I I I I I I I I I  II EXON 12
1 2 3 4 0  CTGAAGGTGGCTGTGGCCCTGACCCTGCTTCGCTTTGAGTTGCTGCCAGA 1 2 3 8 9
2 3 7  TCCCACCAGGATCCCCGGAA.............................  2 5 6
I I I 11 I I I I I I I I I I I EXON 12
1 2 3 9 0  TCCCACCAGGATCCCGGTCCCCATGCCAAGA 1 2 4 2 0
h) Alignment of HG6UCT to CYP4A2
Figure 3.7g-h Alignment of HG6UCT to CYP4A1 and CYP4A2 showing the position 
of exon 12 (underlined).
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Figure 3.8 Alignment of HG6 and HG19 with CYP4A1 and 4A2. Percentage 
nucleotide sequence similarities are shown for the total sequenced regions (introns and 
exons)
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RAT CYP4A1 F S G G A R N C I G K Q F A M N E M K V I
RAT CYP4A2 F S G G A R N C I G K Q F A M S G L K V A
RAT CYP4A2 F s G G A R N C I G K Q F A M N G L K V A
RABBIT CYP4A4 F s G G A R N c I G K Q F A M N G L K V A
RABBIT CYP4A5 F s G G A R N c I G K Q F A M S E L K V A
RABBIT CYP4A6 F s G G P R N c I G K Q F A M N E L K V A
RABQITCYP4A7 F s G G S R N c I G K Q F A M R E L K V A
RAT CYP4A8 F s G G A R N c I G K Q F A M N E L K V I
HUMAN HG6 F s G G S R N c I G K Q F A M N E L K V I
Figure 3.9 A comparison of the amino acid sequences of HG6 and other members of 
the CYP4A family in the conserved haem binding region. The haem-iron liganding 
cysteine residue is indicated (4k) and homologous amino acids are in bold type.
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% AMINO ACID SIMILARITY TO HUMAN CLONES
GENES SPECIES EXONS EXON 9 EXONIO EXONll EX0N12 MEAN
CYP4AÎ RAT 79 81 86 81 83 82
CYP4A2 RAT 79 75 68 69 89 76
CYP4A3 RAT 79 81 63 79 83 77
CYP4A4 RABBIT 79 75 72 81 83 78
CYP4A5 RABBIT 72 75 81 83 86 79
CYP4A6 RABBIT 82 75 86 87 80 82
CYP4A7 RABBIT 82 68 81 87 72 78
CYP4A8 RAT 68 62 77 83 78 74
Table 3.3 Amino acid similarities of HG6 and HG19 to other members of the CYP4A 
family.
% NUCLEOTIDE SIMILARITY TO HUMAN CLONES
GENES SPECIES INTRONS INTRON 9 INTRONIC INTRON 11 MEAN
CYP4A1 RAT 48 59 62 58 57
CYP4A2 RAT 53 52 78 54 59
Table 3.4 Intronic nucleotide similarities of HG6 and HG19 to CYP4A1 and 4A2.
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3.4.4 CONCLUSIONS FROM SEQUENCING RESULTS FOR HG6 AND 
HG19.
The following conclusions were drawn from the data presented in this chapter:
(i) As previously discussed a P450 isoform may be classed into an existing 
sub-family if it displays greater than 60% amino acid sequence similarity to other 
members of the family. From Table 3.3 the amino acid similarities averaged 78% for 
the exons sequenced. While this data did not include the complete human gene, it was 
considered sufficient to classify HG6 and HG19 as part of a human CYP4A gene. At 
this point the only human CYP4A gene isolation reported was by Hardwick as a 
personal communication in the 1991 review of the P450 superfamily (Nebert 1991) 
which had been designated CYP4A9. Since this DNA sequence had not yet been 
published it was considered possible that HG6 and HG19 represented the gene for this 
isoform. Further work had to be performed to see if there were more human members 
of the family.
(ii) The sequencing confirmed the results of the Southern blots and located the 
HG6 and HG19 fragments to the 3' end of the gene. Both fragments were present in 
the vector in the reverse orientation in relation to the gene itself. The fragments did 
not contain the 5' non-coding and regulatory regions of the gene and a library would 
have to be re-screened to locate these regulatory regions of interest.
(iii) From the spatial arrangement of the introns in HG6 and HG19 it appeared 
that the corresponding human gene was more compact than the rat genes. Compared 
to CYP4A1^ HG19 (1.7kb) spans a corresponding region of 2.8kb and HG6 (2.7kb) a 
region of 3.1kb. The same was seen in CYP4A2 with HG19 spanning 2.5kb although 
the corresponding region to HG6 was of the same size, 2.7kb. This data implied a 
significant loss of intronic material in intron 9 (ie between exons 9 and 10) when 
compared to the rat genes. The loss of material from exon 11 compared to CYP4A1 
was also seen in CYP4A2. Because the 2 rat genes were the only ones published with 
the intronic sequence (ie as genes and not just cDNAs) it was not possible to look for 
this difference in other genes of the family.
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3.5 SEARCH FOR OTHER HUMAN CYP4A GENES HUMAN USING 
GENOMIC SOUTHERN BLOTS.
3.5.1 INTRODUCTION
Having tentatively identified that HG6 and HG19 were fi'agments from a human 
CYP4A gene it remained to determine how many other related human genes their were 
in this family. Five human liver samples were kindly donated by Dr. G. Parke and 
used as the source of genomic DNA. It was also hoped that any polymorphism among 
the samples might be detected although the group was not really large enough for this 
type of analysis.
To determine the number of different related genes it was decided to cut the genomic 
DNA with BamHI which was known to liberate the HG19 and HG6 fragments from 
the human gene. If there was a single gene in the family then probing the resulting 
digest with either HG6 or HG19 would result in a hybridisation to a fragment the same 
size as the probe. Both HG6 and HG19 had one DNA end which fell in an intron and 
so would be unlikely to be conserved in a different gene. Thus if there was more than 
one related gene then extra bands would appear in the hybridisation.
3.5.2 PROBE SELECTION
The hybridisation process relies on good matches between the probe and the target 
sequences. While the exons from HG6 and HG19 would cross-hybridise to all the 
other putative members of the family (78% similar) the intronic sequences would be 
significantly less similar and so the resulting hybridisation would not be as strong. 
Therefore it was decided to use HG19 as the probe as the DNA fragments had a higher 
exon to intron ratio than HG6, and might give a better signal.
3.5.3 PREPARATION OF HUMAN LIVER GENOMIC DNA
The human liver samples had been taken from liver biopsies and supplied by Dr. G. 
Parke of Addenbrooke's hospital. On removal from the patient they had been snap- 
frozen in liquid nitrogen and then stored at -70°C until use. Prior to DNA extraction a 
suitable aliquot of liver was fractured from the sample with a mortar and pestle and 
then processed by the previously described protocol (section 2.3.2).The concentration 
of the liver DNA were determined by uv/vis spectroscopy although due to the viscous 
nature of the DNA an accurate concentration determination was difficult.
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3.5.4 BamHI DIGESTION OF HUMAN GENOMIC DNA
20|ag of each sample was digested overnight with lOpI of BamHI (lOU/pl) in a total 
volume of lOOpl. A lOpl aliquot was run on an agarose gel. If a uniform smear of 
ethidium bromide stained DNA fragments was seen the digestion was considered 
complete. If however there was a large concentration of material near the origin then 
another lOpl of the enzyme (and the required amount of buffer) was added to the 
remaining digest mix and re-incubated overnight.
Once the digest was complete the DNA was extracted by phenol/chloroform and then 
ethanol precipitated (section 2.2.4). The pellet was air dried and then resuspended in 
25pi of TAE running buffer. The digests were run with X markers on a 1% agarose 
gel and then Southern blotted to a nylon membrane.
3.5.5 HYBRIDISATION WITH THE HG19 PROBE
A 150ml culture of HG19 was grown up the plasmid DNA prepared with a Qiagen tip 
100 column. 50pg of the DNA was digested with BamHI and run on a 1% agarose 
gel, from which the 1.4kb HG19 band was excised and purified by Geneclean (section
2.2.3). For each hybridisation 500ng of the HG19 probe was labelled using 
Megaprime and incubated in the standard protocol.
The filter from the genomic Southern blot was hybridised using the standard protocol 
(2.2.8.3) but was checked at each stage by exposure to x-ray film. This allowed the 
monitoring of the washing efficiency and prevented the loss of bands of lower 
sequence similarity. The washes were performed to a final stringency of O.lxSSC / 
0.1%SDS/42°C.
In all the autoradiographs a single band was observed at 1.4kb in all of the samples 
(see figure 3.10a). The intensity of this band varied from lane to lane but this was 
probably due to concentration differences. The hybridisation suggested the presence a 
single gene or genes in human DNA which the two BamHI sites were conserved. 
Since it was unlikely that two or more genes would have an identical restriction 
pattern, the presence of a single gene was confirmed by cutting the genomic DNA 
with a second enzyme.
3.5.6 EcoRI DIGESTION OF HUMAN GENOMIC DNA
The restriction enzyme mapping work showed that HG6 and HG19 both contained an 
EcoRI site. In the corresponding human gene these sites were 1.35kb apart. It was 
concluded that if the genomic DNA was digested with EcoRI and analysed by 
Southern blotting using the HG19 probe, this 1.35kb fragment should be hybridised. A
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second band would also be hybridised, the size of which would be determined by the 
position of the next EcoRI site in the 5' direction from HG19.
An EcoRI digest was performed on human liver sample H5 as it gave the strongest 
signal in the BamHI Southern blot. The digest was run on a gel. Southern blotted and 
hybridised with the HG19 probe as before. The resulting autoradiograph (fig 3.10b) 
showed the expected band at 1.35kb and a second band at l.Okb
3.5.7 INTERPRETATION OF SOUTHERN BLOTS
In both of the hybridisations the results were consistent with the existence of a single 
human gene in the CYP4 A family. By monitoring the filters at each of the wash steps 
it was possible to confirm that a weakly hybridising bands were not present and so the 
existence of a related gene could be excluded. If there were two closely related genes 
which gave the same digest patterns, then 5 enzyme sites (3 EcoRI and 2 BamHI) 
would have had to be conserved (Figure 3.10c). This was considered to be unlikely
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Human Liver No. 
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B
Human Liver No. 
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Figure 3.10 Southern blot analysis of human genomic DNA by hybridisation with the 
human HG19 probe.
a) Autoradiograph of Southern blot of human genomic DNA cut with BamHI and 
hybridised with HG19.
b) Autoradiograph of Southern blot of human genomic DNA from liver sample 5 cut 
with EcoRI and hybridised with HG19.
c) Deduced partial map of the human CYP4A gene showing the BamHI and EcoRI 
sites in and around HG19
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3.6 DISCUSSION
From the sequencing and the Southern blot analysis it was likely that HG6 and HG19 
were part of the 3’ end of a unique human CYP4A gene. From the amino acid 
sequence the gene appeared to be most similar to rat CYP4A1 and the rabbit CYP4A6 
(82% to both), which are both regulated by peroxisome proliferators.
Since the genomic Southern blot analysis indicated that probably only one human gene 
existed in this family, the evidence pointed to the unpublished CYP4A9 as the most 
probable candidate. While there was no evidence of polymorphism the population 
was small and a former conclusion could only be obtained with a larger test population.
From the sizes of HG6 and HG19 the human gene seemed to be more compact than 
the rat CYP4A1 gene. There appeared particularly to be a loss of some of the intronic 
material, most noticeably within intron 9. Further work would confirm this finding.
As previously discussed both HG6 and HG19 were situated towards the 3' end of the 
gene well, away fi"om the 5' regulatory regions. It would therefore be necessary to re­
screen a libraiy to obtain the regions of interest. There was a choice of two possible 
approaches:
a) Rescreen the libraiy with the 600bp rat CYP4AI cDNA probe This would have 
the advantage of concentrating the search on the region of interest. The disadvantage 
would be that using a rat cDNA probe on a human gene might lead to problems with 
low hybridisation to the human introns which would reduce the affinity of the probe for 
its target.
b) Use the HGI9 fragment as a probe for walking up the gene This approach 
would have the advantage of using a human genomic probe on human genomic 
material and so the hybridisation should be complete. However there was no 
guarantee that the rest of the gene including the 5' non-coding regions could be 
isolated on the first attempt. If this was the case then the library would have to be 
screened yet again using the most 5’ fi’agment fi’om the previous screen.
It was decided to try the first approach in an attempt to isolate the 5' end of the gene in 
one go. To this end a human placental genomic DNA library was purchased (the 
previous library had been screened three times by Dr McGeoch and only yielded HG6 
and HG19) and screened with the 600bp rat CYP4A1 cDNA probe. This work is 
discussed in the next chapter.
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CHAPTER 4
FURTHER SCREENING OF A HUMAN GENOMIC 
LIBRARYWITH RAT CYP4A1 cDNA CLONES
CHAPTER 4 ; FURTHER SCREENING OF A HUMAN GENOMIC 
LIBRARY WITH RAT CYP4A1 cDNA PROBES.
4.1 INTRODUCTION
As the work described in the last chapter proceeded it became evident that HG6 and 
HG19 were from the 3' end of the human CYP4A gene and would not therefore 
contain the regulatory regions. It was therefore decided to rescreen a human library 
with rat CYP4A1 5' cDNA probes in parallel with the HG6 and HG19 sequencing.
The human genomic library from which the HG6 and HG19 clones had been isolated 
had been screened twice without yielding any more CYP4A clones and therefore a new 
human genomic placental library in XEMBL3a was obtained from Clonetech Ltd.
In order to isolate as much of the human gene as possible the first two rounds of 
screening was performed with the full length 2.1 kb CYP4A1 cDNA as a probe. This 
was followed by further rounds of screening with the 600bp 5' CYP4A1 cDNA probe. 
It was hoped that this approach would produce a clone linking the HG6 and HG19 
clones to the 5' end and thus the regulatoiy regions isolated were from a human 
CYP4A gene.
4.2 LIBRARY SCREENING
4.2.1 HUMAN GENOMIC LIBRARY
The Clonetech libraiy had been constructed using the EMBL3a bacteriophage vector 
and human placental genomic DNA. The genomic DNA had been partially digested 
with Sau3a (which recognises the site /GATC ) and run on a preparative gel. Bands 
of approximately 14kb had been inserted into the vector which had been cut with 
BamHI (G/GATCC).
While this recombination was possible due to the homology of the sticky ends between 
the 2 enzyme sites it is significant to note that the BamHI site was not always 
conserved. The site can only be re-cut with BamHI if the base 3' of the Sau3a site is 
cytosine (ie /GATCÇ ) and thus there is a 25% chance of site conservation.
4.2.2 TITRATION OF THE LIBRARY
The library was titred using the method described previously (section 2.4.1). The 
recombinant phage was serially diluted down to 10'^ and the 10"^  to 10"^  dilutions 
used to infect LE392 cells. These were added to top agarose and were plated out in 
triplicate onto LB plates containing lOmM MgS0 4 . The plates were left inverted
102
overnight at 37°C for the lawns to grow and the plaques to form. The library titre was 
determined at 3.2 x 10^ ® pfli/ml, representing 10  ^different recombinants.
4.2.3 PRIMARY SCREENING OF THE LIBRARY
The screening of the library was performed as detailed (section 2.4.2) with the 
following modifications.
4.2.3.1. Plating out.
A 100ml fresh overnight culture of LE392 cells was centrifuged (4000g / lOmins / 
RT) and resuspended in 10ml LB + lOmM MgS0 4  . lOpl of the libraiy was diluted 
1:20 in phage buffer and lOpl of this added to the cells. The cells were incubated at 37 
°C for 30mins and then 2ml aliquots added to 5 x 40ml of top agarose. The top 
agarose was poured onto five 22 x 22cm LB + lOmM MgS0 4  plates (labelled A - E) 
and these were grown up overnight at 37°C. The dilutions had been calculated so that 
each plate would contain 10  ^plaques.
The following day the plates were examined and found to be confluent (ie completely 
covered with plaques) The plaques were lifted onto 20 x 20 cm nylon membranes in 
duplicate and the DNA fixed to the membrane by uv bonding. The 2nd filter from each 
lift was cut in half to allow both filters to fit in a single autoradiograph cassette, and 
prepared for hybridisation.
4.2.3.2. Hybridisation
The procedure was performed by the standard method (section 2.2.8). 5 x 500ng 
aliquots of CYP4A1 cDNA was radiolabelled with dCTP using the Megaprime 
system and hybridisation performed at 42°C. The filters were washed to a stringency 
of 0.5% SSC / 0.1% SDS at 55°C and autoradiographed for 72hrs.
4.2.3.3. Results
The developed autoradiographs were examined and positive plaques recorded if they 
hybridised on both of the filters. From this analysis 21 positive clones were identified; 
4 from plate A (lAl-4), 3 fi*om B (XBl-3), 10 fi'om C (^Cl-10) and 4 fi"om D (XDl- 
4) (there were no positive plaques firom E). The autoradiographs were matched to the 
original plates and a plug cut out of the agar corresponding to the positive plaque. 
Each plug was incubated in 1ml of phage buffer and left at 4°C overnight to allow the 
phage to dififijse into the solution. A drop of chloroform was also added to prevent 
any bacterial growth.
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4.2.4 SECONDARY SCREENING
The screening process was repeated on the 21 positive clones using 90mm petri dishes 
and round filters. Dilutions of 10-3 to io-5 were plated out as before. Plates with 
between 200-1000 plaques were lifted and hybridised with the 2.1 kb CYP4A1 cDNA 
probe. The filters were washed to a stringency of 0.5% SSC / 0.1% SDS / 55°C and 
autoradiographed for 72hrs. The resulting autoradiographs showed good positives 
and, where possible, 4 discrete plaques were picked from each plate (labelled a-d). 
These were stored in phage buffer as before.
4.2.5 THIRD ROUND OF SCREENING
The plaque purification was repeated for a 3rd round and 10"2 to 10"3 dilutions plated 
out. The results of this lift are shown in Table 4.1. Plates with 10 - 100 plaques were 
selected to ensure the separation of the plaques and triplicate filter lifts performed.
The plaques were considered discrete enough to select the clones containing sequence 
that hybridised to the 600bp rat probe and one of the three triplicate filters was 
hybridised with this probe while the other two were hybridised with the 2.1 kb probe as 
before. This was another control as 600bp positive clones should also hybridise to the
2.1 kb probe and so confirm the reliability of the hybridisation. The hybridisation and 
washing conditions were as for the previous round of screening.
In this round of screening four clones were rejected for lack of growth and two others 
were negative for the 600bp probe and therefore 5' negative. If plaques hybridised on 
all three replicate filters they were considered 5' +ve clones (see Figure 4.1) and four 
plaques were selected and picked into phage buffer as before. The clones selected are 
shown in Table 4.1.
4.2.6 FINAL ROUND OF SCREENING
A further round of screening was performed on the 5' +ve clones as before and the 
filters were hybridised with the 600bp probe. In each case all the plaques on the plates 
hybridised to the probe and so the recombinant phage stocks were considered 
homogeneous. They were then used to prepare phage DNA.
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NUMBER OF PLAQUESAT EACHI)ILUTION RESULT OF
CLONE 10-2 10-3 10-4 10-5 PROBING
XAl 400 30 2 0 5' +ve
XA2 20 2 0 0 no clones
XA3 - 15 4 0 5' +ve
XA4 5 0 0 0 5' +ve
XBl 12 3 0 0 no clones
XB2 2 0 0 0 5' +ve
XB3 40 3 0 0 5' +ve
XCl - 40 2 0 5' +ve
XC2 - 40 3 0 5’ +ve
XC3 - 20 0 0 no clones
XCA - 7 0 0 no clones
XC5 - 50% 100 6 5' +ve
XC6 - 30% 80 7 5' +ve
XCl - 200 5 0 5' +ve
XC8 - 200 7 0 5' +ve
XC9 - 40 12 1 5' 4-ve
XCIO _ 40 8 0 5'+ve
XDl 250 21 0 5' +ve
XD2 - 50% 40 6 5' 4-ve
XD3 - 40% 30 4 5' -ve
XD4 - 50% 40 7 5' -ve
Table 4.1 Number of plaques/plate for third round of purification. Plaque lift taken 
from plates with bold numbers. (%=% confluence for plates were individual plaque 
counts could not be determined)
The results of the probing are : no clones = no positives with either probe
5' -ve = positives with 2.1kb but not 600bp probe 
5' +ve = positive for both probes.
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Figure 4.1 Autoradiograph of round filters from the 3rd round of screening. Filters A 
and B were probed with the 2.1 kb CYP4A1 cDNA and filter C with the 600bp probe. 
The plaques selected for further purification are boxed.
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4.3 PREPARATION AND ANALYSIS OF PHAGE DNA FROM POSITIVE 
CLONES
4.3.1 PHAGE DNA PREPARATION
Phage DNA was prepared from each of the fifteen positive clones by the liquid lysate 
method (section 2.4.3). This was a method which usually gave good yields of clean 
DNA but sometimes had to be repeated 2 or 3 times to get a satisfactory preparation. 
After several attempts it was not possible to get a good preparation of clone XB2 and 
this clone was abandoned. The clones were divided into two sets to facilitate handling 
of the phage DNA preparations and subsequent analysis. Set I contained XAl,XCl, 
XC2, XC5, XC6, XC8 and XCIO, Set II contained XA2, XA4, XB3, XC7, XC9, XDl and 
XD2. The DNA preparations were then used for restriction mapping of the clones.
4.3.2 CLASSIFICATION OF PHAGE CLONES
The first mapping task was to tiy and reduce the number of clones requiring analysis. 
Since it was ühlikely that there was 14 different clones isolated there was probably 
some duplication.
5pg of DNA from each of the Set I clones was digested with BamHI and run on a gel 
with 5 jig of the uncut phage DNA. From the resulting gels it was possible to identify 
3 distinct groups of clones by their banding patterns and these were designated Group 
1 (XA1,XC6 and XCIO), Group 2 (XC1,XC5 and XC8) and Group 3 (XC2). The 
BamHI restriction digest patterns of these groups can be seen on the gel in Figure 4.2 
and are described in Table 4.2. This gel was Southern blotted to nylon for further 
analysis.
The same analysis was repeated with the clones in Set II and the resulting gels showed 
that all the clones in this group could also be classified into Groups 1, 2 and 3 as 
before. The final distribution of clones was as follows :
Group 1 : Clones XA1,XA3, XA4, XB2, XC6, XC7, XC9, XCIO, XDl and XD2
Group 2 : Clones XCl, XB3, XC5 and XC8
Group 3 : Clones XC2
For further mapping work the first clones in each group (marked in bold print) were 
used as representative of the group. The screening results up to this point is 
summarised in Figure 4.3.
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Figure 4.2 BamHI restriction digests of recombinant phage XAl, XCl and XC2 
showing characteristic banding patterns of the groups, see Table 4.2 (below) for 
loading order.
LANE CONTENTS FRAGMENT SIZES
1 X marker see (section 2.2.1)
2 0  marker see (section 2.2.1)
3 uncut XAl >23.7
4 BamHI cut XAl 20, (12), 9.0, 6.8, 6.7, 5.5+ 1.5
5 uncut XCl >23.7
6 BamHI cut XCl 20, 11, 6.7+ 2.3
7 uncut XC2 >23.7
8 BamHI cut XC2 20, 11 6.7, 1.2
Table 4.2 Loading for Figure 4.2 showing BamHI restriction fragment patterns
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HUMAN PLACENTAL 
DNA LIBRARY
3 FALSE POSITIVES
10 CLONES
2.1 cDNA SCREEN
21 POSITIVE 
CLONES
I  2.1 cDNA SCREEN 
600  bp SCREEN
2 5'-ve CLONES
16 POSITIVE 
5' CLONES
GOObpcDNA 
SCREEN
DNA PREP AND 
RESTRICTION ENZYME 
DIGEST
GROUP 1 GROUP 2 GROUP 3
5 CLONES 1 CLONE
Figure 4.3 Flow chart for the screening of the human library to produce the 3 groups 
of clones.
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4.3.3 RESTRICTION MAPPING OF PHAGE CLONES XAl,  XCl  AND XC2
The three clones were mapped as extensively as possible. In order do liberate the 
human DNA inserts from the phage arms the clones were cut with Xhol which cuts in 
the phage multiple cloning site. EcoRI and SphI were also used as these cut in and 
around the multiple cloning site and should liberate the inserts. Bgll was used as this 
cut in the phage arms and so gave an indication of their identity. The results of the 
mapping gels are seen in Table 4.3 and the deduced maps are shown in Figure 4.4.
The gels used for the mapping work were Southern blotted to nylon and were probed 
with the 600bp cDNA probe. The filters were then stripped of the probe and then re­
hybridised with the 2.1 kb cDNA. This data was used to localise the regions of the 
clones to which the probes hybridised and so determine the position of the exonic 
sequence. This information is displayed in Table 4.3.
Group 2 and 3 From the mapping it became apparent that XCl and ^C2 were related 
and it appeared that XC2 was a truncated version of ^Cl. Significantly, the short 
phage arms (11 kb) for both clones did not fit the expected size (9kb) and this could 
not be explained from the mapping.
From the probing, the 2.2kb fragment in X.C1 and the 1.3kb fragment in XC2 both 
hybridised to the 600bp probe. In both clones the adjoining 6.6kb fragment was 
negative for the 600bp and 2.1 kb probes. If this large fragment was located 3' to the 
600bp positive region (ie were HG6 and HG19) it would be hybridised by the 2.1 kb 
probe. As this was not the case it was concluded that the 6.6kb fragments must 
contain part of the 5' non-coding region for the gene. It was also concluded that exon 
1 must be contained in the 1.3kb fragment of Group 3 clones and therefore in the 
corresponding part of the 2.2kb fragment of Group 2 clones.
Group 1 Both XCl and XC2 were significantly different to XAl, whose mapping was 
more complex. By the same probing argument used above the 3.8, 5.5 and 1.5kb 
fragments of this group were also designated as 5' non-coding.
The next stage was to subclone these fragments into plasmid vector for further 
mapping and sequencing.
110
CLONE ENZYME(S) FRAGMENT SIZES AND HYBRIDISATIONS
XAl BamHI 20, (12), 6.8, 6.7, 5.5+ 1.5
Bgll 18,16, 3.1, .5, 2.3, 1.5, 1.3, 1.1+ 1.1
Xhol 23.0+18.0
BamHI + EcoRI 16, (12), 6.0, 6.0, l i ,  5.1, 3.8 + 1.45
BamHI + Xhol 23.7, M  7.0, 5.6, 1.25 + 0.92
EcoRI + Xhol 23.7,14 + 15
Bgll + EcoRI 12,16, 3.1, 2.5, 2.3, L7, 1.5, 1.3, 1.1 +1.1
XCl BamHI 20, 11,6.7,21
Xhol >23
BamHI + EcoRI 23, 14, 6.6+1.15
BamHI + Sfil 23,14,6.6 + 2.15
Sfil + EcoRI 23, 20 + U
XCl BamHI 20, 11, 6.7+1.25
Xhol >23
BamHI + EcoRI 18, 11, 6.6,1.1+0.15
BamHI + Sfil 23, 11.1 6.6+1.25
EcoRI + Sfil 23+20
Table 4.3 Restriction digests of human clones ^Al, %C1 and kC2. Fragments 
underlined are positive for 600bp and 2.1 kb rat CYP4A1 cDNA probes.
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4.4 SUBCLONING OF XCl AND XC2 PHAGE INSERT FRAGMENTS INTO 
PLASMID VECTOR
4.4.1 STRATEGY
It was decided to start the subcloning with groups 2 (clone ^Cl) and 3 (clone A,C2) as 
they seemed to be related from the mapping data, the 6.6kb fragments should be the 
same and the smaller fragments should share one end.
The plasmid selected for the vector was pGEM7zf(+) from Promega Ltd. It was 
chosen as it had a comprehensive multiple cloning site which had been designed for use 
in the Erase-a-Base nested deletion system.
As Group 2 clones were larger than those of Group 3 it was decided to start with 
recombinant ^C1 and a fresh batch of phage DNA was prepared.
4.4.2 SUBCLONING OF THE XCl FRAGMENTS INTO PLASMID
The ligations were performed by the shotgun method (section 2.5.1), care being taken 
to ensure that the phage DNA : vector molar ratios were correct (ie 1:1, 1:3 and 3:1). 
The vector was 3kb and the phage was 43kb although the latter contained 2 potential 
inserts and so half the amount was needed in comparison to a single insert phage.
Both vector and phage were digested overnight with BamHI and an aliquot of each run 
on a gel to confirm complete digestion. The DNA was then phenol/chloroform 
extracted, ethanol precipitated (section 2.2.4) and resuspended in a suitable volume of 
TE buffer. The plasmid vector was treated with alkaline phosphatase (section 2.2.7) to 
prevent self religation. Each ligation was designed to contain lOOng of plasmid and 
the total reaction volume was adjusted to 10ml with buffer and H2 O. The following 
controls were also run with the ligations:
Control 1 : Cell growth control to check for background, - 0 colonies expected.
Control 2 : Plasmid control to check transfection with uncut plasmid, - hundreds of 
blue colonies expected.
Control 3 : Digestion control to check vector has cut, - 0/few blues expected.
Control 4 : Phosphatase control to check dephosphorylation of plasmid when 
incubated with ligase, - few colonies expected.
Control 5 : Ligase control to check ligase with cut untreated plasmid, - similar to 
control 2.
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The ligations were performed overnight at 14°C and the ligated DNA transfected into 
JM109 competent cells (section 2.5.3), and plated out onto X-Gal plates (section
2.5.4). The ligation reactions and the resulting colonies are summarised in Table 4.4.
The resulting white colonies from the test plates were restreaked onto fresh X-Gal 
plates to confirm their identity and to establish a cell stock. The confirmed whites 
were then screened for inserts by the 'cracking' procedure (section 2.5.5) on two gels 
and ten sub-clones were identified as having inserts by the retarded DNA banding 
pattern.. One of the cracking gels is shown in Figure 4.5 and in lanes 11, 16, 17 and 
20 the plasmid band is retarded in relation to the pGEM plasmid DNA run in lanes 1 
and 15.
From the gels ten plasmids with inserts were identified and Qiagen tip 10 plasmid 
preparations performed on them (section 2.5.6). These subclones were designated HI 
toHlO.
4.4.3 SUBCLONING OF THE XC2 FRAGMENTS INTO PLASMID
The ligation process was repeated for XC2 using the same protocol described above. 
The results from the ligation plates are shown in Table 4.5 (controls gave expected 
results and are not shown). The colonies were restreaked and the true whites screened 
by the 'cracking' process as before. This process yielded seven clones showing shifted 
banding patterns and these were designated HI 1 - H I7.
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Top
14 13 12 11 10 9 8 7 6 5 4 3 2 1
21 20 19 18 17 16 15
Bottom
Figure 4.5 Cracking gel of clones from XCl subcloning. (Photograph divided to 
identify lanes.)
Lane 1 and 15 contains uncut pGEM
14 and 21 X marker
2-13 +16-20 cracked samples.
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RATIO NO. OF COLONIES
(Plasmid : Insert) BLUE WHITE
1 : 1 85 11
1:3 85 3
3 : 1 14 11
Table 4.5 Subcloning of the inserts from Phage clone XC2 into pGEM7zf(+)
117
4.5 ANALYSIS OF SUBCLONES FROM XCl AND XC2
4.5.1 MAPPING OF INSERTS
BamHI digests were performed for all the sub-clones to determine the sizes of the 
inserts. The gels were Southern blotted and the filters hybridised with the 600bp 
probe.
The XCl subclones H8 and H9 contained the 2.3kb insert (600bp +ve), HI and H5 
contained the 6.6kb insert (600bp -ve) and H7 contained both. The others (H2, 3, 4, 
and 6) contained inserts of unpredicted sizes which were attributed to artefactual 
recombinations. The XC2 subclones H ll and H12 contained the 1.3kb (600bp +ve) 
insert and the others H13 - 17 all contained the 6.6kb insert.
The orientation of the inserts was determined by restriction mapping with Hindlll and 
EcoRI. The H8 and H9 inserts proved to be inserted in the same orientation while the 
H ll and H12 inserts were inserted oppositely to each other. The mapping also 
strengthened the evidence that HI 1 (phage clone XC2) is a truncated version of H9 
(phage clone XCl) as both have EcoRI and Hindlll sites in the same place. From this 
data H12 was shown to be in the same orientation as H8 and H9 (See Figure 4.6). 
This strengthened the theory that the two 6.6kb bands were the same.
The 6.6kb inserts (HI, H5, H13 - H I7) would not cut with EcoRI, BamHI, Xhol or 
Kpnl and so their orientation could not be determined. This was not considered 
important as the clones would shortly be sequenced.
4.5.2 SEQUENCING OF THE SUB-CLONES
The sub-clones were sequenced using the Sequenase system (section 2.6.1). The 
sequencing primers used were the T7 (forward direction) and SP6 (reverse) primers. 
In pGEM7zf(+) these are sited closer to the multiple cloning site than the conventional 
Ml 3 Universal and Reverse primers (see Figure 2.8) and so extends the effective range 
of the sequencing reaction.
The ends of the clones (HI, 5, 8, 9, 11-17) were sequenced as extensively as possible 
and consensus sequences determined as before. These were entered into the 
Microgenie computer and analysed as in Chapter 3.
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BamHI
H8/H9
EcoRI Hind 3 BamHI
2.2kb
H 1 2
BamHI EcoRI Hind 3 BamHI
I .Skb
HI  1
BamHI Hind 3 EcoRI BamHI
I .Skb
Figure 4.6 Alignment of H8 / 9 with HI 1 and 12 inserts.
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4.5.3 ANALYSIS OF SEQUENCING DATA
Comparison of the short gel sequences from H8 and H9 showed that they were 
identical in both the forward (T7) and reverse (SP6).directions (see Figure 4.7a and b). 
The sequences were combined to give a forward and reverse consensus, designated 
2.2UCON and 2.2RCON (Figure 4.8a and b).
The H ll and H12 clones were confirmed to be inserted in the opposite direction since 
the T7 consensus from H ll matched the SP6 sequence from H I2 and vice-versa ( see 
Figure 4.9a and b). To maintain the same alignment as the 2.2kb clone the directions 
for the sequences were taken from H12; Thus H12UC and HI IRC combined to give 
1.3UC0N and H12RC and HllUC to give 1.3RC0N (Figure 4.8c and d). 
Comparison of 1.3RC0N and 2.2RCON showed the clones to be identical (see Figure 
4.10) and so confirmed the mapping results.
All the 6.6k fragments matched in the same direction (data not shown) and from the 
sequences 6.6UCON and 6.6RCON consensus sequences were generated (Figure 4.8e 
and f). This again confirmed that the XC2 phage clone was a truncated version of the 
XCl clone.
A comparison of all the sequences against CYP4A1 and other members of the family 
(including HG6 and HG19) did not show any significant homology that could explain 
the hybridisation of the probe. It was concluded that exonl must have been contained 
in the unsequenced region of the 1.3kb fragment as it was the smallest region positive 
for the 600bp probe. This proposed arrangement of the fragments is shown in Figure 
4.11.
In an attempt to find similar sequences the consensus sequences were sent to be 
compared to the EMBL database at Daresbury. This was a lengthy process due to the 
time delay between the computer systems and our low processing priority. The results 
were unexpected as the 2.3kb and 6.6kb fragments both showed near homology with 
the short phage arm of X phage (Figure 4.12). The only part of the clones that did not 
display homology to the X phage was 2.3UCON and it was proposed that this could be 
part of an insert.
From the results of the EMBL searches the library screening had to be re-evaluated.
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H8US 2 / S  
H9DS 2 / 5
1 GGATCCGGGCCCGCCACTCGTCCGAGGTAGACGGTATGGATAAGCTTXATATCGTTCGAA
III 111 III 111 III 111II1111 III;111 III 111 III 1111IIII111 III 111 III
1 GGATCCGGGCCCGCCACTCGTCCGAGGTAGACGGTATGGATAAGCTTXATATCGTTCGAA
6 1 ATAGATATATGCATTGTGATAGCGTGCTAGGAATTACGCATTGACTAGGCAAAAATTGGG
1 2 1  ACATGGGACAAT
m m m
M a t c h e s  =  1 3 2  M i s m a t c h e s  =  0 U n m a tc h e d  =  o
L e n g t h  =  1 3 2  M a t c h e s / l e n g t h  =  1 0 0 . 0  p e r c e n t
a) Alignment of H8U and H9U
H8RS 2 / 5  
H 9 R S 2 /5
1 g GATCCGCCTACCTTCACGAGTTGCGCAGTTTGTCTGCAAGACTCTATGAGAAGCAGATG
“  îMMnniMIMMIIMŒ
1 2 1  GGACAAAATTAAATCAAATA
M a t c h e s  =  1 4 0  M i s m a t c h e s  =  0 U n m a tc h e d  =  0
L e n g t h  =  1 4 0  M a t c h e s / l e n g t h  =  1 0 0 . 0  p e r c e n t
b) Alignment of H8R and H9R.
Figure 4.7a and b Alignment of H8 and H9 clones showing their sequence 
similarity.
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1 0  2 0  3 0  4 0  5 0  6 0
GGATCCGGGC CCGCCACTCG TCCGAGGTAG ACGGTATGGA TAAGCTTXAT ATCGTTCGAA
7 0  8 0  9 0  1 0 0  1 1 0  1 2 0
ATAGATATAT GCATTGTGAT AGCGTGCTAG GAATTACGCA TTGACTAGGC AAAAATTGGG
1 3 0
ACATGGGACA AT
a) 2.2UCON
1 0  2 0  3 0  4 0  5 0  6 0
GGATCCGCCT ACCTTCACGA GTTGCGCAGT TTGTCTGCAA GACTCTATGA GAAGCAGATA
7 0  8 0  9 0  1 0 0  1 1 0  1 2 0
AGCAGATAAG TTTGCTCAAC ATCTTCTCGG GCATAAGTCG GACACCATGG CATCACAGTA
1 3 0  1 4 0  1 5 0  1 6 0  1 7 0  1 8 0
TCGTGATGAC AGAGGCAGGG AGTGGGACAA AATTGAAATC AAATAATGAT TTTATTTTGA
1 9 0  2 0 0  2 1 0  2 2 0  2 3 0  2 4 0
CTGATAGTGA CCGGTTCGTT GCAACAAATT GATGAGCAAT GCTTTTTTAT AATGCCAACT
2 5 0  2 6 0  2 7 0  2 8 0  2 9 0  3 0 0
TAGTATAAAA AAGCTGAACG AGAAACGTAA AAATGATATA AATATCAATA TATTAATTAG
3 1 0  3 2 0  3 3 0
ATTTGCATAA AAACAGACTA CATAATACGT TAAACACAC
b) 2.2RCON
1 0  2 0  3 0  4 0  SO 6 0
GGATCCGCCT ACCXXXCACG AGTTGCGCAG TTTGTCTGCA AGACTCTATG AGAAGCAGAT
7 0  8 0  9 0  1 0 0  1 1 0  1 2 0
AAGCGATAAG TTTGCTCAAC ATCTTCTCGG GCATAAGCGG ACAGGATGGC ATCACGTATG
1 3 0  1 4 0  1 5 0  1 6 0  1 7 0  1 8 0
TGATGACAGA GGCAGGGAGT GGGACAAAAT TGAATAAATA ATGATTTTAT TTTGACTGAT
1 9 0  2 0 0  2 1 0  2 2 0  2 3 0  2 4 0
AGTGACCTGT TCGTTGCAAC AAATTGATAA GCAATGCTTT TTTTTAATGC CAACTTAGTC
2 5 0  2 6 0
TAAAAGCTGA CGAGAACGAA GATATAT
c) 1.3 UCON
Figure 4.8a -c Consensus sequences for the sub-clones from phage XCl and XC2
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1 0  2 0  3 0  4 0  5 0  6 0
GGATCCATTT CTATACTCAT CAAACTGTAG GGGTTGTAAT AGTTTATCCG ATTTCTCGCT
7 0  8 0  9 0  1 0 0  1 1 0  1 2 0
GTAGGGGTAC ACGAGAACCA CCGAGCCTGA TGTGGTTAAA AGACAGGCAC AATCTTTACT
1 3 0  1 4 0  1 5 0  1 6 0  1 7 0  1 8 0
ACCGCAATCC ACTATTTAAG GTGATATATG GAAGAAGAAT TTGAAGAGTT CGAAGAGCAT
1 9 0  2 0 0  2 1 0  2 2 0  2 3 0  2 4 0
CCTCAGGATG TGATGGAACA ATACCAGGAC TATCCGTATG ACTACGACTA TTGATAAAAT
CATGGTG
d) 1.3RC0N
1 0  2 0  3 0  4 0  5 0  6 0
GGATCCCCTT CGAAGGAAAG ACCTGATGCT TTTCGTGCGC GCATAAAATA CCTTGATACT
7 0  8 0  9 0  1 0 0  1 1 0  1 2 0
GTGCCGGATG AAAGCGGTTC GCGACGAGTA GATGCAATTA TGGTTTCTCC GCCAAGAATC
1 3 0  1 4 0  1 5 0  1 6 0  1 7 0  1 8 0
TCTTTGCATT TATCAAGTGT TTCCTTCATT GATATTCCGA GAGCATCAAT ATGCAATGCT
1 9 0  ^  2 0 0  2 1 0  2 2 0  2 3 0  2 4 0
GTTGGGATGG CAATTTTTAC XCCTGTTTTG•CTTTGCTCGA CATAAAGATA TCCATCTACG
2 5 0  2 6 0  2 7 0  2 8 0  2 9 0  3 0 0
ATATCAGACC ACTTCATTTC GCATAAATCA CCAACTCGTT GCCCGGTAAC AACAGCCAGT
3 1 0  3 2 0  3 3 0  3 4 0  3 5 0  3 6 0
TCCATTGCAA GTCTGAGCCA ACATGGTGAT GATTCTGCTG CTTGATAATT TCAGGTATCG
e) 6.6UCON
1 0  2 0  3 0  4 0  5 0  6 0
GGATCCCCCG GGCTGCAGGA ATTCAGCAGA GTGATAAAGG TGCCTGCAAC AAAACTGACC
7 0  8 0  9 0  1 0 0  1 1 0  1 2 0
ACCCAAGGTA ATGGTGGACA GCAAGGCGAG AATCCTCATC CTGCAAAGCA GACGAGGGGG
1 3 0  1 4 0  1 5 0  1 6 0  1 7 0  1 8 0
AACTGCAAAG TGGGGTTCGT GGGTAACCTT AGCTTCTACC GGAATTCGAT ATCAAGCTTA
1 9 0  2 0 0  2 1 0  2 2 0  2 3 0  2 4 0
TCGATACCGT CGACCTCGAG GXGGGGXXXC XXXCCGTACC CAATTCGTCC CTATAGTGCT
2 5 0  2 6 0  2 7 0  2 8 0  2 9 0  3 0 0
TCGATTACAA TTCACTGGGC CGTCGTTTTA CAACATTGTT ACGGGAAAAC CCTGATCTTA
3 1 0
CCCAACTTAA TGCCTTA
f) 6.6RCON
Figure 4.8d-f Consensus sequences for the sub-clones from phage XCl and XC2
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H 12Ü CON
H llR  COM
EnnimJISnESŒIŒ nnMiMMMHiinnnnnn^
120
1
60
1 1 8
Ç^ÇTGÇl^GTGGGGTTCGTGGGTAACCTTAGCTTCTACCGGAA
g a a c t g c a a a g t g g g g t t g t t g g g t 1 a c t t a g t g i4 c t Âc c t a a t t g a t a
M a t c h e s  =  1 4 7  M i s m a t c h e s  =  1 4  U n m a tc h e d  =  9 
L e n g t h  = 1 7 0  M a t c h e s / l e n g t h  =  8 6 . 5  p e r c e n t
a) Alignment ofH12U and H llR
E12R  COM 
H llU  CON
GGATCCGCCTACCXXXCACGAGTTGCGCAGTTTGTCTGC^GACTCTATGAG^GCAGAT
mnnniinnnmns
1 
1 
61  
61  
121 
121
1 8 1  AGTGACCTGT
«1 I M A
M a tc h e s  =  1 7 7  M is m a t c h e s  =  9 U n m a tc h e d  =  4
L e n g th  = 1 9 0  M a t c h e s / l e n g t h  =  9 3 . 2  p e r c e n t
b) Alignment of H llR  and H12U.
Figure 4.9 Alignment of HI 1 and H12 clones showing their sequence similarity
124
1 .3  R CON
2 .2  R CON
1 GGATCCGCCTACCXXXCACGAGTTGCGCAGTTTGTCTGCAAGACTCTATGAGAAGCAGAT
l l l l l l l l l l l l l  l l l l l l l l l l l l l l l l l l l l l l l l l i i l l l l l l l l l l l l l l l l l
1 GGATCCGCCTACC TTCACGAGTTGCGCAGTTTGTCTGCAAGACTCTATGAGAAGCAGAT
6 1  AAGC GATAAGTTTGCTCAACATCTTCTCGGGCATAAG CGGACAGGATGGCATCAC GT
I I I !  IIIII11 III Millill III I I I I I I I I  Mil Mini II MM MM II
6 0  AAGCAGATAAGTTTGCTCAACATCTTCTCGGGCATAAGTCGGACACCATGGCATCACAGT
1 1 8  AT GTGATGACAGAGGCAGGGAGTGGGACAAAATTG AAT AAATAATGATTTTATTTTG
II MMMMMMMMMMMMMMMMI  Ml MMMMMMMMMI
1 2 0  ATCGTGATGACAGAGGCAGGGAGTGGGACAAAATTGAAATCAAATAATG ATTTTATTTTG
1 7  5 ACTGATAGTGACCTGTTCGTTGCAACAAATTGATAAGCAATGCTTTTTTTTAATGCCAAC
l l l l l l l l l l l l l  MMMMMMMMMM MMMMMMM MMMMM
1 8 0  ACTGATAGTGACCGGTTCGTTGCAACAAATTGATGAGCAATGCTTTTTTATAATGCCAAC
2 3 5  TTAGTCT AAAAGCTG ACGAG AACGAAGATAT AT
Mi l l  I MMMM Mi l l  MM I I II II
2 4 0  TTAGTATAAAAAAGCTGAACGAG AAACGTAAAAATGATATAAATATCAATATATTAATTA
3 0 0 GATTTGCATAAAAACAGACTACATAATACGTTAAACACAC
M a t c h e s  =  2 5 5  M i s m a t c h e s  =  1 1  U n m a tc h e d  =  7 4  
L e n g t h  =  3 4 0  M a t c h e s / l e n g t h  =  7 5 . 0  p e r c e n t
Figure 4.10
similarity.
sequence alignment between 1.3RC0N and 2.2RCON showing their
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2.2 U Con EcoRl 2.2 R Con T
H8/H9 H1/H5 (6.6Kb)
2.2 U Con T 2.2 R Con
1.1Kb 1.1Kb
1.3UCon 1.3RCon T
H12 H13-H17 (6.6Kb)
1.3UCon T 1.3 R Con
1.3 Kb
KEY
Extent of areas sequenced
Direction and name of sequence
Figure 4.11 Relationship of subclones to each other and position of the consensus 
sequences
INSERT MGS SHORT PHAGE ARM
2M 6v6 kb
Figure 4.12 Revised positioning of clones against the short arm of X phage
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4.6 RE EVALUATION OF THE LIBRARY SCREENING
The results from the sequencing of the XCl and XC2 phage clone inserts questioned 
the identification of the other clones isolated. While the Group 1 clones had a 
significantly different restriction map to the ones sequenced the sizes of the phage arms 
were unexpected and the small phage arm (9kb) seemed to be cut with EcoRI (Table
4.3).
The filters from the original mapping gel of the 600bp positive X clones (Figure 4.2) 
was hybridised with a radiolabelled X phage probe and washed to the same stringency 
as before. The resulting autoradiograph showed that all the DNA bands in all the 
clones were positive for the probe. At this point the it was concluded that isolation of 
the regions of interest was unlikely fi'om these clones and work on the clones was 
stopped.
4.7 DISCUSSION
From the results it was not clear if the problem encountered was due to contamination 
of the 600bp CYP4A1 cDNA probe with plasmid or X sequences, or whether there had 
been cross-contamination with a recombinant containing rearranged X phage DNA 
fragments
While this episode was obviously a diversion from the research aim, it allowed many of 
the problems with the system to be identified and rectified. From this point onwards 
all new DNA sequence was checked immediately against the database with emphasis 
on comparison with cloning vector sequences.
At this point sufficient DNA sequence from HG6 and HG19 (Chapter 3) had been 
completed to be clear that they represent genuine fragments from a human CYP4A 
gene. The genomic library was re-screened under stringent conditions with an HG19 
probe in order to maximise the likelihood of isolating further authentic human CYP4A 
sequences and to walk up the gene in the 5' direction. This work is discussed in 
Chapter 5.
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CHAPTER 5
SCREENING OF HUMAN PLACENTAL GENOMIC DNA
LIBRARY WITH HG19
CHAPTER 5 ; SCREENING OF HUMAN PLACENTAL GENOMIC 
DNA LIBRARY WITH HG19
5.1 INTRODUCTION
The previous library screen using the 600bp rat CYP4A1 cDNA probe had not 
produced any recombinant DNA clones that could be used for characterisation of the 5' 
regulatory regions of a human CYP4A gene. It was therefore necessary to re-screen 
the library with one of the human fragments (HG6 or HG19) in order to isolate 
recombinant phage containing DNA from a region closer to the 5’ end of the gene. It 
was expected that this approach might not give much of the 5' regulatory region and a 
further screening of the library would be required, using a probe from the 5' end of the 
recombinant phage isolated in this screen to walk up the chromosome.
HG19 was selected as the probe for the following reasons :
a) HG19 was isolated from a human library and so there would be no species 
differences accounting for low homology between probe and target DNA.
b) HG19 was a genomic fragment and therefore contained both intronic and 
exonic sequence. The resulting hybridisation between the probe and the target DNA 
would be uniform for both intronic and exonic nucleotide sequence, a property not 
shared with cDNA probes.
c) Previous hybridisations using HG19 as the probe had not shown any of the 
vector contamination problems which were seen with the CYP4A1 cDNA derived 
probes.
d) If HG6 was used as a probe, any isolated recombinant phage which 
contained 5' regions would also contain HG19. As the recombinant inserts were sized 
to 14kb during the original library manufacture the amount of novel nucleotide 
sequence would be reduced. It was therefore considered better to use HG19 as the 
probe of choice.
5.2 LIBRARY SCREENING WITH HG19
5.2.1 DETERMINATION OF LIBRARY TITRE
The library was titred as before (section 4.2.2) and a titre of 2.8 x 10^  ^ pfu/ml was 
calculated. This was considered high enough to proceed with the screening process.
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5.2.2 PRIMARY SCREENING OF THE LIBRARY
The library was plated out over 5 square plates (A-E) as before (section 4.2.3.1) and 
the plaques were grown overnight. Duplicate filter lifts were made and these were 
prepared for hybridisation.
SOpg of HG19 DNA was prepared using a Qiagen tip 100 and was digested with 
BamHI. The digest was electrophoresed and the 1.4kb HG19 insert band excised from 
the gel and purified by the Glassmax process (section 2.2.3). Five 500ng aliquots of 
the purified HG19 probe were radiolabelled using the Megaprime procedure and 
incubated with the filters overnight at 42°C. The filters were washed to a stringency of 
0. IxSSC / 0.1%SDS / 55°C and exposed for autoradiography.
After a 72hr exposure the resulting autoradiographs were developed and examined for 
positive plaques. 9 potential positives were identified, XAl, XA2, XA3, XBl, XCl, 
XC2, XDl, XD2 and XEl. These were picked into phage buffer and incubated at 4°C 
overnight to allow diftusion of the phage into the solution.
5.2.3 SECONDARY SCREENING OF POSITIVE PHAGE
The 9 positive recombinant phages were serially diluted (10’^  to 10'^) and plated out 
onto 90mm petri dishes of L agar + MgS0 4  as before (section 4.2.4). The plaques on 
each plate were counted and a plate with 100-500 plaques selected for filter-lifts. The 
filters were hybridised with an HG19 probe and washed to a stringency of O.lxSSC / 
0.1%SDS / 55°C and exposed for autoradiography.
The resulting autoradiographs showed that 4 of the recombinant phages (XAl, XCl, 
XC2 and XEl) were not hybridised by the HG19 probe and were rejected as false 
positive. Of the remaining 5 phage XBl and XD2 were strongly hybridised while XA2, 
XA3 and XDl gave a weaker signal.
Due to the relatively small number of plaques on the plates selected for the filter lifts it 
was possible to pick positive plaques which were discrete. These plaques probably 
originated from a single recombinant phage and thus would cut down the number of 
rounds of screening to ensure a homogeneous stock. As before four plaques were 
picked for each plate and stored in phage buffer overnight at 4°C.
5.2.4 FINAL ROUND OF SCREENING
The 5 remaining recombinant phage clones were diluted (10'^ to 10-^ ) and plated out 
as before. The resulting plaques were counted and plates with 10 to 100 plaques were 
selected for filter lifts. The filters were hybridised and washed as for the second round
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of screening (section 5.2.3) and exposed to autoradiography for 48hrs. Recombinant 
phage XBl and XD2 both gave strong hybridisations and all the plaques on the plate 
again were positive for the HG19 probe. These phage were considered homogeneous 
and could be used to prepare phage DNA.
The other three phage (XA2, XA3 and XBl) gave a much weaker signal and were not 
homogeneous. From the experience of the previous chapter these clones were rejected 
as possible artefacts.
5.3 ANALYSIS OF RECOMBINANT PHAGE XBl AND XD2.
5.3.1 PREPARATION OF DNA FROM XBl AND XD2
The phage stocks for XB1 and XD2 were used to prepare primary lysates as before and 
these lysates were used to prepare phage DNA by the liquid lysate method (section
2.4.3). The first phage DNA preparations gave a good yield for XD2 but was not 
successful for XBl. It was decided to continue the analysis of XD2 while further 
efforts were made to prepare good phage DNA from XBl.
5.3.2 RESTRICTION DIGEST MAPPING OF XD2
The XD2 recombinant phage clone was analysed by restriction digest mapping using a 
range of enzymes. Xhol was used to free the phage arms from the insert, BamHI was 
used to detect the presence of HG19 and EcoRI, Hindlll and Xbal were used to 
provide further detail to the restriction map.
5 pi of XD2 DNA was digested with each enzyme, singly and in pairs and the digests 
were electrophoresed on 1% agarose gels with X/OX174 markers. One of the 
mapping gels is shown in Figure 5.1 (the loading order of which is shown in Table 5.1) 
The gels were analysed by Southern blotting using HG19 as a probe. The resulting 
autoradiograph for the gel in Figure 5.1 is shown in Figure 5.2a. The filters were then 
stripped and re-hybridised with the 600bp CYP4A1 cDNA probe. The resulting 
autoradiograph from the gel in Figure 5.1 is shown in Figure 5.2b. The probing aided 
the positioning of the resulting digest fragments in the restriction map. and the 
resulting restriction fragment sizes from all the gels are shown in Table 5.2.
From the results of the mapping and Southern blot analysis the following conclusions 
were drawn.
a) The deduced sizes of the phage arms (20 and 9kb) agreed with the literature, 
unlike the recombinant phage isolated from the previous screen. This confirmed that 
XD2 was a true recombinant phage and not wild type contamination as before.
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14 13 12 11 10 9 8 7
ORIGIN
23.7kb
0.087
0.60
Figure 5.1 Restriction mapping of XD2. The loading order is shown in Table 5.1 
(below).
LANE ENZYME(S)/MARKERS
1 X /0X174
2 BamHI
3 EcoRI
4 Hindlll
5 Xbal
6 X /0X174
7 Hindni + BamHI
8 Hindlll + EcoRI
9 Hindlll + Xbal
10 X /0X174
11 BamHI + EcoRI
12 BamHI + Xbal
13 EcoRI + Xbal
14 X /0X174
Table 5.1 Loading order for mapping gel in Figure 5.1 (above).
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ENZYME RESTRICTION FRAGMENT SIZES (kb) AND 
HYBRIDISATIONS
BamHI 27 + 1.4
Xhol 23,19 + 9.2
EcoRI 27, 1.35 + 1.0
Hindin 27, 12.5, 4.7, JL2 + 0.96
Xbal 27, 14,10 + 2.3
Xhol + BamHI 23, 16, 9.6, 1.4 + 0.8
Xhol + EcoRI 23, 14.5, 9.5, 1.4, 1.0, 0.48 + 0.39
Xhol + Hindm 23, T4, 5.2, 4 .4 ,1 2 +  0.92
Xhol + Xbal 23, 9.2. 6.2. 4.4. 2.7+ 1.9
Hindlll + BamHI 23.11.5. 5.6. 4.5. 1.4. 1.2 + 0.98
Hindlll + EcoRI 23, 11.5,17, 4.6, 1.3, 1.2,1.0 + 0.98
Hindlll + Xbal 23, (11.5), 7.4, 4.7, 3.4, 0.98 + 0.76
BamHI + EcoRI 23, 1.0, 0.65 + 0.37
BamHI + Xbal 23, (18), 12.5 ,15,11, 2.4 + 1.4
EcoRI + Xbal 23.08). 12.5.3.5, 1.3 + 0.98
Table 5.2 Restriction fragment patterns for digest of phage DNA.
Fragments underlined hybridised with the 600bp cDNA probe and fragments in bold 
hybridised with the HGl 9 probe.
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b)The recombinant phage insert contained the whole of HGl 9 which was 
mapped to its 3' end. Further probing of the Southern blots using HG6 as a probe 
confirmed that the 800bp fragment between HGl 9 and the phage arm (liberated by 
Xhol + BamHI) was homologous to HG6. This is shown in Table 5.3 and Figure 5.3a 
and b
c) The first 8kb of the 5’ end of the XD2 phage did not hybridise to the 600bp 
cDNA probe. It was concluded that this region was therefore 5' to the coding 
sequence and probably contained the CYP4A gene's regulatory regions.
d) The distribution of the EcoRI sites around HGl 9 as predicted in the 
genomic DNA Southern blot analysis (section 3.5.6) was confirmed by the restriction 
mapping. The hybridised band sizes from the genomic DNA were 1.35 and l.Okb and 
these sizes are confirmed by the EcoRI digestion pattern in Table 5.2 .
e) The Southern Blot analysis using the 600bp cDNA probe locate the probable 
transcriptional start site to the 3' end of the 4.0kb Xbal fragment. This region can be 
removed from the 4.0kb fragment with Hindlll to give a 0.76kb fragment which is 
hybridised by the 600bp probe.
The deduced restriction map of ^ D2 is shown in Figure 5.4.
5.3.3 RESTRICTION MAPPING OF XBl
During the restriction enzyme analysis of X,D2 a good preparation of IB l phage DNA 
was also obtained. This DNA was digested with BamHI, Xbal and Xhol and the 
restriction fragments separated by electrophoresis in parallel with the corresponding 
digests from XD2. The resulting gel is shown in Figure 5.5 and the loading order and 
restriction fragment sizes are shown in Table 5.4.
On digestion with BamHI, two fragments, 2.7 and 1.4kb, were liberated from the 
phage arms and these fragments co-electrophoresed with HG6 and HGl 9 respectively. 
This implied that ^B1 extended further towards the 3' end of the gene.
The Xbal digest liberated two fragments from the phage arms, 4.0 and 2.3kb and these 
matched the fragments of the same size in the Xbal restriction pattern for XD2. 
Samples of the 2 fragments from XBl were prepared by the Glassmax process (section
2.2.3) and used as probes for Southern blot analysis of the filters from the XD2 
mapping gels. In both cases the probes hybridised to their corresponding homologues 
from ^D2 and it was concluded that they were the same (data not shown).
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5 4 3 2 1
ORIGIN
23.7kb
9.4
6.7
4.3
2.3 
2.0
0.60
B
5 4 3 2
ORIGIN
#
0.80kb
Figure 5.3 Southern blot analysis of A.D2 with the HG6 probe. The ethidium bromide 
stained gel (A) was loaded as shown in Table 5.3 . The autoradiograph (B) is from a 
72hr exposure of a filter hybridised with the HG6 probe. (NB The photograph of the 
gel and that of the autoradiograph are not to the same scale.)
LANE SAMPLE
1 X Marker
2 Uncut XD2
3 BamHI cut 1D2
4 Xhol cut XD2
5 BamHI/Xhol cut XD2
Table 5.3 loading order for gel in Figure 5.3a.
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Figure 5.5 Comparison of the restriction digest patterns of XBl, XD2. 
Loading order of gel shown in Table 5.3 (below).
LANE SAMPLE ENZYME(S) RESTRICTION FRAGMENT 
SIZES (kb)
1 A,/0X174
2 XBl Xhol 23, 19 + 9.2
3 XD2 Xhol 20, 18 + 9
4 XBl Xbal 27, 14, 4.0, 3.0+ 2.4
5 XD2 Xbal 27, 10, 4.0+ 2.4
6 XBl BamHI 23, 20, 2.7+ 1.4
7 XD2 BamHI >23 +1.4
8 X /0X174
9 XBl Xhol + EcoRI [23, 16.0, 9.5, 2.0, 1.4, 1.0, 0.48]
10 XD2 Xhol + EcoRI [23, 14.5, 9.5, 1.4, 1.0, 0.48, 0.39]
11 XBl Xhol + BamHI 23, (16), 9.6, 2.7, 1.4
12 XD2 Xhol + BamHI 23,(16), 9.6, 1.4, 0.8
13 A,/0X174
Table 5.4 Loading order for gel in Figure 5.5 (above) with deduced restriction digests 
fragment patterns for IB land XD2. Figures in square brackets are derived from other gels 
due to degradation in the samples run on the gel shown in Figure 5.5.
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On comparison of the Xbal + Xhol digest patterns for XD2 and XBl it was apparent 
that the 4.0 and 2.3kb bands were conserved between the two phage DNAs. The 6kb 
fragment seen in XD2 (which contained HGl 9 and part of HG6) was absent but was 
replaced by a 9.5kb fragment in XBl. The 1.9kb fragment at the 5' end of XD2 was 
also absent in XBl but was replaced by a 3kb fragment. It was concluded that XBl 
extended 1.1 kb further upstream than XD2. Therefore XBl contained the whole of 
XD2 and extended further at both ends. The proposed relationship between the two 
recombinant phages is shown in Figure 5.6.
5.3.4 COMPARISON OF XBl AND XD2 TO CYP4A1 AND CYP4A2
From the nucleotide sequence analysis reported in Chapter 3, the relative sequence 
alignment of HGl9 and HG6 against CYP4A1 and CYP4A2 was determined The 
Southern blot analysis of XD2 using the 600bp cDNA probe indicated that the probable 
position of the transcriptional start site (ie exon 1) was located in the last 800bp of 
HG23.
Using these 2 regions of the human gene as reference points, CYP4A1 and 4A2 were 
aligned to XBl and XD2. It became apparent that, if the maps of XBl and XD2 were 
correct, the human gene contained in the recombinant phages was more compact than 
both the rat genes. This corroborated the proposed intronic sequence loss reported in 
section 3.4.4 . The relative sizes XBl, XD2, CYP4A1 and 4A2 are also shown in 
Figure 5.6.
The next stage in the characterisation of XB1 and XD2 was to subclone the insert DNA 
into plasmid for more extensive analysis.
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5.4 SUB-CLONING OF XBl AND XD2 PHAGE DNA INTO PLASMID 
VECTORS
5.4.1 INTRODUCTION AND DESIGNATION OF SUB-CLONES
The next stage in the analysis of the phage DNA was to sub-clone it into a plasmid 
vector. It was necessary to select suitable enzymes which digested the phage DNA 
into smaller fragments suitable for insertion into the plasmid.
It was observed that the Xbal + Xhol restriction pattern of XD2 showed fragments of 
6.2, 4.0, 2.3 and 1.9kb (from Table 5.2). These were suitable for sub-cloning as they 
were well separated and cut the phage DNA into manageable sections. These 
fragments were coded as follows; the 1.9kb was designated HG21, 2.3kb fragment was 
HG22, the 4.0 kb fragment was HG23 and the 6.0 kb fragment was HG24.
During the mapping of the XD2 recombinant phage DNA it was found that a partial 
Xbal/Xhol digest resulted in a 6.3kb fragment consisting of HG22 and HG23. This 
fragment was also of interest as it would give alignment data for HG22 and HG23 and 
would also represent the first 6kb of the human genes non coding region. This 
fragment was designated HG25.
The 800bp Xbal/Hindlll fragment which contained the proposed transcriptional start 
site (part of HG23) was also of interest and this was designated HG26. As the HGl 9 
and HG6 fragments had been characterised previously it was also decided to designate 
the portion of HG23 not covered by HGl 9 and HG6 as HG27.
In XBl the fragment that overlaps HG21 was designated HG28 and the fragment 
between HG6 and the phage arm was designated HG29. All these fragments are 
indicated on Figure 5.6
The plasmid selected for this subcloning was pGEM7zf(+) for the reasoned discussed 
before (see section 4.5.1).
5.4.2 SUB-CLONING OF HG22 AND HG23 INTO pGEM
The first of the fragments to be subcloned were HG22 and HG23 as these were the 
simplest to perform. Both fragments were liberated from XD2 by Xbal and therefore 
both fragments had Xbal sites at either end. This meant that HG22 and HG23 could 
be sub-cloned by shotgun ligation (section 2.5.1).
5jig of pGEM7zf(+) and lOmg of XD2 phage DNA was digested overnight with 5 and 
lOU Xbal respectively. The resulting digest was extracted with phenol/chloroform and 
the DNA was extracted from the aqueous phase and precipitated with ethanol by the
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standard method. The plasmid was treated with CIAP (section 2.2.7) to prevent self- 
re-legation and the DNA was extracted again with phenol/chloroform and precipitated 
with ethanol.
The ligation reactions and controls were prepared as they were in Table 4.6 for the 
ligations of the previous round of screening (the size of the recombinant phage were of 
the same order and so the same ratios could be used). The ligation reactions were 
incubated at 14°C overnight and then transfected into JM109 competent cells (section
2.5.3) and screened on X-Gal plates.
A total of 8 white colonies were identified and these were restreaked from the plates 
and analysed by 'cracking'. A single colony contained plasmid with an insert (data not 
shown) and this plasmid was prepared using the Qiagen tip 10 process. The plasmid 
DNA was linearised by digesting with Xhol ( as it was known that the insert did not 
contain an Xhol site) and isolated with Xbal. The linearised plasmid was sized (by 
electrophoresis with markers) at 9kb and the Xbal digest showed bands at 4.0, 3.0 and 
2.3kb. It was concluded that the inserted fi’agment was HG25 and the Xbal restriction 
fragment pattern consisted of HG23, pGEM and HG22 respectively. Glycerol stocks 
(section 2.5.7) were prepared for the HG25 clone.
It was decided to use the HG25 plasmid DNA as the source of both vector and insert 
for a re-ligation. The molar ratio of vector : insert is 1:1 in HG23 and therefore would 
favour the insertion of a single fragment. Spg of HG25 was digested with 5U of Xbal 
overnight and an aliquot of the DNA was electrophoresed to check complete digestion. 
The remaining DNA was extracted by phenol/chloroform and precipitated with 
ethanol.
The DNA was diluted so that Ipl contained the equivalent of lOOng of vector DNA 
(and therefore 200ng of insert) and Ipl was ligated with lOU of T4 DNA ligase in a 
total volume of 10|il of ligation buffer. The reaction was incubated overnight at 14°C 
and then transfected into JM109 competent cells as before. The transfections were 
screened on X-Gal plates and 200 white colonies were observed. The positives were 
confirmed by re streaking onto fi'esh X-Gal plates and 52 positives were analysed by 
the cracking procedure. A section fi'om on of the gels is shown in Figure 5.7 and this 
is a good representation of the rest of the gels.
The colonies from lanes 2, 5 and 7 were selected as representative of the different 
bands observed and Qiagen tip 20 plasmid DNA preparation performed on them. The 
DNA for each clone was digested with Xbal to determine the insert size.
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14 13 12 11 10 9 8 7 5 4
Figure 5.7 Section from one of the gels used in the 'cracking' analysis of the HG25 
religations. Lane 1 contains super coiled pGEM and lanes 2 - 1 4  contain 'cracked' 
colony preparations. Lanes 2, 5 and 7 were selected as a representative inserts .
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The DNA from clone 2 gave a single band at 3.0kb (data not shown) and it was 
concluded that this clone contained two pGEM plasmids ligated together to form a 6kb 
dimer. This was common in ligations were the plasmid DNA was not 
dephosphorylated with CIAP prior to ligation. In some rare cases 9kb pGEM trimers 
were also identified.
The Xbal digestion of clones 5 and 7 produced insert bands of 4.0 and 2.3kb 
respectively and it was concluded that these were HG23 and HG22. To confirm this 
the plasmids were digested with Xbal, HindlH and Sad both singly and in pairs to 
determine a restriction map of the inserted DNA. The digests were electrophoresed 
with X/OX174 markers and a sample of Xbal cut XD2. The gel is shown in Figure 5.8 
and the loading order and deduced band sizes are shown in Table 5.5. By comparing 
the Xbal banding pattern for clone 5 (lane 2) and XD2 (lane 8) the 4.0kb band can be 
seen in both. The same can be seen for the 2.4 kb band in clone 7 (lane 9).
The gel was analysed by Southern blotting using the 600bp CYP4A1 cDNA and the 
resulting autoradiograph is shown in Figure 5.9. The positive bands are also shown in 
Table 5.5. The hybridisation pattern shows that the 600bp positive region is restricted 
to the 640bp Hindlll/Xbal fragment in HG23 as predicted from the XD2 phage DNA 
mapping.
The deduced restriction map for the clones is shown in Figure 5.10. From the mapping 
data it was concluded that the HG23 fragment was inserted in the opposite direction 
into the plasmid (ie sequencing using the universal primer would give the sequence for 
the anti-sense strand of the XD2 phage DNA).
The evidence confirmed that clone 5 was HG23 and clone 7 was HG22 and glycerol 
stocks (section 2.5.7) were prepared for both of them.
5.4.3 SUBCLONING OF HG21 INTO pGEM
The subcloning of HG21 was not as easy as for HG22 and HG23 as the fragment had 
an Xbal site at one end and an Xhol site at the other. This reduced the potential 
efficiency of the ligation reaction as two separate sites were involved and the 
probability that a single insert would be ligated at both ends to the same vector is less if 
the sites are different.
An attempt was made to shotgun ligate HG21 and HG24 into pGEM in the same 
fashion as for HG22 and HG23. 25pg of XD2 was digested with 25U Xbal and 25U 
Xhol overnight and the DNA was extracted by phenol/chloroform and ethanol 
precipitation. 5pg of pGEM was also digested with 5U Xbal and 5U Xhol and 
extracted in the same manner.
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ORIGIN
23.7kb
0.087
Figure 5.8 Restriction enzyme analysis of clone 5 (HG23) and clone 7 (HG22). 
Loading order shown in Table 5.5
LANE SAMPLE ENZYME(S) RESTRICTION FRAGMENT SIZES 
(kb) AND HYBRIDISATIONS
1 X /0X174 see section 2.2.1
2 Clone 5 Xbal 19  + 3.0
3 Clone 5 Xbal + Hindlll 3.2.3.1+0.64
4 Clone 5 Hindlll 1 7  + 3.4
5 Clone 5 Xbal + Sad 19  + 3.0
6 Clone 5 Sad 19+3.2
7 X /0X174 see section 2.2.1
8 XD2 Xbal >23, 14, 4.0 + 2.3
9 Clone 7 Xbal 3.0, 2.5
10 Clone 7 Xbal + Hindlll 3.0, 1.1, 1.0 + 0.52
11 Clone 7 Hindlll 3.9, 0.9 + 0.54
12 Clone 7 Xbal + Sad 2.9, 1.6, 0.35+0.31
13 CXone 7 Sad 3.3, 1.6 + 0.28
14 X /0X174 see section 2.2.1
Table 5.5 Loading order for the gel in Figure 5.8. Fragments underlined hybridise 
with the 600bp CYP4A1 cDNA probe.
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23.7kb
9 . 4
6.7
4 . 3
2 . 3  
2.0
0.60
Figure 5.9 Southern blot analysis of the gel shown in Figure 5.8 using the 600bp 
CYP4A1 cDNA probe. Sample positions and calculated fragment sizes are shown in 
Table 5.5
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Figure 5.10 Deduced restriction enzyme digest map of HG23 and HG22. 
from Table 5.5
Derived
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There was no need to dephosphorylate the plasmid as it could not self-religate. The 
ligations were set up as reported above (for HG22 and HG23) and the ligations 
performed overnight at 14°C. The resulting mixtures were transfected into JM109 
competent cells and plated out onto X-Gal plates as before. The plates showed a low 
frequency of white colonies and these were shown to be non-recombinant artifacts in 
the cracking procedure. The experiment was repeated with the same result and it was 
therefore decided to try a different approach to the sub-cloning.
The rest of the Xbal / Xhol cut XD2 was electrophoresed on an agarose gel with a 
long sample slot. The 1.9 band was excised from the gel and purified by the Geneclean 
process. The concentration of the purified sample was determined by electrophoresing 
an aliquot with a known concentration of marker. This was the best method as 
residual Nal can effect the concentration measurements by uv/vis spectrophotometry. 
Ligation reactions were performed with the purified insert in the molar ratios of 1:1, 
1:3 and 3:1 with the same controls as before.
A total of 45 white colonies were obtained from the X-Gal plates and these were 
analysed by the cracking procedure. Part of a cracking gel is shown in Figure 5.11 and 
plasmid DNA was prepared from colonies 3, 7 and 8 using the Qiagen tip 20 method. 
The plasmid DNA was digested with Xbal + Xhol and in all three samples a 1.9kb 
insert was separated from the vector when electrophoresed. Glycerol stocks were 
made from colony 7 and these were used as the source for HG21 for further analysis.
The relationship between HG21, 22, 23 and 25 to XD2 are shown in Figure 5.12. The 
loading order for this gel is shown in Table 5.6.
5.4.4 ATTEMPTED SUB-CLONING OF HG24
The 6kb HG24 fragment had a Xhol site at one end and an Xbal site at the other and 
this made it difficult to sub-clone for the reasons discussed above. Added to the 
problem of the different enzyme sites, the size of the insert was approaching the upper 
limit for insertion into pGEM.
As described above, the shotgun ligation of the Xbal/Xhol cut XD2 did not produce 
any 6.0kb inserted plasmids in either of the attempts. The 6.0kb was also cut out of 
the gel and purified by the Geneclean technique. This purified insert was used in 
directed ligations into Xbal/Xhol cut pGEM but again no positive results were 
obtained. The XD2 DNA preparation and digestion was repeated 5 times and each 
time the 6.0kb band was purified and attempts were made to ligate the insert into 
pGEM with no results.
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14 13 12 11 10 9 8 7 6 5 4 3 2 1
Figure 5.11 Section from one of the gels used in the 'cracking' analysis of the HG21 
ligations. Lane 1 contains supercoiled pGEM and lanes 2 - 1 4  contain 'cracked' colony 
preparations. Lane 7 was selected as a representative insert.
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Figure 5.12 Relationship between HG21, HG22, HG23 and HG25 to XD2. The 
loading order is shown in Table 5.6 (below).
LANE SAMPLE RESTRICTION FRAGMENT SIZES 
(KB)
1 X Marker 23.7, 9.4, 6.7, 4.3,2.3,2.0 + 0.6
2 Xhol/Xbal cut HG21 3.0+ 1.9
3 Xbal cut HG22 3.0+ 2.4
4 Xhol/Xbal cut XD2 20, 9, 4.0, 2.4, 1.9
5 Xbal cut HG23 4.0+ 3.0
6 Xbal cut HG25 4.0,3.0 + 24
7 X Marker 23.7, 9.4, 6.7, 4.3, 2.3,2.0 + 0.6
Table 5.6 Loading order and restriction fragment sizes for the gel in Figure 5.12 
(above). The 3kb band in lanes 2, 3, 5 and 6 is pGEM plasmid vector.
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In a change of approach the 6.0kb insert was blunt ended using the Klenow fragment 
(section 2.2.7) and attempts were made to ligate it into the Smal site in pGEM. It was 
thought that did not produce inserts with the correct size.
To determine whether the vector was a contributory factor pBluscript SK(-) (Figure
2.4) was used instead of pGEM. This was tried for both Xbal/Xhol and Smal 
insertion, but no authentic 6.0kb inserted plasmids were obtained.
Finally the 6.0kb insert was digested with BamHI to produce 3.8kb (HG27) and 2.2kb 
(HGl9 and part of HG6) fragments. The 3.8kb fragment represented the last piece of 
the coding sequence (except the 3' end of exon 12) that had not yet been sub-cloned. 
An attempt was made to insert this fragment into BamHI/Xbal cut pGEM and 
pBluescript but neither vector accepted the insert.
Work is still ongoing to sub-clone this fragment. While it contained exons 2 - 7  and is 
therefore important for the coding sequence, it did not contain any of the 5' regulatory 
regions and so it was worked on in the background.
5.4.5 SUBCLONING OF HG6 AND HGI9 INTO pGEM
Although HG6 and HGl 9 were already subcloned into the plasmid pUC9, the multiple 
cloning site was limited and did not contain suitable enzyme sites for the Erase-a-base 
nested deletion system (section 2.7.1) which was to be used for the complete 
sequencing of the clones from XD2 /XBl. It was therefore necessary to transfer the 
inserts to pGEM which had a suitable multiple cloning site. To avoid confusion the 
pUC9 based recombinant plasmids were reclassified pHG6 and pHG19 to avoid 
confusion with the pGEM derived plasmids which were designated HG6 and HGl 9.
A clean preparations of pHG19 insert was prepared as for use in hybridisation and this 
was used in ligation reactions. Because the insert was generated from plasmid rather 
than phage it was possible to accurately determine the correct plasmidivector ratios 
and the fragment was inserted on the first attempt. This was designated HGl9 and 
glycerol stocks were made.
The subcloning of the HG6 insert was more difficult as it co-electrophoresed with the 
pUC9 vector. The BamHl/PvuI double digest resulted in a high frequency of pUC9 
vector being inserted into the pGEM vector instead of the HG6 insert. This was only 
detectable when the plasmid DNA had been prepared and mapped and so lead to 
several false positives. The problem was overcome by digesting the pHG6 plasmid 
DNA with Pvul overnight to ensure complete digestion. This resulted in 2 fragments, 
4.9kb (containing the HG6 insert) and a 0.9kb pUC fragment. The larger band was 
excised and purified by the Geneclean method.
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This fragment was then digested with BamHI to yield the 2.7kb HG6  insert and two 
plasmid fragments of 1 .8  and 0 .1 2 kb which were separated easily by electrophoresis. 
The insert was then excised and purified using the Geneclene method and used in 
ligation reactions with pGEM. This approach worked well and the resulting plasmid 
was designated HG6 . Glycerol stocks were produced from the cultures.
5.4.6 SUB-CLONING OF HG26
The 600bp CYP4A1 cDNA probe hybridisation result from HG23 (see Table 5.4) 
indicated that the 0.64kb Hindlll/Xbal fragment (HG26) contained the start of the 
coding region of the human CYP4A gene. It was therefore of interest to isolate and 
sequence this fragment completely as it was probable that it contained both exon 1 and 
the immediate 5' regulatory regions.
From the mapping of HG23 it was noted that digestion of the plasmid with Hindlll 
resulted in the excision of that part of the insert not contained in HG26. 5pg of HG23 
was digested with Hndlll and the DNA was extracted by phenol/chloroform and 
ethanol precipitation. The DNA was diluted to lOOng of plasmid/p.1 and recircularised 
with T4 DNA ligase in a total of lOpl of ligase buffer. It was calculated that the 
reaction should favour the recircularisation of the plasmid compared with the 
reinsertion of the deleted fragment. This was confirmed when the resulting white 
colonies were screened by cracking as of the 26 colonies screened all contained the 
HG26 insert alone (confirmed by Hindlll/Xbal digestion of the resulting plasmid). 
Glycerol stocks were prepared from a selected colony and was used as the source for 
HG26 DNA.
Once sub-cloned, the DNA was ready to be analysed by sequencing. This was a large 
scale project and required the assimilation of two new techniques, the Eras-a-base 
nested deletion system and automated sequencing technology for the large number of 
deleted sub-clones.
5.5 DISCUSSION
Due to limitations of time it was decided not to pursue the sub-cloning of other 
fragments from XBl (ie HG28 and HG29) as they were considered to be of lower 
priority than the sequencing of the existing clones, which included the 8 kb of the 5' 
flanking region of the human CYP4A gene. The other clones were therefore allocated 
a lower priority.
The human CYP4A sub-clones were then ready for DNA sequence analysis and this is 
reported in the next chapter.
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CHAPTER 6
NUCLEOTH)E SEQUENCE ANALYSIS OF THE HG21, 
HG22, HG23, HG26, HG19 AND HG6 SUBCLONES
CHAPTER 6 : NUCLEOTIDE SEQUENCE ANALYSIS OF THE 
HG21. HG22. HG23. HG26, HG19 AND HG6 SUBCLONES.
6.1 INTRODUCTION
6.1.1 SUBCLONES FOR SEQUENCING.
The subcloning of the recombinant DNA from XD2 into the pGEM7zf(+) vector had 
resulted in the formation of sub-clones HG21, HG22, HG23 (including HG26). From 
the previous screen HG6  and HGl 9 were also recloned into pGEM from their original 
pUC9 vectors. While attempts continued to sub-clone HG24 and HG27 (the missing 
parts of the coding region) time restraints dictated that the sequencing of the existing 
subclones took priority.
The subclones represented 12.4kb of human CYP4A genetic material, 7.7kb of which 
appeared to be from the 5' regulatory regions of the gene. When sequencing novel 
DNA it is necessary to sequence both strands to eliminate problems with mis-reading 
and compressions in the sequence. Therefore a final total 25kb of nucleotide sequence 
would need to be determined and analysed.
It became apparent that the manual sequencing system used in the laboratory at Surrey 
did not have the capacity to handle such a large amount of DNA in a reasonable time. 
Using the sequencing system utilised in the laboratory, the longest reliable nucleotide 
sequences obtained from one run were about 300-350bp. If oligonucleotide primers 
were to be used then one oligonucleotide would be required for every 250 base pairs 
of target DNA to allow a good overlap between steps. As the total amount of DNA to 
be sequenced was 25kb, the number of oligonucleotides needed (>100) would be 
prohibitive for both cost and the time to produce them.
An alternative strategy for the sequencing had to be adopted and the nested deletion 
sequencing and the use of an automated DNA sequencing machine was the method of 
choice.
6.1.2 THE ERASE-A-BASE NESTED DELETION SYSTEM
The reasons for using a nested deletion system are outlined in Section 2.7. There are 
two accepted methods for sequencing large fragments (>500bp) of DNA, using 
synthetic oligonucleotide primers to walk the sequence along the insert or to make 
deletions and then sequence the shortened DNA using the same primer each time.
Nested deletions offered a cheaper and quicker alternative to the problem since it was 
possible to generate up to 24 deletions (equivalent to 24 primers in the 'walking'
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method) for each reaction in 2 to 3 days, and several reactions could be run 
simultaneously. This was the method of choice but the problem still remained of 
sequencing the expected 200-300 deletions. With the DNA sequencing capacity of the 
laboratory at that time it would have taken 6-9 months to perform this sequencing and 
such time was not available. An alternative was therefore required.
6.1.3 AUTOMATED DNA SEQUENCING USING AN ABI373A SEQUENCER.
At this point it was suggested by my Industrial Supervisor, Mr M. Tarbit of Glaxo 
Group Research that a collaboration should be undertaken with the Glaxo Institute of 
Molecular Biology (GIMB) in Geneva, Switzerland where an ABI 373A automated 
sequencing machine had been installed. A three month visit was arranged and the 
subsequent laboratory work was performed in Geneva.
It was decided that it would also be easier to perform the deletion reactions in Geneva 
to avoid the problems of transporting a large number of deletion clones. To this end 
glycerol stocks of HG21, HG22, HG23, HG25, HG26, HG6  and HGl 9 were taken to 
Geneva along with two Erase-a-base deletion kits (Section 2.7.1).
6.2 ERASE-A-BASE NESTED DELETIONS OF THE PLASMID SUB-CLONES.
6.2.1 INTRODUCTION
The principle of the Erase-a-base system is explained in section 2.7.1 and requires the 
use of two restriction enzyme sites in the multiple cloning site of the plasmid (pGEM). 
The first site must be nearer the insert and must result in a 5' overhanging or blunt 
'sticky end' on digestion. This is the site at which the ExoIII enzyme will start 
digesting in the 3' to 5' direction. The other site must be closer to the primer arid leave 
a 3' overhang on digestion. If no such site was available, a 5' overhang cutting site was 
selected and the overhang filled in with a-phosphorothioate dNTPs to prevent ExoIII 
digestion from this site. Both of the sites had to be unique in the plasmid construct to 
allow recircularisation after ExoIII deletion.
The first task was therefore to find suitable sites at both ends of the various genomic 
DNA inserts to allow both strands to be sequenced. The multiple cloning site of 
pGEM7zf(+) is shown in Figure 6 .1 (the nucleotide sequence of the multiple cloning 
site is shown in Figure 2.3 and Table 2.2). HG21 was inserted between the Xbal and 
Xhol sites, HG22 and HG23 was inserted into the Xbal site and HG6  and HGl 9 into 
the BamHI site.
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6.2.2 SELECTION OF RESTRICTION ENZYME SITES FOR THE ERASE-A- 
BASE DELETIONS.
6.2.2.1 HG21
At the universal/T7 primer end of the insert the available sites were limited to Xbal as 
the 5‘ cutter and SphI as the 3' cutter. It was known that there was no internal Xbal 
site in the HG21 insert from the sub-cloning and so this enzyme was suitable. 5|xg of 
HG21 was digested with SphI producing a single band (data not shown) indicating that 
this was also a unique site in the HG21 plasmid construct. Deletion clones generated 
from this end of the insert were designated HG21U.
At the reverse/SP6  end of the insert there was a greater choice of sites. Digestion of 
HG21 with EcoRI, Kpnl and Sad all gave single bands and EcoRI (5'cutter) and Sad 
(3' cutter) were selected as they digested efficiently in the same buffer. Clones from 
these enzymes were designated HG21R.
6.2.2.2 HG22
The HG22 insert had been cloned into the Xbal site of the vector and this enzyme 
could therefore not be used as the 5' cutter since it would cut at more than one site. 
As a consequence there was no 5' cutting site at the universal/T7 end of the insert and 
an alternative approach was adopted. There were no problems selecting the sites for 
the reverse/SP6  end of the insert and EcoRI(5') and Kpnl(3') were selected.
To overcome the problem of the lack of sites at the universal/T7 end of the insert it 
was decided to reverse or 'flip' the insert in the vector. 5pg of the HG21 plasmid was 
digested with Xbal and lOOng of the resulting digest was religated with T4 ligase. The 
resulting ligations were transfected, screened on X-Gal plates and analysed by cracking 
as before (Section 5.3.2). 85% of the resulting white colonies had 1.9kb inserts and 
plasmid was prepared from 10 of the colonies. About 50% of the clones should contain 
the insert in the reverse direction.
From the restriction mapping of HG22 (see Figure 5.4) it was noted that the digestion 
of the plasmid with Hindlll would lead to an asymmetric banding pattern depending on 
the direction of the insert. 5pi of each of the 1 0  plasmid preparations were digested 
with Hindlll and analysed by electrophoresis. From this analysis 2 plasmids were 
isolated with inserts in opposite directions. The clone with the insert in the same 
direction as the original HG22 was designated HG22U and the reversed insert clone 
was designated HG22R. Glycerol stocks were made of the HG22R clone.
155
Both the HG22U and HG22R clones could now be digested with the same enzymes 
for the Erase-a-base reaction, EcoRI and Kpnl, and the SP6  primer used for both sets 
of deletion sub-clones.
6.2.2.3 HG23
The same problem occurred with HG23 as had with HG22 at the universal/T7 primer 
end of the insert as it was also inserted with Xbal. At the reverse/SP6  primer end the 
only sites which cut the plasmid once were BamHI and EcoRI, both of which produced 
5' overhangs. It was decided to use BamHI and then block the overhang with a- 
phosphorothioate dNTPs as a substitute for a 3' cutter.
The same procedure for reversing the insert was used as for the HG22 clone and 
Hindin was again used as the characterising asymmetric enzyme site. Plasmid DNA 
from a total of 60 colonies was analysed by Hindin digestion and all of them gave the 
same restriction pattern. This was obviously unexpected as 50% of the inserts should 
have been reversed and it was concluded that there must be some factor favouring this 
orientation of insertion.
It was noted that the insert in HG23 was oriented in the reverse sense to that in the 
gene itself and it was proposed that insertion in the opposite direction would put the 
promoter region of the human gene in the same sense as the T7 promoter in the 
plasmid. It was postulated that this arrangement lead to a plasmid construction 
containing a ’poison sequence' [Laws and Dalbey, 1989] which would prevent the 
growth of cells into which the plasmid had been transfected. This phenomena had been 
seen by other workers at GIMB when cloning other inserts into plasmid vectors.
Attempts were made to re-clone the HG23 insert into pBluescript SK(-) with a view to 
inserting the fragment into the multiple cloning site in a position where other restriction 
enzymes could be used (see Figure 2.4). This approach did not yield any useful 
constructs. In a further attempt the insert was blunt ended using the Klenow fragment 
(Section 2.2.7) with a view to insertion into the Smal site of pGEM and pBluescript. 
Again this did not prove fruitful and the effort had to be abandoned due to time 
constraints.
6.2.3.4 HG19
The HGl 9 insert had been cloned into the BamHI site of the pGEM vector and this 
lead to similar problems to those encountered with HG22 and HG23. The BamHI site 
was the closest 5' cutter to the reverse/SP6  primer site and since this was the insertion 
enzyme it could not be used to generate the 5' overhang. It was therefore necessary to 
'flip' the insert and use the same restriction sites for each direction and sequence from
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the universal/T7 primer site. A range of enzymes were tried and Kpnl(3') and CIaI(5') 
were selected.
5|ig of HG19 DNA was digested with BamHI and lOOng was religated and transfected 
as before. The resulting colonies were screened by the cracking procedure and plasmid 
DNA was prepared from the positives. The DNA was digested with EcoRI, which cut 
the insert asymmetrically and so gave an indication of the alignment. From this 
analysis clones were isolated with the insert oriented in both directions. The clones 
with the insert in the same direction as HG19 were designated HG19U and the clones 
in the opposite direction were designated HG19R. Glycerol stocks were made from an 
HG19R clone.
6.2.2.S HG6
The HG6  insert had a BamHI site at both ends as had HG19 and so there were no 5' 
overhang cutting sites at the reverse/SP6  end of the insert. At the universal/T7 end of 
the insert several enzymes were tried and Smal(blunt) and Sphl(3') were selected since 
they were well separated and cut efiSciently in the same buffer.
Attempts were made to 'flip' the insert so that both strands could be sequenced from 
the same primer but this proved unsuccessful and in the 27 different plasmid DNA 
preparations examined, the insert was in the same orientation as HG6 .
The restriction enzymes and sequencing primer selected for each plasmid are shown in 
Table 6.1. To confirm that the enzymes cut each plasmid DNA efficiently 5pg of each 
of the plasmids were digested with the selected enzymes and electrophoresed with 
markers. A single clean DNA band indicated that the enzymes had digested efficiently 
in the same buffer and that no 'star' activity (non-specific digestion) had occurred.
The results of these digests are shown in Figure 6.2 and demonstrate that the relevant 
restriction enzymes digested the plasmid DNA efficiently and could be used to 
generate the required overhangs for the Erase-a-base deletion reactions.
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SUBCLONE LANE No. IN 
Figure 6.2
ENZYMES SEQUENCING
PRIMER
HG21U 1 Xbal + SphI Universal/T7
HG21R 2 EcoRl + Sad Reverse/SP6
HG22U 3 EcoRI + Kpnl Reverse/SP6
HG22R 4 EcoRI + Kpnl Reverse/SP6
HG23U 5 BamHI (B) + EcoRI Reverse/SP6
HG19U 6 Clal + Kpnl Universal/T7
HG19R 7 Clal + Kpnl Universal/T7
HG6 U 8 Smal + SphI Universal/T7
Table 6.1 Selected restriction enzymes and sequencing primers for the Erase-a-base 
deletion of HG21, HG22, HG23, HG19 and HG6 .
BamHI (B) indicates a BamHI site that has been filled in withj a-phosphorothionate 
dNTPs.
The digests are shown in Figure 6.2.
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6.2.3 ERASE-A-BASE DELETION REACTION FOR HG19U
Although the capacity existed to handle more than one deletion reaction at a time it 
was decided to first perform one of the reactions on its own and HG19U was selected 
since it was the smallest fragment. The Erase-a-base protocol was followed as 
described in Section 2.7.1 and care was taken in the following areas. All the buffers 
are provided in the kit.
A fresh Qiagen tip 100 plasmid DNA preparation was performed to ensure that the 
starting plasmid DNA was free of nicks that could effect the reaction. 20pg of this 
plasmid DNA was digested overnight with 20U of Kpnl and 20U of Clal in a total 
volume of lOOjil of the appropriate restriction enzyme buffer. The DNA was extracted 
from the digest solution with phenol/chloroform and precipitated with 1 0 0 % ethanol. 
The pellet was briefly dried and then resuspended in 60pl of H2 O. The tube was left 
for an hour in a 37°C water bath to ensure the complete resuspension of the pellet. A 
6 pl aliquot of the resuspended DNA solution was taken and electrophoresed to check 
the resuspension. 6 pl of the lOx ExoIII buffer was then added to the remaining 54pl 
to give a total of 60pl of DNA in Exo buffer.
The key decision was the temperature at which the reaction was to be performed since 
this determined the rate of deletion (see Figure 2.9). The deletions had to be short 
enough to allow for a good overlap between the adjacent nucleotide sequences, a 
factor determined by the effective range of the sequencing system used. As the 
effective sequencing range of the automatic sequencer had not been properly 
determined, it was decided to delete HG19U in steps that could be analysed by both 
manual and automatic methods. A reaction temperature of 35°C was chosen as it gave 
a deletion rate of 390bp/min. As an aliquot was taken every 30 secs this was expected 
to be equivalent to 195bp/timepoint.
The reaction was performed at 35°C according to the protocol and samples were taken 
at 1 2  timepoints (T1-T12). Prior to the religation step a sample of each timepoint was 
electrophoresed with HG19 and pGEM (both linearised with Xbal) as markers. This 
gel is shown in Figure 6.3 and it was possible to see a stepwise decrease in the sizes of 
the DNA bands.
The procedure was completed and the resulting religated deletions were transfected 
into JM109 competent cells and plated out onto LB Amp plates. X-Gal screening was 
not necessaiy as all the plasmids had inserts. The plates were grown up overnight at 
37°C and 8  colonies from each timepoint were restreaked onto four master plates 
(labelled a-d).
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Figure 6.3 Ethidium bromide stained gel of Erase-a-base timepoints from the deletion 
of HG19U. Lane 1 contains HG19U linearised with Xbal, lanes 2 to 13 contain 
timepoints T1-T12 and lane 14 contains pGEM hnearised with Xhal.
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Two sets of timepoints (a and b) were analysed by the cracking procedure using uncut 
HG19U and pGEM as markers. This gel is shown in Figure 6.4 and the decrease in 
plasmid size can be clearly seen. In the 'a' deletion series the bands all follow the 
downward trend except the plasmids from timepoints 5 and 6  (T5  and T6 ).This 
deviation from the deletion series was not considered too great a problem to warrant 
the selection of a replacement from another deletion series.
Qiagen tip 20 plasmid DNA preparations were performed on the 'a' series and these 
clones were used as the deletion series. It was necessary to give these clones 
systematic names for easy recognition during the sequencing and analysis procedures. 
The GCG sequence analysis software package used at GIMB allowed a maximum of 6  
characters in the name of a sequence. The first timepoint from the 'a' series of the 
HG19U deletion was designated 19Ula and the last was 19U12a.
From Figure 6.3 it was calculated that the insert should have been completely deleted 
by Tio. To determine the exact size of the deletions 5pg of each plasmid DNA was 
linearised by digestion with Xbal. The digests of the first 10 timepoints were 
electrophoresed with linearised HG19 and pGEM for reference and 1 markers to 
calculate the band sizes. This gel is shown in Figure 6.5.
The deleted clones, 19Ula - 10a were ready to be sequenced by both manual and 
automated means. The deletions were then performed on the rest of the clones before 
any sequencing was performed on the automatic machine.
6.2.4 ERASE-A-BASE DELETIONS OF HG19R, HG21R, HG22U AND 
HG22R
The double digests for HG19R, HG21U, HG21R, HG22U and HG22R were 
performed in parallel. The digestion of HG21U was not efficient and this clone was 
put aside for later deletion. The four remaining plasmids were prepared for the 
deletion reaction as before. This procedure was greatly facilitated by the use of 96 
well microtitre plates on a PCR thermal cycler rather than microcentrifuge (eppendorf) 
tubes in a waterbath.
The reaction was performed at 35°C as before and 12 timepoints were taken for each 
clone. The deletions were checked by electrophoresis (Data not shown). As before 
the deletions showed a decrease in size and so the plasmids were recircularised and 
transfected as before.
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Figure 6.4 Cracking analysis of the 'a' deletion series from HG19U. Lane 1 contains 
uncut HG19U, lanes 2-13 contain timepoints Ti to T12, lane 14 contains uncut pGEM.
1 4  1 3  12 11 10 9 8  7 6  5 4 3 2 1
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Figure 6.5 Gel of Xbal linearisation of HG19U timepoints Ti to Tio. Lanes 1 and 14 
contain ^ marker, lane 2  contains Xbal linearised HG19U, Lanes 3 to 1 2  contain 
timepoints Ti to Tio and lane 13 contains linearised pGEM.
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For each clone, four colonies were picked from each timepoint and restreaked onto 
master plates ( 2 series per plate). The 'a' series of deletions from each clone were 
analysed by cracking (data not shown) and plasmid DNA was prepared. This DNA 
was linearised with Xbal and electrophoresed on a large gel. Linearised parent plasmid 
and pGEM was used as references and 1 markers were used to determine the size.
The gel is shown in Figure 6 . 6  and it was immediately apparent that the deletions had 
not progressed as well as before. Many of the timepoints in each of the clones were 
smaller in size than the pGEM marker and this indicated that the deletions had 
progressed into the vector in an uncontrolled fashion. It was decided to repeat the 
cracking analysis on the remaining deletion series (b-d) and any plasmids that were 
larger than the pGEM marker were picked and DNA prepared from them. The 
following clones were selected from the cracking gels:
HG19R : 19Rla, 3a, 5a, 6 a, 8 a, 3b, 10b, 11b, Ic, 2c, 4c, and 11c (total 12)
HG21R : 21Rla, 2a, 9a, 7b, 8 b, Ic, 2c, 3c, 8 c, Id, 2d, 3d and lid  (total 13)
HG22U : 22U3a, 4a, 7a, 8 a, 9a, 12a, lb, 2b, 3b, 6 b, 7b, 8 b, 9b, 11b, Ic, 4c, 6 c, 8 c, 
10c, 12c, 4d and lOd (total 22)
HG22R : 22Rla, 2a, 5a, 6 a, 7a, 9a, 10a, 4b, 9b, 10b, 2c, 4c, 5c, 6 c, 8 c, 10c, 12c, 2d 
and 3d (total 19)
While the Erase-a-base reactions did not seem to have worked properly it was hoped 
that the cracking procedure would select a suitable range of deletions. The 
effectiveness of this approach would become apparent after the clones had been 
sequenced and their relative positions determined.
6.2.5 ERASE-A-BASE DELETIONS OF HG21U AND HG23U
The deletion reactions were performed on HG21U and HG23U under the same 
conditions as for the previous clones, taking 12 and 24 timepoints respectively. Four 
deletion series were restreaked for each clone and the 'a' series from each clone was 
analysed by cracking (data not shown). This analysis again showed that the deletions 
were not regular and it was decided to crack the remaining colonies for each series. 
From the cracking gels it was again considered that there was sufficient range of 
deletion to commence sequencing. The deletions selected for sequencing were as 
follows:
HG21U : 21U2a, 3a, 5a, 7a, 11a, 2b, 3b, 7b, 2c, 3c, 4c, 5c, 9c and 11c (total 14).
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Figure 6 . 6  Xbal digests of the plasmid DNA from the 'a' series of deletions for 
HG21R, HG22U, HG22R and HG19R.
Lanes 1, 30, 31 and 60 contain X marker;
Lane 2 contains Xbal linearised HG21R;
Lanes 3 to 14 contain HG21R 'a' deletion series linearised with Xbal;
Lanes 15, 29, 45 and 59 contain Xbal linearised pGEM;
Lane 16 contains Xbal linearised HG22U
Lanes 17 to 28 contain HG22U 'a' deletion series linearised with Xbal;
Lane 32 contains Xbal linearised HG22R
Lanes 33 to 44 contain HG22U 'a' deletion series linearised with Xbal;
Lane 46 contains Xbal linearised HG19R
Lanes 47 to 58 contain HG22U 'a' deletion series linearised with Xbal;
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HG23U : 23Ula, 2a, 3a, 4a, 9a, 13a, 14a, 15a, 18a, 22a, 24a, lb, 2b, 4b, 5b, 7b, 9b, 
13b, 15b, 18b, Ic, 2c, 3c, 4c, 6 c, 8 c, 9c, 10c, 16c, 17c, 3d, 21d, 24d (total 33).
The failure of the Erase-a-base system to give consistent stepwise deletions was 
examined before the HG6 U clone was processed. The only difference in protocol 
between the HG19U deletions and the others to date was the plasmid DNA 
preparation procedure. While all the DNA had been prepared by the Qiagen tip 100 
method prior to the deletions, the manufacturers had changed the composition of one 
of the buffers (P3) from 2.55M potassium acetate (pH4.8) to 3.0M potassium acetate 
(pH 5.5). This change had lead to a drop in yield which had been seen by other 
colleagues in Guildford and GIMB. Although the same amount of DNA had been 
deleted in each case the quality may have been effected leading to an increase in the 
amount of nicked DNA in the sample. These nicks would lead to irregular deletion 
and may explain the apparent randomness of the timepoint sizes.
6.2.6 ERASE-A-BASE DELETION OF HG6 Ü
An 'old style' Qiagen tip 100 kit was located and this was used to prepare plasmid 
DNA from HG6 U. 20pg of the DNA was digested with Smal and SphI and then 
extracted as before. The deletion reaction was performed at 35®C and 24 timepoints 
were taken. The timepoints were run on a gel prior to the religation and the result is 
seen in Figure 6.7. Two bands can be seen, on remaining at a constant size (5.7kb the 
size of the HG6  parent plasmid) and a second band decreasing with time. The constant 
band is a result of the 5' cutting enzyme not completely digesting the plasmid. This 
resulted in a linearised plasmid with 3' overhangs at each end which are resistant to 
Exoin digestion. This fragment would religate to give the original HG6  parent 
plasmid and give a background in the subsequent screening.
While the difference between the parent and deleted plasmid was easily identifiable in 
the later timepoints this was not so clear for the early ones. It was decided to back 
select the deletions for the first 9 timepoints. 20|Lil of the religated reaction mixture 
was taken and digested with Xbal. The deleted plasmids did not contain an Xbal site 
as this is situated between SphI and Smal in the pGEM multiple cloning site and would 
have been deleted in the Erase-a-base reaction. The parent plasmid would still contain 
the Xbal site and so be linearised by the digestion. The digest was then transfected 
into competent cells in parallel with the ligations from the original reaction and plated 
out as before. The transfection efficiency of this batch of ligations was low but four 
colonies per timepoint were restreaked were possible. The colonies from the 'a', 'b' and 
'c' deletion series were analysed on cracking gels. The gels are shown in Figure 6 . 8  
and the loading order is shown in Table 6.2. The first back selected timepoint was 
designated 6 Ulxa to distinguish it from the original timepoints (ie 6 Ula).
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UNDELETED
HG6
Figure 6.7 Deletion series for HG6  showing 2 bands in each lane. Lanes 1 contains 
Xbal linearised HG6 , lanes 2-25 contain timepoints TI to T24 and lane 26 contains 
Xbal linearised pGEM.
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LANE CLONE SELECTED
?
LANE CLONE SELECTED
?
1 HG6 U 31 HG6 U
2 6 Ula / 32 6 Ulxa
3 6U2a y 33 6U2xa
4 6U3a 34 6U3xa y
5 6U4a / 35 6U4xa
6 6U5a / 36 6U7xa y
7 6 U6 a 37 6 U8 xa
8 6U7a 38 6 Ulxb
9 6 U8 a 39 6U3xb
1 0 6U9a y 40 6U4xb
1 1 6 U lla 41 6U7xb y
1 2 6U12a 42 6 U8 xb y
13 6U15a 43 6U3xc y
14 6U16a 44 6U4xc
15 6U17a 45 6U7xc y
16 6U18a y 46 6 U8 xc
17 6U19a y 47 pGEM
18 6 Ulb 48 6 Ulc
19 6U2b y 49 6 Ulc
2 0 6U3b y 50 6U2c
2 1 6U4b 51 6U3c
2 2 6U5b y 52 6U4c y
23 6 U6 b 53 6U5c y
24 6U7b 54 6 U6 c
25 6 U8 b 55 6U7d y
26 6U9b y 56 6 U8 c
27 6U15b y 57 6U15C y
28 6U17b 58 6U16C
29 6U18b y 59 6U17C
30 pGEM 60 6U18C y
Table 6.2 Loading order for cracking gels shown in Figure 6 .8 . ' y  indicates a clone 
selected for sequencing.
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6.3 SEQUENCING OF ERASE-A-BASE DELETIONS FROM HG21. HG22. 
HG23. HG19 AND HG6
6.3.1 SEQUENCING APPROACHES
The nucleotide sequencing of the deletions and parent plasmids was mainly performed 
on an ABI 3 73A automatic DNA sequencer (Applied Biosystems inc.) using the Taq 
Dye Primer sequencing system (section 2.6.2). The system had several advantages 
over the manual system (section 2 .6 .1):
(a) The automated sequencer was capable of high throughput (24 different clones per 
run) and the manufacturers predicted accurate base calling for up to 400-450bp from 
double stranded plasmid DNA from a single run.
(b) The sequencing reaction was a modified version of the dideoxy termination 
reaction which used thermostable Taq polymerase. This allowed the reaction to be 
performed in a cyclic method similar to PCR and thus amplify the DNA output. The 
high reaction temperature (70°C) reduced the problems with 'GC compressions, 
caused by GC rich regions remaining double stranded during the sequencing reaction, 
thus causing the polymerase to stall or mis-read the base sequence. An example of a 
printout from the Automatic sequencer is shown in Figure 6.9.
(c) The sequence data was automatically read into the computer and so removed the 
problems of mis-reading of autoradiographs.
(d) There were no radiolabelled nucleotides in the reaction and so no special 
containment procedures associated with the use of radiochemicals were required.
To get an initial comparison of the two sequencing systems the HG19U deletion series 
was sequenced by both manual and automatic methods.
6.3.2 PLASMID DNA PREPARATION
The plasmid DNA templates for the sequencing reactions was prepared by the Qiagen 
tip 20 protocol (section 2.5.6). For 60% of the plasmids sequenced this method lead 
to good sequence data. However for the remaining clones problems were encountered 
with this method of plasmid DNA preparation. The problem was localised to the NaCl 
that was used to elute the DNA from the column. In samples where the DNA 
concentration was low the DNA was concentrated by ethanol precipitation and 
resuspended in a smaller volume. This precipitation increased the relative 
concentration of NaCl in these samples and this interfered with the Taq polymerase 
which is Na"  ^sensitive.
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This problem was overcome by using the Magic Miniprep system (Promega Ltd) which 
has a different method of elution. The elution solution for these columns was warm 
TE and so there was no problem with Na"  ^ contamination of the sequence reaction. 
The main problem with this alternative method was that the minimum elution volume 
require for the column was 50pl compared with a final resuspension volume of 20pl 
for the Qiagen system. In some cases this lead to the resulting DNA solution being too 
dilute (< lOOng/pl) to be used directly in the sequencing reaction. This problem was 
overcome by reducing the volume of the solution by evaporation for 5 mins in a 
centrifugal evaporator. When the solution had reduced to 20-25pi the DNA 
concentration was determined by uv/vis spectroscopy (section 2.2.5).
6.3.3 SEQUENCE ANALYSIS AND ALIGNMENT OF OVERLAPPING 
SEQUENCES (CONTIGS)
The nucleotide sequence for each of the deletions and the parent plasmids was 
analysed on the GCG system (section 2 .8 .2 ) which had direct links with the sequencer. 
The contiguous sequences (contigs) were determined using the Gelassembly programs 
as they proved more adaptable than the Staden software. The nucleotide sequence 
from the manual sequencing was entered into the database via the keyboard and 
consensus sequences determined as before. To distinguish the manually generated 
from the automatically generated sequences the manual sequences were entered in 
lowercase letters.
It was vital that the nucleotide sequence was tailored as poor sequence data effected 
the compilation of the contigs. The sequences were first aligned using the Fast A 
option and then grouped together into various contigs using the Geloverlap function. 
The individual sequences were then used to generate a consensus sequence for the 
contig. The consensus sequences are displayed in the following sections and the 
individual sequences are displayed in their contigs in Appendix B.
During the initial plasmid preparations of the 'a' string deletions for HG19R some of 
the DNA samples were exchanged with those from HG22R. This became evident in 
the sequence analysis and it was decided to keep the names of these sequences the 
same to avoid confusion. Therefore the sequences that appear with HG22R 
designations in the HG19R contig do originate from the HG19R clone and vica versa.
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6.3.4 RESULTS OF SEQUENCING OF HG19
The HG19U deletion clones were sequenced manually using the Sequenase system 
using both normal and gradient gels (section 2.6.1). With split loading techniques it 
was possible to obtain SOObp of good nucleotide sequence for each timepoint and 250 
bp of sequence from the parent plasmids. The sequences from timepoints 19Ula, 2a, 
4a, 5a, 6 a, 7a, 8 a and 10a were combined to give a consensus of 763bp ending in the 
BamHI site at the reverse primer end. This sequence showed homology to the 
HG19CT sequence reported in section 3.4.2. The same deletion clones were 
sequenced by the automatic dye primer technique and these sequences were stored in 
the database.
The deletion clones from HG19R were also sequenced on the machine and the 
sequences compared against those obtained from the HG19U deletions. It became 
apparent that all the 'a' series timepoints (HG19Rla, 3a, 5a, 6 a and 8 a) were from the 
HG22R deletions. During the subsequent sequencing of 22R6a it was found that this 
clone was from the HG19R 'a* deletion series.
The HG19U and HG19R parent plasmids were sequenced by the automated method 
with the T7 and SP6  primers. The sequences obtained from the original pUC clone of 
HG19 (section 3.4.2) were also entered at this stage to give more data.
The sequences were analysed and grouped into two consensus sequences:
HG19CONU : The consensus starting from the universal primer end of the insert. 
This was constructed from HG19um (the universal sequence from the HG19 pUC 
clone), HG19rm (the T7 sequence from the HG19U pGEM clone), HG19rr (the SP6  
sequence from HG19R) and 22R6a. The total length of this consensus was 230bp.
HG19CON1 : This was a consensus which occupied the last 1203bp of the HG19U 
insert ending in the BamHI site at the reverse primer end of the insert. This was 
constructed from 19Rllb, 19Rllc, 19U3a, HG19Ucon (the manually determined 
consensus sequence), 19U5a, 19Ule, 19U6a, 19R2c, 19U7a, HG19TR (translation of 
the manual sequence of HG19R using the T7 primer), 19U8a and HG19CT (from 
section 3.4.2).
The positions of the two contigs and their contributory sequences are shown in Figure 
6.10. The gel assembly printout for HG19C0NU is shown as an example in Figure 
6.11 while the construction of HG19CON2 (and all subsequent contigs) is shown in 
Appendix B. The consensus sequences of HG19C0NU and HG19CON2 are shown in 
Figure 6.12a and b.
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A)HG19CONU Length: 230
1 GGATCCTCTA TGCTCTGGCC ACACACCCCA AGCATCAGGA GAGGTGCCGG
5 1  GAGGAGATCC ACAGCCTCCT GGGTGATGGA GCCTCCATCA CCTGGTGAGT
1 0 1  GAGGGCTCAA AAGATGGGGT TCCCTGCCTT CTCCACAGGG GCCCCTGGTC
1 5 1  TGCCCAGGCC TTTCTGGTGT TCAGGATGGA ATTGTTTAGG AACCACCTGA
2 0 1  CCAGATNCCC TACNCCACCT ATGTGCACCA
B) HG19CON1 Length: 1203
1 ACCNAGATGC CCCTAAACCA CCCAATGTGC AWTWAARGAG GCMAMTGAGG
5 1  CTGYTACCCA NCGGTNCCAG GCATTGGCAR RGAGCTCAGC ACTCCCGTCA
1 0 1  MCTTCCCTGA TGGGCGCTCC TTGCCCAAAG GTATGAAGTT CCCCCACNCT
1 5 1  CTCACCTAAA CTCTCCACAG GGACGTGTGG AGGGTGAGAA ATCCATGTGT
2 0 1  GCATCAGAAT TCTGCACATC TCTGGGTCTC CCTTTTGTTC TAAAAAAATC
2 5 1  GAAAACATAC TTTGTACTTG GGATAAAGAA TTTRAAAAGT CTGGCTGAGA
3 0 1  GCTTGAACCC ACCAAAAGTT CAAGAAATAA ATGTTAATCT CTGAATGTGG
3 5 1  CCTTGGGTCA GTAACCGTAA AATTCTATTC CCTGAGATGT GCAGGGCTGG
4 0 1  AAAGNGANTC AGACAAGGGC AGAGAGGGNT GTGTTTCTTT CCTCATGGGG
4 5 1  TCAGTGCAAA AGAGGCTTTA TCAGGAATTT MATTTCCTGG GTCAGCTGTT
5 0 1  GTCCAGTCTC TGAGGAACCC YCAGGTTGAT GGCAGAGAGA AAGTGATGAC
5 5 1  CAGATCTGGG GACACCAAGG TGCAACTCCC TGGGTTCTGG TCCCAGTCCT
6 0 1  GCCATAACCT AGTTGTGTGA ACATAGACAA GACAATTGGT CTCTCTGAGA
6 5 1  TTCAGGTATC TCCCCTGAAA ACTGAGAGCA AAAGAATGTC TTACTTGGAG
7 0 1  CGTTGTTGTA CTGAGTGAGT TCATGTATAT TCTCCAATGA CCCTTGGAGG
7 5 1  ATATTTAATG AATGTRAATG TCACTGGRCT TACTCTAAAG AGTAATGCTC
8 0 1  TGATTCTTTC TTGCTTCTCA TTCCTGCATA AATGATTGTC TAT CAT CATC
8 5 1  TGAACTCACA TGCTTTGTTA AGCCTAACCC ACCTGCATAA TGGCAGAATC 
9 0 1  ATCCCAGTCA AAGTGAAAAT TTGTGGAAAG TAGGCTTTTT GGGCCTTCTT 
9 5 1  TTGTGCCTGC TGGCTGAAGT ACCAGGCCAC CCCATGCAAA TVATTGGTCT 
1 0 0 1  TCTCTCTGTT TCCAACCTGC ACCACAGGTA TCATGGTCCT CCTCTCCATT 
1 0 5 1  TATGGCCTTC ACCACAACCC AAAAGTGTGG CCCAACCCAG AGGTATGTGG 
1 1 0 1  TCCTTGAGAG GAGGAAATGA GGTGATCCCT CAAGACCAAT ACCTTCTCCT 
1 1 5 1  GCTTCCACCT CTGGGAGTCC TGTCCCCCAT GGTGGCAAGT AGGTGCTGGA 
1 2 0 1  TCC
Figure 6 . 1 2  Consensus sequences for A) HG19C0NU and B) HG19C0N1
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Deletions 19Rlc, 19R4c and 19Ulla were found to be pGEM derived implying that 
the reaction had run into the vector or that they came from pGEM as a parent. 
Deletion 19R2a remained unsequenced after four attempts and had to be abandoned.
If the electrophoretic sizing of the HG19 band as 1.4kb was accurate, it was expected 
that the 2 contigs should overlap. This was not seen and this could have been 
explained in two ways. If the HG19 fragment was marginally (<100)bp longer than 
previously calculated the contigs would not overlap. The more probable explanation 
was that the sequence at the 3' end of HG19C0NU and at the 5' end of HG19CON2 
was not 100% accurate and so a match was not identified. Efforts to find a deletion to 
fill the gap were unsuccessful.
This problem was solved when the sequence was compared against the CYP4A11 
cDNA sequence [Palmer ei al, 1993b] that was published after this work was 
performed (see section 6.4.1).
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6.3.5 RESULTS OF SEQUENCING OF HG21
The sequencing of the deletions for this clone were all performed on the ABI 373A 
machine and 20 out of 27 of the clones were successfully sequenced. The sequences 
were analysed and were divided into four contigs, the orientation of which have been 
taken from XD2  and not the plasmid in which the insert was reversed:
HG21CONU : Comprised of HG21R (the SP6  sequence of the parent) and 21U9c. 
Total length 405bp.
HG21CON1 : an unanchored contig. comprising of 21Rla, 21Rlc and 21 Rid. total 
length 213bp.
HG21CON2 : an unanchored contig. located 3' to HG21C0N1 (determined by 
examination of cracking gels), comprising of 21R2a, 21R2d, 21R9a and 21R3c. Total 
length 419bp.
HG21CONR : Comprised of HG21Ur (the universal primer sequence of HG21), 
HG21U (the T7 sequence of HG21), 21U4c, 21R7b, 21U2b and 2  lU 2 a.Total length 
552bp.
21U3a, 21U3b,21U3c, 21U7a, 21U7b, 21U2c, 21R8b, 21R3d and 21R8c were 
homologous to pGEM and 21U5a, 21Ulla, 21U5c 21Ullc, 21R2c, 21R2d and 
21R1 Id remained unsequenced after four attempts and had to be abandoned.
The relationship of the deletion sequences and the contigs to HG21 is shown in figure 
10.13 and HG21C0NU, HG21C0N1, HG21CON2 and HG21C0NR are shown in 
Figure 10.14a-d. (the contig constructions are shown in Appendix B).
There were obviously gaps between the contigs due to the discrepancy between the 
total length of the contigs (1570bp ) and the predicted fi*agment length (1900bp from 
the restriction mapping. It was hoped that the gaps would be filled by the remaining 
unsequenced deletions. Alternatively that the gaps could also be filled by using 
oligonucleotide primer to complete the sequencing
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a) HG21CONU Length: 405
1 TCCTCGAGGA TCAGTAGGAA AGGTAGGGGC ACACGCATCG GCCTGTTGTG
5 1  GGTTGGGGGG AGGGTGGTGG GATAGCATTA GGAGATATAC TTAATGTAAA
1 0 1  TGACGAGTTA ATGGGTGAAG CACTCCAACA TGGCACATGT ATACATATGT
1 5 1  AACACACCTG CGAGTTGTGC ACATGTATCC TAGAACTTAA CGTATAATAT
2 0 1  AAAAAAAAAA GAATGAAAGC ATGTCCTCTT CAGCAACATG GATACANCTG
2 5 1  GGAAGNCNTT TACCCTAAGC CGGTTTNNCA CAGTAACAGG AAAGNCAANT
3 0 1  TTCTGCATNG TTATCACTTT TAANNTGGGA CCTNANACNN TTGGGTTACA
3 5 1  CNTGGGACNC AAAANGTTNG GGTTTNGNAG ANACTNNAGG GTNTCCNAAA
4 0 1  AATGT
b)HG21CONl Length: 213
1 ATTAACACAG TAACAGAAAG CCAAATACNG CATGTNATCA CTTATAACTG
5 1  GGACCTAAAC ATTGGATACA CATAGACACA AAGATGGGAA TGGCAGACAC
1 0 1  TGAGGACTCC AAAAAGGGAT GTGATGGCGG GAGGGGGAAA GGGTGGGAAA
1 5 1  GCTACCTHTT WGGTACTAGT ATTCACTACC TGGNCTAGGA GCCCAAAMTT
2 0 1  CAGCATCATG CGA
c)HG21CON2 Length: 419
1 GAGAAAAAAA GAAATAAAGC CATGCACCTA CAGCCATCTG ATCCTCAACA 
5 1  ATGTTGACAA AAATAAGCAA TGGGAAAAGG ACTCCCTATA CAATAAATAG 
1 0 1  TACTGGGAAA ACTGGGTGAC CATATGCAAA AGATGCAACT GGACCCTGAC 
1 5 1  TTTNCACCAT ATATCATTAA GTTAAGATGG ATTAAAGGGG CCGGGCACGG 
2 0 1  TGGCTCACGC TTGTAATCCC AGCACTTTGG GAGGCCGAGG TGGGAAGATC 
2 5 1  ACGMGGTTWG AAGGTCGGAC CATCCGGCTA ATTGGGTGAA ACCCATCTCT 
3 0 1  ACTAGAATTT CAAAAAATTT GCTGNGCGTG GCGGTGNGCA NCGNNAGTCC 
3 5 1  CAGCTACTCA NNNTGGNGAG GCAGTNGAAT GGNATGAACC TNGGNAGGCC 
4 01 NANGCTTTCA GNGAGCCNG
d)HG21CONR Length: 552
1 CTCTAGAACC AGAAATACCA TTTGACCCAG CAATCCCATT ACTGGGTATA 
51  TACCCAAAGG ATTATAAATC ATTCTACTAT AARGACACAT GCACATGTAT 
1 0 1  GTYCATTGCA GCACTGTTCA CAATAGARGA CTTGGRGCCA ACCCAAATGC 
1 5 1  CCATCAATGA TAGATTAGAT AAAGAAACTG TGGCACGTAT ACACCATGGA 
2 0 1  ACACTATACA GCCATAAAAG MGGATGAGGT CATGTCCTTT GCAGGGACAT 
2 5 1  GGATGADGCT GGAAACCATY WTTTTHWGCA AACTAWCMCA AGANCAGAWR 
3 0 1  AMCAAACACC ACTTGTTCTC ACTCATAAGT GGGAGTGGAA CAATGAGAAC 
3 5 1  ACATGGACAC AGGGAGGGGA ACATCACACA CAGGGACCTA TCTGGCATGG 
4 0 1  GGGGTTAGGG GAGGGATAGC ATTAGGAGAA ATACCTAATG TAAATNACGG 
4 5 1  GTTGATGGGT GCAGCAAACC ACCATGGCAC ATGTWTACCA ATGTAACAAA 
5 0 1  CCTGCACTTT YTGCACATGT ATCTCCGAAC TTKAAGTATA ATAAAAAAAT 
5 5 1  GA
Figure 6.14a to d Consensus sequences from HG21
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6.3.6 RESULTS OF SEQUENCING OF HG22
The orientation of this fragment in relationship to the XD2 phage was determined by 
sequencing the ends of the HG25 clone with T7 and SP6  primers. It was known that 
HG25 was derived from a partial Xbal digest of XD2 and therefore HG22 and HG23 
were in the same orientation in HG25 as they were in the gene. The SP6  sequence of 
HG25 matched the T7 sequence of HG23 (which is reversed in the plasmid) whose 
orientation in relationship to XD2  was known. The T7 sequence of HG22U matched 
the T7 sequence of HG25. It was therefore concluded that HG22U was in the same 
orientation as XD2 and therefore the gene.
The sequencing of the deletions for this clone was performed on the machine. Of the 
41 deletions selected 27 were successfully sequenced. The sequences were analysed 
and four contigs were produced. Due to the mix up of the HG19R and HG22R 'a' 
series deletions the 19Ra series sequences were also compared to the contigs and 
incorporated where appropriate. There were again 2 unanchored sequences and these 
were arranged by examination of the cracking gels. The contigs were as follows:
HG22CONU : Comprised of HG22UM (T7 sequence from HG21U), 22Ulc, 
22U10c, 22R4c, HG22U1 (T7 sequence of 22U10c giving the undeleted end of the 
insert), HG22U2 (T7 sequence of 22Ulc), 22R4c, 22R5c, 22R9b,19R3a and 19R6a. 
Total length 403bp.
HG22CON1 : Comprised of 22U4d and 22U7a. Total length 244bp.
HG22CON2 : Comprised of 22R2a, 22U2b, 22U7b and 22U8a. Total length 344bp.
HG22CONR : HG22RM (T7 sequence of HG22R), 22R4d, 19Rla, 19R5a, 19R8a 
and 19R12a. Total length 404bp.
The relationship of the deletion sequences and the contigs to HG22 is shown in Figure 
6.15 and HG22CONU, HG22CON1, HG22CON2 and HG22CONR are shown in 
Figure 6.16a-d. (the contig constructions are shown in Appendix B).
22Ullb and 22R12c were homologous to pGEM. 22U6b, 22U4c, 22U6c and 
22U8cgave sequences that did not fit into any of the contigs and were not similar to 
each Other. 22U3a, 22U4a, 22U9a, 22U12a, 22U3b, 22U9b, 22U12c, 22Rla, 22R7a, 
22R10a, 22R4b, 22R5c, 22Rla, 22R8c and 22R10c were not sequenced after 4 
attempts and had to be abandoned.
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a)HG22CONÜ Length: 403
1 TCTAGAGAAT AAAATGAATT AATGTAAACA TTTTAAATCA CACAATGCCT
5 1  TTATATAATC ATACTTGTAA TATTTTCAAT ATTATCCCAG CATATACGGT
1 0 1  AAATATTTGT TAAGATAAAA TAGCATTTGG GATGTGTATT GGTAAGCAAA
1 5 1  AAAAGATTAA CTATAAAATT GTGTGCATAA TAGTATTCTA CATGTTGAAT
2 0 1  ATGTACAGAT TTATGGGATG GAGTCTGATA TATGCATATG GTGCTGGTGT
2 5 1  TGGGCCATAA TTTTAGATTG GGGTTTTCAT CCYCATTTCC ACTTTTCAAC
3 0 1  GGCATTATGG AGCNCCCKGC NGCCTGCGGT CATCCTTCTT AAAACTTCCG
3 5 1  ATGTGGGTTC ACAAAAGCCC TTGGTTTCCT GGGCTTCAAC CTTCCTCTGT
4 0 1  TTT
b)HG22CONl Length: 244
1 CCCAATGTCT TTAAGGGTTC CAGATGAGAT TAAAGCAAAG CTGAGTCTTG
51  AAAGCTGAGG AGAGGTGGCT GCNCTGTGGC AGAGGGGATG GGCATTCAAG
1 0 1  GTAGAGAAAA GAGCAAGTGC CAGGGCCCAG AAGAGTGCGC ATRTGTAGCT
1 5 1  GGTGTRCGAT TCAGCAGNAG TRGTGGCATC GGCATTTGAG CTGAAAACAA
2 0 1  CGGGGGTGAT GGTGGAATTT CCAGCAAGAG CTWGGAGGCA AAGM
c) HG22CON2 Length: 344
1 TAATGTNCAG TNCTGAGTTA GGNCCCNCTT CAAAGCTTCC CCAGATGCTT
5 1  GTCCTTCATT CCATATCATG TCCATTATCC CCTACTGCAC AGCCTCTAAT
1 0 1  CTTTCTTACC CCCCAACTAG ACTGAAAATT CCACACAGAT AAGGACCACA
1 5 1  GCTGTATCCT AACGCAKGCC CTGAGCCACA CTGGGCACAT AGTATGTGTG
2 0 1  CAGTAAGCAT GGGCTGAATG AAGGAGCCTA CCCCACAGTA GGGCAAGCTG
2 5 1  CCTCAGAGCT GGACAATATG ATTATCAGAG GAGATGGCAG TTATTCGATA
3 0 1  CCTATGTGGT AGACAGTTGC TTTAATTTAC TAGAAGCAGT TTAA
d)HG21CONR Length: 404
1 GCTCTCTGCC CAGTCACTCA ATGCCATCAC TCTGCCTGGC CCTGTGTTTG
5 1  CCAGGGAGCA CAGACACCCA TCTAAGGAAT CCATGCCATG AGGAGTTTAT
1 0 1  GGTCTGTAAA GAATACAGGC AGGAATTTAA GAAGGTGTCA GACTGCAGGA
1 5 1  AAGGAGCTCA CTCTGCTGGG GTGGATATCT GAGGCAGAGA TCTGCTGGTA
2 0 1  TAGGGGACCA ACTGGCTAAG TAAGTTTCCC CAAGACTCAC GGAATTTCCA
2 5 1  CAACAGGTGA TTTGGATCTG AAAACCTGAC AATTATGGGT ACACATNAGG
3 0 1  GGGGGCAGCC TTNCACAATN TTCTCCCAGG TNAGGGAGAC TANTTGTTTT
3 5 1  NANTTTGNAC ATTNTAACAA GGGGTGTTGT TTNANCCTNN CNTGGNTTCT
4 0 1  TTCT
Figure 6.16a to d Consensus sequences from HG22
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6.3.7 RESULTS OF SEQUENCING OF HG23
A total of 34 deletions were selected and 30 were successfully sequenced using the 
machine. HG26 was also sequenced with the T7 and SP6  primers and the sequences 
added to the data from HG23. Both HG23 and HG26 had also previously been 
sequenced manually and this data was also incorporated. The sequences were analysed 
and arranged into 4 contigs and as the HG23 insert was oriented in the opposite sense 
to XD2, the XD2 orientation was adopted in the naming of the contigs:
HG23CONU : Comprised of HG23UR (SP6  sequence of HG23 determined by 
automated sequencing), HG23RM (SP6  sequence of HG23 determined by manual 
sequencing), 23Ula and 23Ulc. Total length 460bp.
HG23CON1 : Comprised of 23U2a, 23U24a, 23U2b, 23U7b, 23U13b, 23U2c, 
23U8C, 23U10C and 23U24d. Total length 442bp.
HG23CON2 : Comprised of 23U4a, 23U9a, 23U14a, 23U18a, 23U22a, 23U5b, 
23U9b, 23U3c, 23U16c,23U21d, HG26R1 (SP6  sequence of HG26 from machine), 
HG26R2 (as HG26R1 but from a different plasmid preparation) and HG26RM (SP6  
sequence of HG26 from manual sequencing).Total length 720bp.
HG23CONR : Comprising of HG23UM (T7 sequence from manual sequencing of 
HG23) and HG26UM T7 (manual sequence of HG26). Sequence was incomplete and 
therefore no concensus is shown.
HG23CON1 and HG23CON2 have a short region of overlap which is bridged by 
23U10c (see contig constructs in Appendix B for the join line). As HG23CON2 also 
contains the start of HG26 (the 600bp Hindlll/BamHI fragment of HG23) both of 
these contigs were anchored to the 3' end of the insert. The relationship of the deletion 
sequences and the contigs to HG23 is shown in figure 6.17.
A combined consensus sequence was constructed by joining HG23CON1 and 
HG23CON2 and was designated HG23-5' (total length of 1160bp). This consensus 
and those for HG23CONU and HG23CONR are shown in Figure 6.18a-c. It was 
expected that HG23-5' would overlap with HG23CONR but no good match was 
observed. This was probably due to the quality of the HG23CONR sequence.
Timepoints 23U15a, 23U4b, 23U15b, 23U9c and 23U3d all mapped to pGEM and 
23U3a, 23U13a, 23U18b and 23U4c all failed to sequence after 4 attempts.
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a)HG23CONU Length: 460
1 TCTAGACCTT CGAGGAATTG CCACACTGCC TTCCACAATG GTTGAATTAA
5 1  TTTGCAATCC CACCAACAGT GTAAAAGCAT TCCTATTTCT CCACATCCTC
1 0 1  TCCAGCATCT GTGGTTTCCT GACTTTTTAA TGATTGCCAT TCTAACTGGC
1 5 1  ATGAGTGGTA TCTCATTGCG GTTTTGGTTT GCATTTCTCT AATGACCAGT
2 0 1  GATGATGAGC TTTTTTTGCT GTTTTTTTGG CTGCATAAAG TCTTCTTTTT
2 5 1  GAGAAGTGTC TGTGCATATC CTTTGACCAC TTTTTGAAAG GGGGTTGTTT
3 0 1  TTTWTCTTGT GAATTTTGTT TAGGGTCCCT TTGTAGGNTT CCYCGATATT
3 5 1  AAGNCCCTTT GTNCAAGANG GGNTTAGTTC CGCAAAAANT TTTTNTTNCC
4 0 1  CCNTTCTGNN AGGGTGGCCC TTTTCAAACC CNNAAGGNAT AGGTTTCNTT
4 5 1  TGGCCCCCTT
b) HG23-5’ Length: 1276
1 ATTTTTTTAA ATTGTCATGT ATATGAATTG AGAAAAAAAA TCATGCTATG
5 1  CATATTATGA GACCAGTTTC CCCAATGGAA TAAAATAAAG TACTTGAACA
1 0 1  GCTGCTATAT TAGCATCTGT TTGTCCATAT CATCATCCAG TTACTAGAAA
1 5 1  GACATAATTC CCACTCTTCA CTCAATATAT AGATGGAAGT GGTTTTTATG
2 0 1  GTAAATAAAA TTAGATTTGC AATAAGACAA AAGTAATGAT TCAGGGCTTG
2 5 1  GTTAATGTTA AGTTTAAATG TACATATCAT GTTGAGGAAT TTTCTTTGAA
3 0 1  CACATAACAA AAAAAAAGTG CTACTGAATG AACATTATTG CAATGTAGTA
3 5 1  AAGCAGAATG CAAATTCCTT GAGGTCAGCA TTCAAGTCTG TTTTCCTCGC
4 0 1  AGCGGTGCCC ACACACCTAG CATACTGCCT GGCACACAGT AAATGCTCAT
4 5 1  TAAATATTTG TGAGGTACAT GGACAGGGGA ATGTGGTAGA CAGCTGATGA
5 0 1  AGCTTTTCTC CCACTGTTGC CCTAGGTGGA TCATCCATAG TCAATTGATT
5 5 1  CTGAACTCTG AGGTCCAAGT TCTGCCCTCC TCCTTCACTM TCCCCACAAG
6 0 1  TGGGCGGGAC AATCCTCCCT GGATTTGAGC ACAGGGGGAC GGGGGTGGTC
6 5 1  AGAGAGAGGT AGGGGCACTC AGAGATCCAG CAGGTGCTGC ACCATGAGTG
7 0 1  TCTCTGTGCT GAGCCCCAGC AGACTCCTGG GTGATGTCTC TGGAATCCTC
7 5 1  CAAGCGGCCT CCCTGCTCAT TCTGCTTCTG CTGCTGATCA AGGCAGTTTC
8 0 1  AGCTCTAACC TACACAGGCA GTGGCTTCTT CAAAGCCCTT CCAGCAGTTC
8 5 1  CCTNTNGCCN TATCNTNACN ACTGGCTNCT TTCGGGGNAC ATTCCAGGGT
9 0 1  GGTTAGGGTA GGGNAACTTC AANTNGGGAG GAATTNNGGA NGGGANAAAG
9 5 1  ANGGGAGTTG NGGGNTTCTN AAGGANCCCT TGGTTAACAA NAANCCCTTG
1 0 0 1  TGGGAAAAAA GCTTTTNTTT TNTTAACAAA TTTTTNGGGT TTNAAANGGG
1 0 5 1  AACANACACA GCGTTANCNA TTTTAGNATT TAAGGTTTTT CCCNNTNNTN
1 1 0 1  GGGGNATTNA
Figure 6.18a and b Consensus sequences from HG23
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The lack of any sequence in the middle 2kb of the clone indicates that the deletion 
reaction did not proceed correctly. The grouping of so vast a range of timepoints in 
the same place suggested sites of degradation at which the ExoIII was performing 
uncontrolled deletion. The deletions would have to be repeated in order to get a better 
distribution and care must be taken to ensure the quality of the DNA.
6.3.8 RESULTS OF SEQUENCING OF HG6
The sequencing of the HG6  deletions were performed at the end of my stay at GIMB 
and unfortunately I ran out of time before all the clones could be sequenced 
successfully. However 20 out of 25 deletions were successfiilly sequenced and contigs 
were constructed. Although 2 of the four contigs were not anchored, their positions 
could be determined by comparison to the published sequence of the CYP4A1 gene. 
The contigs were as follows:
HG6 CONU : Comprising of 6 Ula, 6U18b and HG6 UU (HG6  sequenced with T7 
primer). Total length 382bp.
HG6CON1 : Comprising of 6U4a, 6U2a, 6U4a, 6U7d, 6U3xa, 6U7xa, 6U7xb and 
6U7xc. Total length 936bp
HG6CON2 : Comprising of 6U2b,.6U8xb,.6U15c and.6U18a. Total length 775bp.
HG6 CONR : Comprising of 6U2b,.HG6UR (the SP6  sequence of HG6 ) and PHG6 U 
(the T7 sequence of pHG6  - the original pUC derived HG6  plasmid). Total length 
309bp.
The relationship of the deletion sequences and the contigs to HG22 is shown in Figure 
6.19 and HG6C0NU, HG6C0N1, HG6CON2 and HG6C0NR are shown in Figure 
6.20a-d. (the contig constructions are shown in Appendix B).
Deletions 6U9a, 6U9b, 6U19a, 6U5c and 6U18c were homologous to pGEM. 6U3b, 
6U5b, 6U15b, 6U4c and 6U3xc were not successfully sequenced after 3 attempts.
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a)H G 6 CONU Length: 382
1 GGATCCTTAA CTATCCTGGC TCTGGTGCTC TCTCTGCAGG TGTTTGACCC
51  TTCCCGTTTT GCACCGGGTT CTGCTCAACA CAGCCACGCT TTCCTGCCCT
1 0 1  TCTCAGGAGG ATCAAGGTGA GACGTCCTGT GTGGTAATTC GAATAGAGGA
1 5 1  ATGAGGGAAG TCTCTGGTCA ACCCTCTGAT CTTTGTGAGC CTGATGTTCA
2 0 1  TATGTGGCAT CTTCAGGTGT GCTCTTAAAT GTTGGTATTT GTGGGAAAGT
2 5 1  CAGGCACCTG GTGTGGGCGT CTCTGTGTAC AAAAGGAAGG TGGCATTCAG
3 0 1  AGCACCCCAT GGAGACTTTG TTCCCTCTGC TTCTTCAAAT GGGCAGCCTG
3 5 1  AATTCACTGC AGTGCATGTT YCCAAAACTT CA
b)H G 6 CONl Length: 936
1 NGGCNGACGA AGCAACNNCA GCTGTTTGCT TTTNTCAGTT GTCAGGAATA 
51  GTAAACTGTA GATTTNTNNC CCCCCACACA TCCTCAATGC AGCACACNAC 
1 0 1  CTTCCCTATT TAATTCACTA GNCTGTCGTA GAGATGAATC ATTGAAGTCT 
1 5 1  TTGCATCTGT TTATAATACA GATGACCNGC AAGTMCTACC TTTCAAGTCA 
2 0 1  TATAAGGGAG AGGTTAAGGT AGCCCTTTGA AGAAAGTTTT ACAACAGTGT 
2 5 1  GTGTCATATC ATACATTCTT CTGTCTTGCC CAATGAAATT TTTACTGCAT 
3 0 1  TATATAGTGT TCACATATTT ACATCTATTT TCCCGTTTGA CAAATTCTGT 
3 5 1  ACATGCCTTG AGATCTTTAT ACCATAGTCC TGTAATCCAC TTAGCACAAT 
4 0 1  ATTGGCCAAA AACATAAAAA TGTGAACAGT ACACTGTCTT GGAGAGAAAA 
4 5 1  GSCCAATAAT TATCATATAA CGGACAACAT TGAAGCCTCC TGGTATGTGA 
5 0 1  AATATAAAAC ACACTTGAAA TTGCTTTTGA GCTGGAGAGG AAAACTCCAG 
5 5 1  AATGGTTGCG GTGGAGATCA TTGTGGCATC AGGAATCGTC CTGTGACATA 
6 0 1  CACACAGGCA AAAACGATAT AAATTCTTAG TAGAAACAAA GTTTGTTCAA 
6 5 1  AGAAATAATT ATGTGACTTT TTGAAACGGT GAGTCCACTT ACACAGAACA 
7 0 1  GGCTTTAAGA AAAAGCTTCC TCCTGAAACT CCTTCTCCAG CACTGGTCTG 
7 5 1  TCTATCCCAG CATGAGAAAG TCCTCCTAAA CATTGCCTGC AAATCATGTC 
8 0 1  GCTGCCACTA GAGAACTGGA GAGCATTCCT AAGGTCCATT TCTAGCTCAG 
8 5 1  AATTWATATT TACTCTCAGT GTATTTCATT ATATTTTATT CAATTTTAAA 
9 0 1  AACTTAACCA TCATTTCAAA TTTTTGGRGG t TTTTT
Figure 6.20a and b Consensus sequences for A) HG6C0NU and B) HG6C0N1
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c)HG 6 CONU Length: 775
1 CCCCCNNCCG ACNGTANNTG GGTCAAGTCC TATGCAGCAT GATGAGAAAA
5 1  CAGAGATAAA AAGTACAAAA ATGTGTTGTA CAGAAATATA TCCTGTACTC
1 0 1  CAGACACACA TCGTTCCATC AACCATCCTT TCACTCATTC ACTCACTGAG
1 5 1  TGGCGTGTTG AGTGTCCCTG TCCCTGGTGC TGTCCTTGGC ACTGGACTGT
2 0 1  GAGTGTTCAT GGATAAATCG TGAATGCTHM CTGGGGGCCT GGGAGGGAGA
2 5 1  GGTCCAGCTG GCAGGGAGTG AGAGGCAGCT GGGATCTGAC TTTAGCCTTA
3 0 1  GGATTTGGCA GGCAGAGGTG GAGGGAGGAC ATTCTGAGCC ATCTCCACAT
3 5 1  GAACAGGGSC AGGACGTGGG CTGGACAGGT AAAATGTGGG TGAGGCAAGA
4 0 1  GCCCATGGAG GGCTTATCTG CCAGCTGAGG CATTGGGATG CTGTCCCACC
4 5 1  TGTGATGAAG AGCGTGGGAG GGTCTGAGCT GGGCTKTGGC TTCAGTGTTC
5 0 1  TGGGAGGGGA AGCAGAAAAC CATAAAGTCC AGGCAAGAAT ACTGAGGAAG
5 5 1  GGCAAGGAAG NATGTTTCTG GAGTAGANTT AGAAGGCTAC AGGGGCTGGT
6 0 1  GGATNGNAGN AGTTAGGGTT AGACAAGGAG NCCCGNCCCT GGGGTTNGGA
6 5 1  AGGGCAANGT TTGGNGAAAN AATTNAGGGA NTNAACCCAA CCCCAAATTT
7 0 1  GTTCTNCCNG GGAAAGGCNT TCCCAAAANT TNCCCCNTTC TTNAACTTCC
7 5 1  CNTTAAATNA CAACCCCATT TNGGG
d) HG6 CONl Length: 309
1 KCTASCCCAG GAANACGTCT CTGTCAAAGG ATCGGGATAG TGTCAAATCC
51  AGGACGGGGT AGAAGTGTCC ATGGGCTGTA TGTGTGCAGG GGCTGGACAC
1 0 1  ATGAGGTTGG GCACTGAATG TCCAGCTCAG GGCTGGGGTS AGGGNCCAAA
1 5 1  ACCTGCTCAG ATCAGAATGG GGCCTGAGGA CACTTCTCAA TTCATTATCT
2 0 1  CCACCTGGCC CAGGAACTGC ATCGGGAAAC AATTTGCCAT GAACGAGCTG
2 5 1  AAGGTGGCCA CGGCCCTGAC CCTCTCCGCT TTGAGCTGCT GCCTGATCCC
3 0 1  ACCGGATCC
Figure 6.20c and d Consensus sequences for C) HG6CON2 and D) HG6C0NR
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6.3.9 SUMARY OF SEQUENCING
A total of 153 deletions were selected from the cracking gels and 128 of these were 
successfully sequenced. Of these 128 deletions, 8 8  (61%) were sequenced at the first 
attempt, 27 (18%) at the second and 13 ( 1 0 %) at the third. Most of the 33 
unsequenced clones (bar those for HG6 ) were attempted at least four times but failed 
to give good results. The HG6  clones were sequenced at least twice and time 
constraints prevented further attempts.
A total of 9.5kb of consensus sequence was produced of which 8 kb was anchored to 
known reference points (either the ends of the subclones or by comparison to the 
CYP4A1 gene sequence).The total extent of sequencing of ^D2 is shown in Figure 
6.21 and a summary of the contigs is shown in Table 6.3.
The automated sequencing was performed in 19 overnight runs, some of which were 
not up to the full capacity (24 samples). The success rate for the sequencing was 
approximately 60% and the lack of success for some clones was probably due to the 
DNA preparations or a deletion of the primer binding site due to poor protection. 
Even with this modest success rate the automated sequencing produced approximately 
80kb of usable sequence. The duplication of sequencing and overlapping of the 
deletions accounted for the final total from the contigs.
With a good DNA preparation 400bp sequences were obtained. With the Erase-a-base 
system working well, the automated sequencer was capable of constructing 6-7kb 
contigs in a single run, depending on the size of the deletions. This capacity for large 
scale sequencing was not present in the laboratory in Guildford and would be difficult 
to emulate manually at GIMB.
Once the contigs were constructed they could be further analysed by comparison to 
other members of the CYP4A family.
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CONTIG SIZE (bp) No. OF 
SEQUENCES
ANCHORED? EXONS
C0NTAE4ED
HG21C0NU 405 2 /
HG21C0N1 419 3
HG21CON2 213 5
HG21C0NR 540 6 /
HG22CONU 532 11 y
HG22CON1 334 2
HG22CON2 244 4
HG22CONR 420 6 y
HG23CONU 461 4 y
HG23CON1 444 9 y
HG23CON2 720 13 y exon 1
HG23CONR 300 2 y exon 1
HG19C0NU 230 4 y exons 8+9
HG19C0N1 1203 1 2 y exon1 0
HG6C0NU 382 3 y exon 1 1
HG6C0N1 936 8 y
HG6CON2 775 4 y
HG6C0NR 309 3 y exon 1 2
Table 6.3 Summary of the contigs from the XD2 sequencing project.
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6.4 ANALYSIS OF CONTIG SEQUENCES FROM THE SUB-CLONES OF 
A.D2
6.4.1 COMPARISON OF THE CONTIGS WITH THE HUMAN CYP4A11 
cDNA SEQUENCE
In January 1993, during the final analysis of my contigs, a pre-print of a paper [Palmer 
et al, 1993b] in which the first isolation of a human CYP4A was reported, was sent to 
me by one of the authors (Dr T. Richardson). This cDNA, designated CYP4A11, was 
2596bp long with a 1560bp open reading fi"ame coding for a protein of 579 amino 
acids (59.347 kDal). This sequence was down-loaded fi*om the EMBL database where 
it had recently been deposited, and compared against the contigs using a FastA search 
(compares both strands of all specified target sequences).
The longest stretch of similarity was found in HG19C0NU and was 100% over 95bp. 
This was identified as the 3' end of exon 8  by comparison of the amino acid sequence 
to that of other members of the CYP4A family. It starts at the exonic BamHI site that 
forms the 5' end of HG19U and is shown in Figure 6.22a.
The next longest region of similarity was found in HG19C0N1 which showed 100% 
homology over 64 bp and corresponded to the short exon 10, shown in Figure 6.22b. 
A second region of similarity was also seen on this contig. The similarity score was 
85% over 147bp, a figure that was lower due to some non-significant matching after 
the intron splice site. This corresponded to exon 9 and is shown in Figure 6.22c
Similarity was also observed in HG6C0NR which was 96% homologous over 102bp 
(the difference was 2 mismatches and 2 deletions). This region was identified as the 5' 
end of exon 12 which stopped at the exonic BamHI site found at nucleotide 1490 in 
the CYP4A11 cDNA. See Figure 6.22d. The alignment indicated that a region coding 
for 31 amino acids (93 bp) was missing from the 3' end of the genomic coding sequence 
and would have been found in HG29.
Further similarity was found in HG23CON2 (and HG23-5'CON) and was 89.2% over 
231 bp. The sequence aligned to exon 1 and the mismatches were mainly due to 
insertions/deletions or unreadable bases in the contig sequence. See Figure 6.22e.
Finally HG6C0NU also showed similarity with CYP4A11 cDNA (75% over 160bp) 
which mapped to exon 1 1  and is seen in Figure 6.22f.
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a) CYP4A11 vs HG19CONU
SCORES Initl: 380 Initn: 380 Opt: 380
100.0% identity in 95 bp overlap
1000 1010 1020 1030 1040 1050
4 A l l
H gl9u
4 A l l
GCCACGACACCACAGCCAGTGGGATCTCCTGGATCCTCTATGCTCTGGCCACACACCCC
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
GGATCCTCTATGCTCTGGCCACACACCCC 
10 20 3
1060 1070 1080 1090 1100 1110
AGCATCAGGAGAGGTGCCGGGAGGAGATCCACAGCCTCCTGGGTGATGGAGCCTCCATC
H gl9u AGCATCAGGAGAGGTGCCGGGAGGAGATCCACAGCCTCCTGGGTGATGGAGCCTCCATC
40 50 60 70 80 9
4 A l l
1120 1130 ■ 1140 1150 1160 1170
CCTGGAACCACCTGGACCAGATGCCCTACACCACCATGTGCATTAAGGAGGCACTGAGG
H gl9u CCTGGTGAGTGAGGGCTCAAAAGATGGGGTTCCCTGCCTTCTCCACAGGGGCCCCTGGT 
100 110 120 130 140 15
b) CYP4A11 vs HG19CON1
SCORES I n i t l :  276 I n i t n :  276 O pt: 304 
91.1% i d e n t i t y  i n  90 bp o v e r la p
20 30 40 50 60 70
Huitian4 GCACTCCCGTCACCTTCCCTGATGGGCGCTCCTTGCCCAAAGGTATCATGGTCCTCCTC
I I I  I I I  I I I I I I I I I I I I I I I I I I I
H gl9co GCAAATVATTGGTCTTCTCTCTGTTTCCAACCTGCACCACAGGTATCATGGTCCTCCTC
990 1000 1010 1020 1030 1040
80 90 100 110 120 130
Human4 CCATTTATGGCCTTCACCACAACCCAAAAGTGTGGCCCAACCCAGAGGTGTTTGACCCT
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I  I I I
Hgl 9co CCATTTATGGCCTTCACCACAACCCAAAAGTGTGGCCCAACCCAGAGGTATGTGGTCCT 
1050 1060 1070 1080 1090 1100
140
Human4 TCCGTTTTGCACCGGGT
H gl9co GAGAGGAGGAAATGAGGTGATCCCTCAAGACCAATACCTTCTCCTGCTTCCACCTCTGG 
1110 1120 1130 1140 1150 1160
Figure 6.22a and b Comparison of CYP4A11 to A) HG19C0NU showing the 
position of exon 8  and B) HG19C0N1 showing the position of exon 10.
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c) CYP4A11 vs HG19CONR
SCORES I n i t l :  308 I n i t n :  308 Opt : 430
85.0% i d e n t i t y  i n . 147 bp o v e r la p
1110 1120 1130 1140 1150
4 a l l  TGGAGCCTCCATCACCTGGAACCACCTGGACCAGATG-CCCTACACCACC—ATGTGCA
1:11111 M i l l  I I M l  I I I  I I  I I  I 
Hgl 9co ACCNAGATGCCCCTAAACCACCCAATGTGCA
10 20 30
1160 1170 1180 1190 1200 1210
4 a l l  TTAAGGAGGC-ACTGAGGCTC-TACCCACCGGTGCCAGGCATTGGCAGAGAGCTCAGCA
I : I I  : I I I I  I I : I I  I I  I I  I I  I I  I I  I I  : I I  I I  : I I  I I  I I  I I  I I  I I  I : : I I  I I  M I I  I I  
Hgl 9co TWAARGAGGCMAMTGAGGCTCYTACCCANCGGTNCCAGGCATTGGCARRGAGCTCAGCA
40 50 60 70 80 90
1220 1230 1240 1250 1260 1270
4 a l l  TCCCGTCACCTTCCCTGATGGGCGCTCCTTGCCCAAAGGTATCATGGTCCTCCTCTCCA
I I  I I  I I  I I  : I I  I I  I I  I I  I I  I I  I I  I I  I I  I I  I I  I I  I I  I I  I I  I I  I I I I I  I I I  1:1
H gl9co TCCCGTCAMCTTCCCTGATGGGCGCTCCTTGCCCAAAGGTATGAAGTTCCCCCACNCTC 
100 110 120 130 140 150
1280 1290 1300 1310 1320 1330
4 a l l  TTATGGCCTTCACCACAACCCAAAAGTGTGGCCCAACCCAGAGGTGTTTGACCCTTTCC
Hgl 9co CACCTAAACTCTCCACAGGGACGTGTGGAGGGTGAGAAATCCATGTGTGCATCAGAATT 
160 170 180 190 200 210
d) CYP4A11 vs HG6 CONR
SCORES I n i t l : 241 I n i t n :  341 Opt : 362
96.1% i d e n t i t y  in  102 bp o v e r la p
1370 1380 1390 1400 1410 1420
4 a l l  GCCACGCTTTCCTGCCCTTCTCAGGAGGATCAAGGAACTGCATTGGGAAACAATTTGCC
I I I  I I  I I  I I  I I  I I I  I I  I I  I I  I I  I I  I I  I
H g6rco ACACTTCTCAATTCATTATCTCCACCTGGCCCAGGAACTGCATCGGGAAACAATTTGCC 
180 190 200 210 220 230
1430 1440 1450 1460 1470 1480
4 a l l  TGAACGAGCTGAAGGTGGCCACGGCCCTGACCCTGCTCCGCTTTGAGCTGCTGCCTGAT
I I  I I  I I  I I  I I  I I  I I  I I  I I  I I  I I  I I  I I  I I  I I  I I  I I  I I  I I  I I  I I  I I  I I  I I  I I  I I  I I  I I  I I
H g6rco TGAACGAGCTGAAGGTGGCCACGGCCCTGACCCT-CTCCGCTTTGAGCTGCTGCCTGAT 
240 250 260 270 280 290
1490 1500 1510 1520 1530 1540
4 a l l  CCACCAGGATCCCCATCCCCATTGCACGACTTGTGTTGAAATCCAAAAATGGAATCCAC
I I  I I  I I I  I I  I I  
H g6rco CCACC-GGATCC 
300
Figure 6.22c and d Comparison of CYP4A11 to c) HG19C0N1 showing the 
position of exon 9 and d) HG19C0NR showing the position of exon 12.
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e) CYP4A11 vs HG23-5’
SCORES Initl: 516 Initn: 516 Opt : 686
89.2% identity in 231 bp overlap
10 20 30
4 a l l  GAATTCCGCAGAGATCCAGCAGGTGCTGCACCATG
I I I I I I I I I 1 I I I I I I I 1 I I I I I I I I I I 
Hg2 3 -1  GACGGGGGTGGTCAGAGAGAGGTAGGGGCACTCAGAGATCCAGCAGGTGCTGCACCATG 
640 650 660 670 680 690
40 50 60 70 80 90
4 a l l  GTGTCTCTGTGCTGAGCCCCAGCAGACTCCTGGGTGATGTCTCTGGAATCCTCCAAGCG 
I I I I I I I I I I I I I I I I I 1 I I I I I I I I I I I I I I I I I I I I I I II I I I I I II I I I I I I I I I I 
Hg23-1 GTGTCTCTGTGCTGAGCCCCAGCAGACTCCTGGGTGATGTCTCTGGAATCCTCCAAGCG 
700 710 720 730 740 750
100 110 120 130 140 150
4 a l l  CCTCCCTGCTCATTCTGCTTCTGCTGCTGATCAAGGCAG-TTCAGCTCT-ACCTGCACA
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I
Hg23-1 CCTCCCTGCTCATTCTGCTTCTGCTGCTGATCAAGGCAGTTTCAGCTCTAACCTACACA 
760 770 780 790 800 810
160 170 180 190 200
4 a l l  GCAGTGGCTGC-TCAAAGCCC-TCCAGCAGTTCCC-GTGCCC TCCCTCCCACTGGC
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I : I : II I I : : I : I I I I I I
Hg23-1 GCAGTGGCTTCTTCAAAGCCCTTCCAGCAGTTCCCTNTNGCCNTATCNTNACNACTGGC 
820 830 840 850 860 870
210 220 230 240 250 260
4 a l l  C— TTC-GGGCACA-TCCAGGAGCTCCAACAGGACCAGGAGCTACAACGGATTCAGAAA
: I I I  111:111 I I I I I I
Hg23-1 NCTTTCGGGGNACATTCCAGGGTGGTTAGGGTAGGGNAACTTCAANTNGGGAGGAATTN 
880 890 900 910 920 930
Figure 6.22e Comparison of CYP4A11 to HG23-5' showing the position of exon 1
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f) CYP4A11 vs HG6CONU*
SCORES Initl: 313 Initn: 313 Opt: 314
75.0% identity in 160 bp overlap
1290 1300 1310 1320 1330 1340
4 a l l  ACCACAACCCAAAAGTGTGGCCCAACCCAGAGGTGTTTGACCCTTTCCGTTTTGCACCG
I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
Hg6uco TAACTATCCTGGCTCTGGTGCTCTCTCTGCAGGTGTTTGACCCTTCCCGTTTTGCACCG 
10 20 30 40 50 60
1350 1360 1370 1380 1390 1400
4 a l l  GTTCTGCTCAACACAGCCACGCTTTCCTGCCCTTCTCAGGAGGATCAAG— GAACTGCA
I I I I I I I I I  I I I I I I I I I I I I I i I { I I I I I I I I I I I I I I I I I I I I I I I I I I  I
Hg6uco GTTCTGCTCAACACAGCCACGCTTTCCTGCCCTTCTCAGGAGGATCAAGGTGAGACGTC 
70 80 90 100 110 120
1410 1420 1430 1440 1450 1460
4 a l l  TGGGAAACAATTTGCCATGAACGAGCTGAAGGTGGCCACGGCCCTGACCCTGCTCCGCT
I I I  I I I I I I I  I I I  I I I  I I  I I I I I I I I I I I I I I
Hg6uco TGTGTGGTAATTCG-AATAGAGGA-ATGAGGGAAGTCTCTGGTC-AACCCT-CTGATCT 
130 140 150 160 170 180
1470 1480 1490 1500 1510 1520
4 a l l  TGAGCTGCTGCCTGATCCCACCAGGATCCCCATCCCCATTGCACGACTTGTGTTGAAAT
I I I  I I I
Hg6uco TGTGAGCCTGATGTTCATATGTGGCATCTTCAGGTGTGCTCTTAAATGTTGGTATTTGT 
190 200 210 220 230 240
Figure 6.22f Comparison of CYP4A11 to HG6C0NU showing the position of exon 
11.
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By using the CYP4A11 sequence as a guide it was shown that HG19C0NU and
HG19C0N1 did overlap by 32bp at the start of exon 9. There is only one mismatch
between HG19C0NU and CYP4A11 due to an insertion of an extra base. There are 4 
miss-matches between HG19C0N1 and CYP4A11 (and HG19C0NU), all due to 
insertion of an extra base (one of which matches the insertion in HG19C0NU). The 
overlap is shown below with the first and last base of each string numbered in brackets 
and the homologous sequences underlined.
HG19C0NU (199) ACC-AGATNCCC-TACNCCACCT-ATGTGCA (231)
I I I  I I I I I I I I I I I I I I I I I I I I I I I I
CYP4A11 (1130) ACC-AGATGCCC-TACACCACC—ATGTGCA (1161)
I I I  I I I I I I I I I I I I I I I I I I I I I I I I
HG19C0N1 (1) ACCNAGATGCCCCTAAACCACCCAATGTGCA (32)
The miss-matches were enough to prevent the overlap being detected by the computer 
program and so the CYP4A11 sequence proved useful at this point.
From the similarity data it was concluded that A.D2 was part of the gene coding for the 
CYP4A11 cDNA or a very close homologue. This was a welcome conclusion as it 
reduced the importance of the missing HG24 section of the XD2 sequence as its only 
real significance to this project was the determination of the nucleotide and amino acid 
sequences of exons 2 to 7.
6.4.2 AMINO ACID SIMILARITY BETWEEN CYP4A11 AND THE OTHER 
MEMBERS OF THE CYP4A FAMILY
The amino acid similarity of CYP4A11 and the other members of the CYP4A family has 
been reported by Palmer. From the total sequence they find that CYP4A11 is 80% 
similar to the four rabbit genes (CYP4A4-7) and 73% similar to the three rat genes 
(CYP4A1-3). The partial sequencing of HG6  and HGl 9 reported in Chapter 3 gave 
comparable results although fi-om that data the rat and human genes seemed to have % 
similarities in the same range (76-82%) as shown in Table 3.3. GYP genes from this 
and other families tend to show more conservation of amino acid sequence at the 3' 
end when compared across species. It was concluded that the 5' end of the CYP4A11 
protein must share greater amino acid homology to those of the rabbit than those of 
the rat. To check this hypothesis the amino acid sequence of exon 1 (deduced from 
HG23-5'CON and HG23CONR) was compared to that of the other reported members 
of the CYP4A family. The results are shown in Figure 6.23. From the similarities it 
was concluded that the human gene was more similar to those of the rabbit than those 
of the rat.
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6.4.3 SEARCH FOR PUTATIVE REGULATORY SITES IN THE 5' NON­
CODING REGIONS OF THE HUMAN GENE
The 5' flanking regions of 4 other members of the CYP4A sub-family were available on 
the EMBL/Genebank database. CYP4A1 and 4A2 had been sequenced by Kimura 
[1989a], CYP4A4 by Palmer [1993a] and CYP4A6 had been sequenced by MuerhofF 
[1992]. The sequences were downloaded onto the database and the HG23-5' contig 
sequence was compared against them. HG23-5' was also analysed using a program 
which searches for the binding sites of known transcriptional regulatory factors. In 
order to standardise the positions of the site the transcriptional start site was identified 
from the CYP4A11 cDNA sequence and was located at nucleotide 670 of HG23-5' and 
this was designated +1 for the gene. All nucleotides upstream of this point were given 
a negative number counting away from the transcriptional start site. The following 
was observed:
a) In common with the other members of the CYP4A family there is no TATA box 
(binding site of transcriptional factors responsible for Polymerase II binding). A 
CCAAT box was detected at -593 in my CYP4A11 sequence and this complements 2 
such boxes at -464 and -448 in CYP4A6. No similar sequences were seen in 
CYP4A1M2 and 4A4.
b)There is a consensus recognition sequence for the eukariotic transcriptional factor 
Spl between -69 and -57 in CYP4AI1. This site is also seen in CYP4A6 ( -47 to -37) 
and partial versions are seen in CYP4A4 and CYP4A1 but not in CYP4A2.
c) Immediately upstream of this partial SPl site in CYP4A1 lies a 19bp region that is 
also seen in CYP4A2. Parts of this 19mer can be also seen in CYP4A4, 4A6 and 4A11 
to a lesser extent. The function of this region is unclear and MuerhofF questions its 
importance in view of its lack of complete conservation across species. It is therefore 
possibly a binding site for a factor unique to the rat. MuerhofF also reported a region 
of sequence in CYP4A6 (-221 to -211) conserved in CYP4A1 (-382 to -372). This 
region is part of a larger area of similarity seen between CYP4A6 and CYP4A11 ( - 
251 to -209 and -262 to -220 respectively)
d) A region close to the transcriptional start site in CYP4A6 mà CYP4A1 was 
identified as a possible binding site for HNF-4 ( a hepatocyte nuclear factor). However 
this site was not present in CYP4A2, 4A4 or 4A11. The partial binding site for another 
member of this group of factors, HNF-1, was seen in CYP4A6 (-106 to -94) and this 
was also found in CYP4A11 as a partial site (-153 to 133). This site is involved in the 
constitutive regulation of the CYP2E1 gene [Ueno and Gonzalez, 1990].
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A comparison of the regulatory regions of the CYP4A1, CYP4A2, CYP4A4, CYP4A6 
and our CYP4A11 genes is shown in Figure 6.24a-c and the sites listed above are 
marked on the regulatory region of CYP4A11 (Figure 6.25).
6.4.4 SEARCH FOR STERGH) HORMONE RECEPTOR BINDING SITES.
The role of steroid hormone receptors in the regulation of the peroxisome proliferative 
response (including the induction of members of the CYP4A family) was first proposed 
by Issemann and Green [1991] who identified a peroxisome proliferator associated 
receptor in the mouse (mPPAR) which appeared to mediate the response of CYP4A1 
to peroxisome proliferators. From analysis of its DNA binding domain it was 
proposed that the receptor would bind the sequence TGACC and may act as a dimer.
Acetyl Co A Oxidase (ACO) is an enzyme which is co-induced with CYP4A1 in 
response to peroxisome proliferators [Bell et al, 1990] The 5' region was sequenced by 
Osumi [1991]. and was shown not to have a TATA box. Tugwood [1991] identified 
a tandem repeat sequence 570bp upstream in the 5' promoter region of ACO which 
regulated the genes response to PPAR mediated induction. This Peroxisome 
proliferator response element (PPRE) in ACO consisted of an imperfect hexamer 
repeat with a single base between the repeat elements. A motif similar to this is seen in 
the promoter region of CYP4A6 [MuerhofF et al 1992], and a third example is found in 
the promoter region of the rat peroxisomal bifunctional enzyme (BFE) gene [Bardot et 
al, 1993]. These response elements are shown below(the repeats are underlined and 
the nucleotide positions shown in brackets):
CYP4A6 (-575bp) TGGCCTTTGTCCT (-556bp)
I I  I I I I I I I I I I
Acyl CoA (-753bp) TGACCTTTGTCCT (-74  0bp)
I I I  I I  I I I I
BFE (-2947bp) TGACCTATTGAACTATTACCT (-2927bp)
This is similar in structure to the TGACCT recognition site for the receptors of other 
steroid hormones including retinoic acid (RAR), Retinoic-X (RXR), oestrogen, 
Thyroid hormones (TR) and vitamin D3 although only the RXR has the same single 
base spacing as seen in PPAR The presence of a third site in BFE with an alternative 
spacing (DR2 rather than DRl) indicates a potential to be regulated by more than one 
receptor dimer.
The contig sequences representing the 5' non coding regions of the gene (HG21, 22 
and 23) were FastA searched for evidence of the half sites TGAACT, TTACCT, 
TGTCCT, TGGCCT and TGACCT. No evidence was found for any of the sites and 
it was concluded that the sites were absent from the sequenced regions.
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B)
4A1 (-382) CATTAAATGTTT (-372)
I I I I I I I I I I I I
4A6 (-261) AGCATACTGCCTGGCACACAGTAAATGCTCATTAAATGTTTG (-219) 
I i I I I I I I I I I I I I I I I I I I I  I I I  I I I I  I I I I I I I I I I 
4A11 (-251) AGCATACTGCCTGGCACATAGTAGGTGCTCATTGAATGTTTG (-209)
C) HNF-1
4A6 (-110) CAGGGTTAATGATCTCTGCTCT (-90)
Il II I I I  I I I  
4A11 (-130) CATAGTCAATTGATTCTGAACTC (-117)
Figure 6.24b and c Regions of homology between members of the CYP4A family. B) 
- a region seen in CYP4A1, 4A6 and 4A11. C) Partial HNF-1  sites in CYP4A6 and 
CYP4A1L
-669 ATTTTTTTA AATTGTCATG
-650 TATATGAATT GAGAAAAAAA ATCATGCTAT GCATATTATG AGACCAGTTT
-600 CCCCAATGGA ATAAAATAAA GTACTTGAAC AGCTGCTATA TTAGCATCTG 1
-550 TTTGTCCATA TCATCATCCA GTTACTAGAA AGACATAATT CCCACTCTTC
-500 ACTCAATATA TAGATGGAAG TGGTTTTTAT GGTAAATAAA ATTAGATTTG
-450 CAATAAGACA AAAGTAATGA TTCAGGGCTT GGTTAATGTT AAGTTTAAAT
-400 GTACATATCA TGTTGAGGAA TTTTCTTTGA ACACATAACA AAAAAAAAGT
-350 GCTACTGAAT GAACATTATT GCAATGTAGT AAAGCAGAAT GCAAATTCCT
-300 TGAGGTCAGC ATTGAAGTCT GTTTTCCTCG CAGCGGTGCC CACACACCTA
-250 GCATACTGCC TGGCACACAG TAAATGCTCA TTAAATATTT GTGAGGTACA 2
-200 TGGACAGGGG AATGTGGTAG ACAGCTGATG AAGCTTTTCT CCCACTGTTG
-150 CCCTAGGTGG ATCATCCATA GTCAATTGAT TCTGAACTCT GAGGTCCAAG 3
-100 TTCTGCCCTC CTCCTTCACT MTCCCCACAA GTGGGCGGGA CAATCCTCCC 4&5
-50 TGGATTTGAG CACAGGGGGA CGGGGGTGGT CAGAGAGAGG TAGGGGCACT 6
+ 1 CAGAGATCCA GCAGGTGCTG CACCATGAGT GTCTCTGTGC TGAGCCCCAG
+51 CAGACTCCTG GGTGATGTCT CTGGAATCCT CCAAGCGGCC TCCCTGCTCA
Figure 6.26 Proximal regulatory regions of CYP4A11 showing the features discussed 
in section 6.4.3. and shown in Figures 6.24a-c. Exon 1 is emboldened and single 
underlined.
Features indicated are 1) CCAAT Box ; 2) Long homology with CYP4A6; 3) Putative 
HNF-1 site; 4) Part of T9 base pair’ region; 5) SPl site; 6 ) Putative HNF-4 site.
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The PPRE m CYP4A6 was located at -740 in the 5' flanking region of the gene. 
Unfortunately the HG23-5' contig only extended to -669 and so did not encompass the 
corresponding region in the CYP4A11 promoter. This region could easily be reached 
by sequencing using an oligonucleotide complementary to the 5'end of HG23-5'. 
There is no evidence of a PPRE in the corresponding region to that in ACO.
6.5 DISCUSSION
The analysis of the exonic sequences in our gene and its promoter region suggest that 
the CYP4A11 gene is most similar to CYP4A6, although it does show strong 
similarities with the other members of the family, notably CYP4A1. As both CYP4A1 
and CYP4A6 are induced by peroxisome proliferators (probably mediated by PPAR) 
the possibility that CYP4A11 is also regulated in this manner should be addressed. 
The results from the sequencing indicate that there may not be a PPRE in the first 9kb 
of this gene, although further sequencing will have to be performed before this can be 
confirmed.
With the abundance of complete and partial regulatory sites in the promoter region of 
CYP4A11 it is apparent that no-single nuclear factor is responsible for the regulation 
of this gene. The importance of the other sites can only be determined by experiments 
such as footprinting in order to determine if they bind nuclear factors or are just 
evolutionary echoes of such regulatory sequences.
While there is a need to finish the sequencing of the gene and to further characterise 
the regulatory regions using footprinting and transfection techniques I have been 
defeated by time. While the combination of Erase-a-base and automated sequencing 
yielded results in a time scale unattainable in our laboratories by manual sequencing, 
the sequencing produced results at a rate that decreased exponentially. From a total of 
12kb of sub-cloned DNA, 8kb was sequenced relatively quickly (under four weeks). 
The remaining 1.5kb sequenced took 2 months to finish and by extrapolation the 
project could have lasted for several months. If this approach is used again the final 
gaps should be filled by oligonucleotide sequencing as relatively few would be 
required.
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CHAPTER 7 ; FINAL DISCUSSION
7.1 INTRODUCTION
The biological response of rat hepatocytes to the administration of peroxisome 
proliferators is well documented [Levine et al, 1977, Lake et al, 1985; Hawkins et a l, 
1987, Sharma et al, 1988a; Lock et al, 1989]. An induction in the levels of CYP4A1 
and enzymes of the peroxisomal P-oxidation pathway is concurrent with the increase in 
number of peroxisomes and the size of the liver [Sharma et al, 1988a, Bell et al, 1990]. 
These effects have been linked to the onset of non-genotoxic hepatocarcinogenesis 
which occurs after long term chronic exposure to these compounds [Reddy and 
Lalwani, 1983; Lake et al, 1989; Rao and Reddy, 1991].
Whereas the induction of CYP4A1 has not been directly implicated in the formation of 
these tumours, its induction is has become a characteristic effect of peroxisome 
proliferation and it was therefore considered a suitable early marker for this effect 
[Gibson, 1992]. Northern blotting analysis has shown that the latter induction was due 
to an increase in the mRNA levels in the cell thus implicating a mechanism that up- 
regulated the gene at a transcriptional level [Hardwick et al 1987].
The effect of peroxisome proliferators is species and strain specific. Studies on 
different rat strains have indicated a variation in peroxisome proliferation [Makowska 
et al, 1991]. This inductive effect has also been seen in mice, rabbits and hamsters but 
not in guinea-pig or marmoset [Orton et a/,1984; Lake et al, 1989; Agius et al, 1991]. 
In order to extrapolate the animal toxicology data to man it is necessary to understand 
the mechanism of this induction.
The aim of this thesis was to compare the transcriptional regulation of the rat and 
human CYP4A genes in order to predict the susceptibility of man to the same 
peroxisomal proliferation seen in the rat and other responsive species. In order to 
undertake this project it was necessary to isolate the rat CYP4A genes with their 
upstream regulatory regions and their human analogues.
Once isolated the promoter regions of the gene could be analysed in the hope that the 
elements in the rat gene that made it susceptible to induction by peroxisome 
proliferation could be identified and searched for in the human sequence. 
Transcriptional activation assays could also be performed as a further indication of the 
inducibility of the human gene by peroxisome proliferators.
Shortly after the start of this project the sequences of the rat CYP4A1 and CYP4A2 
[Kimura et al, 1991a] genes with a restricted amount of upstream region were
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published along with the sequences of the cDNAs for CYP4A3 Kimura et al, 1991b] 
and CYP4A4 [Matsubara et al, 1987]. Hardwick was reported to have isolated a 
human CYP4A9 clone [Nebert et al, 1987] but the sequence of this gene was not 
available. In order to obtain extreme upstream sequence it was therefore necessary to 
isolate CYP4A genes from both rat and human to achieve the project mission. In order 
to simplify the strategy the work to isolate the rat genes was undertaken by another 
student, Miss Jane Richardson, whereas I undertook the search for the human genes.
7.2 CHARACTERISATION OF THE HUMAN GENOMIC FRAGMENTS - 
HG6 AND HG19
7.2.1 RESTRICTION DIGEST AND SOUTHERN BLOTTING ANALYSIS
Prior to my joining the project a human genomic library had been screened by 
hybridisation with a radiolabelled copy of the rat 2.1 kb CYP4A1 cDNA. A single 
genomic phage clone had been isolated and this yielded two fragments on digestion 
with BamHl. The fragments were sub-cloned into the plasmid vector pUC19 and 
designated HG6  (2.7kb) and HG19 (1.4kb). Therefore the first task of the project was 
the characterisation of these fragments of a human gene that hybridised to the rat 
CYP4A1 cDNA.
The two sub-clones were analysed by single and multiple restriction digest and the 
resulting maps are shown in Figure 3.4. The digests were also analysed by Southern 
blotting utilising both the full length CYP4A1 cDNA probe and a 5' specific 600bp 
probe. The results of these experiments (Figures 3.1 and 3.2) indicated that whereas 
both fragments hybridised with the full length cDNA they did not share any common 
sequence with the 600bp probe. From this result it was proposed that the genomic 
clones were from a human gene similar to the rat CYP4A1 gene but that they 
originated from a 3' region of this gene and were therefore of limited use in the study 
of the transcriptional activation of this gene.
7.2.2 PARTIAL NUCLEIC ACID SEQUENCING OF HG6 AND HG19
In order to strengthen the proposal that the above fragments represented a gene similar 
to CYP4A1 their nucleic acid sequence was determined partially. Direct comparison of 
the nucleic acid (and therefore the deduced amino acid) sequence of the fragments with 
other members of the CYP4A family would strengthen the results from the 
hybridisation data. The ends of each fragment were sequenced repeatedly until an 
good consensus sequence for each was obtained. Using the Microgenie software 
package these consensus sequences were analysed and compared to the published 
genomic sequences for CYP4A1 and CYP4A2 (the only two available in genomic form
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[Kimura et al, 1989a] ). The results are shown in section 3.4. Each fragment showed 
regions of similarity and differences to the other genes and these corresponded to the 
published positions of the exons and introns respectively. It was concluded that HG19 
was situated 5' to HG6  and contained exons 9 and 10 whereas HG6  contained exons 
1 1  and 1 2 .
The cDNA sequences were available for the other known members of the CYP4A 
family (CYP4A3 - 4A8) and the amino acid sequences from these were also compared 
against HG6  and HG19. As expected the amino acid sequence was well conserved 
around the haem-iron liganding cysteine residue in exon 12 (Figure 3.9). This is an 
indication of the importance of this region in the functionality of the protein. A 
comparison of the amino acid sequence of the human clone with the other members of 
the CYP4A family shows that it is most similar (82%) to CYP4Al(jdiX) and 
CYP4A6{x2 )^h\X) [Johnson et al, 1990] although this data was only based on 4 of the 12 
exons.
7.3 DETERMINATION OF MULTIPLICITY OF THE HUMAN CYP4A 
FAMILY
With 4 members of the CYP4A family identified in the rat {CYP4A1, 4A2, 4A3 and 
4A8) and another 4 identified in rabbit (ÇYP4A4 - 4AT) \X was of interest to examine 
how many members of the family existed in human. It was proposed that using HG19 
as a probe in Southern blot analysis of total human genomic DNA would answer this 
question.
HG19 contained a fragment of genomic DNA defined by a BamHI site at either end. If 
a sample of human genomic DNA was digested with BamHI and then analysed by 
Southern blotting using HG19 as a probe, the genomic copy of the fragment should be 
detected and give a single band a 1.4kb. As one of the BamHI sites was found in an 
intron (between exons 1 0  and 1 1 ) it is less likely to be conserved in closely related 
family members. If there were more than one human member of the CYP4A family 
more than one band would be expected to hybridise to the HG19 probe on the 
Southern blot.
In all 5 genomic DNA samples a single 1.4kb band was observed on the 
autoradiograph. Mindful that this could indicate the conservation of both BamHI sites 
in closely related genes a second digest was undertaken. It was noted that HG19 had 
an internal EcoRI site which was 1.35kb from a similar site in HG6  (assuming that the 
clones were adjoining in the gene). The genomic DNA from one of the livers was 
digested with EcoRI and analysed by Southern blotting. Two bands were observed, 
one at the expected 1.35kb and another at l.Okb. The latter band was due to a
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fragment formed from the 5' end of HG19 and the adjoining DNA, the identity of 
which was later confirmed by the restriction mapping on the human phage clone XD2. 
The EcoRI sites in HG19 and HG6  were both intronic and, as stated before, were 
therefore less likely to be conserved. It has not been possible to determine the position 
of the 5' most EcoRI site as that area of the gene was not successfully sequenced.
While the Southern blot analysis cannot categorically indicate the presence of a single 
human gene in the CYP4A family, the probability of two genes sharing 5 similar 
enzymes sites, three of which are intronic is, very low and therefore favours this 
hypothesis.
This proposal was further strengthened by the isolation (towards the end of this work) 
of human CYP4A11 cDNAs [Palmer et al, 1993b; Bell et al, 1993; Gonzalez personal 
communication). Three independent groups have isolated the same cDNA from 
different tissues (Palmer from kidney and Bell and Gonzalez from liver).
Palmer et al used a fragment of the CYP4A4 cDNA to screen a human kidney cDNA 
library and isolated a 600bp fragment from the 3' end of a CYP4A like cDNA. They 
then used this fragment to screen a second library from which they isolate their 
CYP4A11 cDNA. Northern blotting analysis of mRNA from human kidney and liver 
samples was performed using this cDNA as a probe, and in both tissues, they detected 
a single mRNA. The results were confirmed by the more sensitive RNase protection 
assay.
Bell's approach was to use oligonucleotides designed to the most conserved regions of 
the rat CYP4A1 cDNA (nucleotides 925-959 and 1381-1410) for use as primers for 
PCR screening of murine, guinea pig and human cDNA libraries. The murine screen 
produced 2 products, one with identity to Cyp4a-10 [Henderson et al, 1992] and the 
other representing a novel form which he designated Cyp4a-12. The guinea pig screen 
isolated a single novel form (designated CYP4A13) and the screening of the human 
library only isolated the CYP4A11 form previously identified by Palmer. The ability of 
these PCR primers to detect isoforms from different species would suggest that they 
should detect multiple copies of a CYP4A gene in human if such a duplication exists.
Finally western blotting analysis of human liver microsomes in our laboratory using a 
polyclonal antibody to rat CYP4A1 detected a single protein band [Chinje, 1992]. 
Although other workers have recorded more than one band on equivalent blots [Dirven 
et al, 1991; Forrester et al 1992], the single cross reacting band seen by Chinje was 
observed on several occasions (in 8  human liver samples) and probably represents a 
true result.
209
The results of the genomic Southern, Northern and western blotting experiments, and 
the cDNA library screening performed in different laboratories indicated the presence 
of a single human gene in the CYP4A family. At the time of the Southern blot analysis 
a human CYP4A cDNA (4A9) had been cited by Hardwick as a personal 
communication in a 1991 review [Nelson et al, 1991]. However the isolation of the 
human CYP4A11 cDNA [Palmer et al, 1993] and the continuing lack of a published 
CYP4A9 sequence lead us to propose that the gene of which HG6  and HG19 originate 
codes for human CYP4A11.
To confirm this hypothesis we set out to isolate the rest of the gene in order to 
compare it to the published CYP4A11 cDNA sequence, and to achieve our primary 
goal of isolating the regulatory regions of the gene fi*om which HG6  and HG19 had 
originated.
7.4 ISOLATION. SUB-CLONING AND SEQUENCING OF A HUMAN CYP4A 
GENE
7.4.1 SCREENING OF HUMAN GENOMIC LIBRARY WITH 600bp RAT 
CYP4A1 PROBE
Because HG6  and HGl 9 represented the 3' end of the gene we were hoping to isolate, 
it was necessary to devise an experimental approach to obtain the 5' end of the gene. 
Attempts to isolate the region of interest by screening a human placental genomic 
library with the 600bp rat CYP4A1 5’ probe are discussed in Chapter 4. With the 
benefit of hindsight, it was not a successful approach due to the problems associated 
with obtaining a clean probe and the relatively low homology of the cDNA probe with 
the large intronic and 5' non-coding regions at the 5' end of the gene. The work on the 
phage clones derived fi’om this screening did enable us to learn and develop new 
techniques such as sub-cloning and Erase-a-base sequencing protocols and therefore 
was not an entirely unproductive exercise.
With 4.5kb of the gene isolated and subcloned as HG6  and HGl 9 it was decided to use 
one of these DNA fragments as a probe to rescreen a human genomic libraiy. HGl 9 
was chosen for this purpose as it was closer to the 5' end than HG6  and was easily 
purified and prepared.
7.4.2 SCREENING OF HUMAN GENOMIC LIBRARY WITH HG19 PROBE
A human placental genomic library was screened for a second time using radiolabelled 
HGl 9 insert DNA as a probe. The initial screen identified 9 possible phage clones but 
after three rounds of plaque purification only 2  positive clones, A.B1 and ^D2 ,
2 1 0
remained. These clones were purified to homogeneity and phage DNA prepared from 
them.
Restriction digest and Southern blotting of XD2 showed that it contained a 14kb 
genomic DNA insert which hybridised to the HGl 9 probe. BamHI restriction mapping 
located this hybridisation to a 1.4kb band which co-ran with the probe on an agarose 
gel. It was concluded that this fi-agment was the same as the insert in HGl 9. The 
fi*agment was located close to one end of the 14kb insert (close to the 20kb phage arm) 
and therefore the phage appeared to contained 1 2 kb of genomic sequence that was 
either 5' or 3' to the HGl9 region in the human CYP4A gene.
To determine the orientation of the 14kb insert in A.D2 relative to that in the genomic 
DNA the Southern blots were reprobed with HG6  and the 600bp rat cDNA probes (as 
3' and 5' markers respectively). The HG6  probe hybridised to an 800bp fragment 
(BamHI/XhoI) closest to the long phage arm (20kb) and the 600bp rat cDNA probe 
hybridised with the rest of the insert indicating that it contained the 3' end of the gene. 
Restriction digestion with Xhol and Xbal divided the insert into 4 manageable lengths 
(1.9, 2.3, 4.0 and 6.2kb) for subcloning and it became apparent from further Southern 
blotting of this restriction pattern that approximately 8 kb of 5' flanking region was 
present in A.D2. The deduced map of this clone is shown in Figure 7.1 (previously 
shown as Figure 5.4).
Similar digestion and Southern blot analysis of A,B1 showed that it included the same 
region of genomic DNA as ^D2 but extended further in both 5' and 3' directions. The 
clone extended a further 2kb in the 5' direction (including the whole of HG6 ) and Ikb 
further in the 3' direction. The presence of HGl9 and HG6  on the same clone 
confirmed their proposed positional relationship and the orientation of the genomic 
insert. This insert was more difficult to purify and as XD2 contained 8 kb of upstream 
region it was taken first for sub-cloning.
7.4.3 SUBCLONEVG OF GENOMIC DNA FROM :^ D2
In order to analyse the genomic clones in more detail it was necessary to sub-clone 
them into a plasmid vector for ease of handling. As it was intended to use the Erase-a- 
base system for generating the nested deletions for sequencing, the plasmid 
pGEM7zf(+) was chosen.
From the restriction mapping of ^ D2 it was shown that the genomic clone was broken 
down into manageable sizes by a double digestion with Xhol and Xbal. The resulting 
band, fi-om 5' to 3', were 1.9kb (Xhol/Xbal), 2.3kb (Xbal/Xbal), 4.0kb (Xbal/Xbal), 
and 6.2kb (Xhol/Xbal). Since the previously identified human clones were HG6  and
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HGl9, the new series was designated HG21 to HG24 respectively, (see Figure 5.6 for 
more details). Restriction mapping indicated that the part of HG23 that hybridised to 
the 600bp rat cDNA probe was located at the 3' end of this fragment and could be 
released as an 800bp HindlE/Xbal fragment. As this fragment probably contained 
part, if not all, of exon 1 it was of particular interest. It was decided to subclone this 
small fragment and to designate it HG26. The fragment was cloned by digesting HG23 
with Hindin to remove the rest of the insert followed by recircularisation of the 
plasmid to give HG26.
HG22 and HG23 were subcloned first as they required a enzyme digest of the vector. 
During the sub-cloning a 6 kb partial digest fragment containing HG22 and HG23 was 
produced due to the incomplete digest of the central Xbal site. This was also inserted 
into the pGEM vector and designated HG25. This clone contained exon 1 and the first 
S.Skb of the upstream region and was later used in transcriptional activation studies 
(Richardson and Hood, unpublished results). The HG25 fragment also enabled the 
orientation of HG22 to be determined with respect to HG23 and the genomic sequence 
as this had not previously been possible by restriction mapping.
The sub-cloning of HG21 was achieved relatively easily and the orientation was 
determined by the forced ligation into the pGEM vector. However HG24 proved 
more elusive and at the end of the project remained uncloned. This was probably due 
to a combination of the large size (6 .2 kb) of the insert and the different sites at either 
end. The stearic problems of a 3kb plasmid opening to accept a 6 kb insert were 
compounded by the statistical chance that an insert joined a one end to the vector will 
also join at the other. As parts of HG24 had already been sub-cloned as HGl 9 and 
HG6  the 'uncloned' remainder (4kb Xbal/BamHl) was targeted for sub-cloning and 
designated HG27. Although this fragment contained exons 2 to 7, it was not 
considered as high a priority as the sequencing of the flanking regions (HG21-23) and 
so, despite several attempts, remained uncloned at the end of the project. The 3' end 
of the ABl insert, between the BamHI site of HG6  and the Xhol site of the large phage 
arm was designated HG29 but remained uncloned at the end of the project. The same 
situation was seen at the other end of the clone where the extended version of HG21, 
between HG22 and the short phage arm, was designated HG28 but also remained to be 
cloned by the end of the project.
HG6  and HGl 9 were originally cloned into pUC9 and it was necessary to transfer 
them into pGEM. This was achieved with little problem although the co-running of 
HG6  and pUC19 on an agarose gel did provide a technical problem which was 
overcome by the use of a double digest of the pUC19 vector with PvuI/BamHI.
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7.4.4 GENERATION AND SEQUENCING OF NESTED DELETIONS
The sub-clones HG21, HG22, HG23, HG6  and HGl 9 had been created by inserting 
the genomic fragments into the pGEM vector and represented 12.4kb of genomic 
DNA (not including HG24 or HG27 which remained un-cloned by the end of the 
project). The size of the fragments presented two technical problems concerning their 
sequencing.
Firstly, in order to reliably sequence such a length of DNA each base pair would have 
to be sequenced in both directions two or three times to confirm its identity. This 
represented a total sequencing mission of 50 to 75kb and it became apparent that the 
manual sequencing techniques in our laboratory at Surrey did not have the capacity for 
such a project. The solution to this problem was facilitated by the use of an automated 
DNA sequencer based at the Glaxo Institute of Molecular Biology (GIMB) in Geneva.
Second, the accepted method of gene walking, where a new primer is made for every 
250 bp of sequence, would require the synthesis of approximately 100 oligonucleotides 
at a prohibitive cost. To overcome this problem we elected to use the Erase-a-Base 
nested deletion system.
The deletion system required the selection of 2 restriction enzyme sites at either end of 
the vector multiple cloning site which were not found in the insert. As the restriction 
enzymes used in the subcloning of the various inserts (Xbal, Xhol and BamHI) were at 
the peripheries of the pGEM7zf(+) multiple cloning site the availability of suitable sites 
was limited (see figure 6.1). After examination of the constructs only HG21 had 
suitable sites at either end of the insert (Xbal/SphI at the T7 primer end and 
EcoRI/SacI at the SP6  primer end).
The remaining clones (HG22, HG23, HG6  and HGl 9) did not have suitable sites at 
both ends but since the inserts had been sub-cloned into a single site (Xbal for HG22 
and HG23, BamHI for HG6  and HGl9) it was theoretically possible to reverse, or 
'flip', the inserts in the vector and use the same primer for each strand. Successfiil flips 
were performed with HG22 and HGl 9 but despite several attempts were unsuccessful 
for HG23 and HG6 . The failure of the latter two inserts to reverse indicated that there 
was some selection pressure against such an orientation. The selection of the deletion 
and primer sites for each clone is sumarised in Table 6 .1.
The selection of the reaction temperature for the deletions was based on the expected 
range of the sequencing system. While the automated sequencer was advertised as 
capable of 400bp of good quality sequence, it was felt that this was a 'best case' figure 
and could not be achieved routinely. The reactions were therefore performed at 35°C
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to give 30 second time points equivalent to a 200bp deletion and 8  colonies were 
picked from each time point.
It became obvious that hundreds of deletion time points would be generated and 
sequenced and a systematic nomenclature was required. As the GCG sequence 
analysis software could only take file names of six characters each sequence was 
designated by a two figure number from the subclone, A letter for the direction, the 
number of the time point and a small letter for the colony. Therefore, for example, the 
sequence 22U17c was the third (c) colony picked from the 17th time point of the 
forward deletion of HG22.
The results of the sequencing of these clones are discussed in section 6.3 and 
sumarised in Figure 7.2 (previously shown as Figure 6.21). The total sequencing effort 
generated 80kb of usable sequence from 19 overnight gel runs indicating the power of 
such a large scale sequencing approach. Several gaps remain in the sequencing contigs 
due to lack of suitable deletion time points and the lack of time to generate them.
7.4.5 ANALYSIS OF SEQUENCING RESULTS
The contigs generated from the sequencing of 7J)2 were compared against the 
published sequences of CYP4A11 [Palmer et al, 1993b] and other members of the 
CYP4A family. By this analysis it was possible to identify the position of six exons; 
(Exon 1 and exons 8  to 1 2 ). which showed virtual identity to CYP4A11 The 
discrepancies could be identified as sequencing errors and miss-reads (see section 
6.4.1). This result strengthened the hypothesis that the A.D2 and XBl genomic clones 
contained the majority of the gene for human CYP4A11.
The deduced amino acid sequence from the contigs and the published CYP4A11 cDNA 
were compared to the other members of the CYP4A fdim\y. The human protein was 
more similar to the rabbit isoforms (80%) than to those of the rat (73%). In Bell's 
truncated sequences [Bell et al, 1993] the deduced amino acid sequence from the 
human fragment (423bp) is 81% similar to the corresponding murine Cyp4a-10 and 
Cyp4a~12 cDNAs and 83% similar to the guinea pig CYP4A13 cDNA although this 
similarity may be altered for the full length cDNAs.
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7.5 REGULATION OF THE HUMAN CYP4A11 GENE EXPRESSION
7.5.1 IDENTIFICATION OF REGULATORY ELEMENTS IN THE 5’ 
FLANKING REGION OF CF/V^ii
From the summary of the sequencing in Figure 6.21 it is apparent that parts of the 5' 
flanking region have yet to be sequenced, the most significant being the 2.5kb region 
of HG23 which approximates to nucleotides -670 to -3100. Another gap is found 
between nucleotides -4000 and -5400 although there are 2 unanchored contigs within 
this region which account for approx. 600bp of the gap.
Finally there is a gap between nucleotides -6400 and -7500 which contains 2 
unanchored contigs totalling 650bp. The lack of these regions meant the search for 
regulatory elements could not be definitive but it was considered that some cis-acting 
transcription factors would probably be found within the first 670bp upstream, a region 
covered by HG23-5'.
The 5' flanking region of HG23-5' was analysed for known regulatory protein binding 
sites and regions of sequence similarity to the corresponding regions in the genes of 
CYP4A1, 4A2, 4A4 and 4A6 [Kimura et al, 1989a; Muerhofif et al, 1992; Palmer et 
al, 1993a]. The results of this comparison are discussed in section 6.4.3 and indicate 
various potential regulatory elements in the CYP4A11 5' region.
The 19bp element conserved in CYP4A1 and 4A2 [Kimura et al, 1989a] is not 
conserved in its entirety across the species (see figure 6.24a) but may still play a role in 
the regulation of these genes. The presence of the binding sites HNF-1 (a 
homeodomain protein) and HNF-4 (a member of the steroid hormone receptor family) 
in this region indicate that the gene is under the control of multiple factors [Frain et al 
1989; Sladek et al 1990]. These factors are seen in the regulation of many other liver 
specific enzymes [Mendel and Crabtree, 1991; Xanthopoulos et al, 1991; Miura and 
Tanaka, 1993] including CYP2E1 [Ueno and Gonzalez, 1990] and would indicate that 
the gene has the ability to be activated in hepatocytes.
Muerhoff [1992] also identified a region of homology between CYP4A1 and 4A6 that 
is conserved in CYP4A11, although the rat region is significantly shorter than that of 
the rabbit and human (figure 6.24b). While this motif does not match any known 
regulatory element it may represent a novel site, a proposal that could be explored 
using DNase footprinting techniques.
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7.5.2 SEARCH FOR PPREs IN THE SEQUENCED CONTIGS
As discussed in section 6.4.4 FastA searches of the HG21, HG22 and HG23 contigs 
was performed using all the known variations of the PPRE seen in Acyl CoA oxidase 
(AGO) [Tugwood et al, 1991], peroxisomal bifunctional enzyme [Bardot et al, 1993] 
and CYP4A6 [Muerhoff et al, 1992] and no PPREs were identified in the sequence 
contigs. This result is not conclusive as there are still significant parts of the clones to 
be sequenced and until this has been resolved a conclusion as to the presence or 
absence of PPREs in the CYP4A11 gene cannot be drawn.
7.5.3 SEARCH FOR PPREs BY TRANSCRIPTIONAL ACTIVATION 
STUDIES.
HG22 and HG23 were used in transcriptional activation assays performed in our 
laboratories [Hood et al, 1992]. The human fi-agments were inserted upstream of a 
Chloramphenicol acetyl transferase (CAT) reporter and this construct was co­
transfected into a mouse hepatoma cell line (Hepal) with an expression plasmid 
containing the cDNA for mPPAR. A control plasmid using the upstream region of 
AGO [Tugwood et al, 1991] instead of the human fragments was used as a positive 
control. The Hepal cells were incubated with the potent peroxisome proliferator Wy- 
14643 at a concentration of lOmM (a concentration previously determined to give 
maximal induction [Tugwood et al, 1991]) and then assayed for CAT activity.
In the positive control (AGO) plasmid containing cells, CAT activity was detected 
indicating that the PPAR had been activated by the Wy-14643 and, in turn, activated 
the PPRE in the AGO promoter. Under the same conditions no activity was observed 
fi’om the cells transfected with HG22 and HG23 containing vectors.
The results from these transfection experiments indicate a number of possibilities. The 
lack of induction by the peroxisome proliferator may indicate the lack of a suitable 
PPRE in the HG22 and HG23 fi-agments. The evidence is not conclusive enough to 
rule out other factors. The lack of other co-factors such as RXR may play a role in the 
lack of response [Bardot et al, 1993] and it is possible that the gene is trans-activated 
by a PPRE further upstream. Finally it is possible that the HG22 and HG23 regions 
contain repressor elements that are down-regulating the gene and so preventing its 
expression, a feature seen in rat AGO [Osumi et al, 1991] and rat bifunctional enzyme 
[Bardot et al, 1993].
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7.6 SUMMARY OF FINDINGS
1) We succeeded in isolating a gene (including its 5' regulatory region) from the 
human CYP4A family which had strong homology in exonic regions with the 
CYP4A11 cDNA sequence published by Palmer et al [1993]. The gene was sub­
cloned into manageable sections and inserted into plasmid vectors for ease of handling. 
The clones were partially sequenced and good consensus contigs obtained for 9.5kb of 
the isolated gene. From the contig sequences a comparison of the human gene to other 
members of the CYP4A family was performed and it was determined that, although the 
whole of the coding region had not been sequenced, the gene belonged to the CYP4A 
family.
2) Using part of the cloned gene in genomic Southern blotting analysis we determined 
that the multiplicity of CYP4A forms seen in the rat and rabbit is not seen in humans. 
While we could not rule out the presence of very closely related isoforms, the weight 
of evidence points to a single CYP4A form in man.
3) Limited analysis on the role of PPAR in the regulation of this gene has proved 
inconclusive. The gene does share several regulatory motifs with other members of the 
CYP4A family and more sequencing of the promoter region may complete the picture.
4) We have developed a protocol for the isolation, cloning and large scale nucleotide 
sequencing of gene fragments within an academic environment and budget. This 
procedure has allowed the evaluation of several novel techniques used in the 
preparation and handling of human gene fragments.
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7.7 FUTURE WORK
7.7.1 COMPLETION OF THE SEQUENCING OF XD2 AND XBl
As discussed in section 7.5.1 there are significant sections of the 5' flanking region of 
the CYP4A11 gene that still remain to be sequenced. In order to achieve this task the 
HG21, HG22 and HG23 clones require a repetition of the deletion process and re 
sequencing of the resulting fragments. This task could be performed with relative ease 
using an automated sequencer. If the new deletions still leave gaps in the contig 
sequences oligonucleotide primers can be designed to the ends of the confirmed 
sequences and utilised as to sequence the remaining gaps.
The sequencing of the remaining coding and intronic regions of the gene will give 
important sequencing data. By comparing the contigs generated to the published 
sequence of the CYP4A11 cDNA [Palmer et al 1992; Bell et al, 1993] it will be 
possible to determine if the cDNAs derive from the gene we have isolated.
7.7.2 ISOLATION OF THE HUMAN P-OXIDATION GENES (AcoA, BiF)
While the 5' flanking regions of the rat AGO and bifimctional enzyme genes have been 
well studied [Osumi et al, 1991; Tugwood et al, 1991, Bardot et al, 1993] the 
corresponding regions of the human genes have not been characterised. If PPAR does 
play a part in the regulation of the human response to peroxisome proliferators it 
would be expected that these regions would contain PPREs. Isolation of these regions 
of the human genes would therefore expand our understanding of the regulation of the 
peroxisomal system.
7.7.3 SEARCH FOR HUMAN CYP4A IN LIVER cDNA LIBRARIES.
The GYP4A11 cDNA [Palmer et al 1993] was isolated from a kidney cDNA library 
and may represent a kidney specific form. While Bell et al [1993] report part of an 
identical cDNA isolated by PCR from a liver mRNA library, there may be other human 
GYP4A forms produced by differential splicing of the message from our gene or from 
a closely related gene. The screening of a human liver cDNA library, possibly made 
from tissue from a donor undergoing treatment with hypolipideamic drugs, might solve 
this question.
7.7.4 DNA FOOTPRINT ANALYSIS OF A,BI AND XD2
DNase I protection analysis (DNA footprinting) could be used to identify and isolate 
the regions of the GYP4A11 gene promoter that are protected by nuclear transcription 
factors. This would lead to a greater understanding of the regulation of this gene. It
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may be necessary to clone the phage inserts into alternative vectors, such as cosmids, 
to aid in their handling and preparation.
7.7.5 CONTINUATION OF THE TRANSCRIPTIONAL ACTIVATION 
STUDIES
The continuation of the PPAR activation assays to include co-transcription factors 
such as the retinoid X receptor (RXR) and other members of the steroid hormone 
family is required. This work will determine the role of PPAR, if any, in the regulation 
of human CYP4A11 and therefore determine the effect, if any, of peroxisome 
proliferators on this important human enzyme.
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APPENDIX 1 
SOLUTIONS AND BUFFERS
APPENDIX 1 - COMMON SOLUTIONS AND BUFFERS
The following is a list of the buffers and solutions used in the project. All solutions 
were either autoclaved or filter sterilised as discussed in Section 2 .2 .
E.coH Cell culture
Luria Bertani medium (LB) : 1% Tryptone, 0.5% yeast extract, 1% NaCI 
L-agarose (LA) : 1.5% Agar in LB
Ampicillin (Amp) lOOmg/ml, made up in sterile water and filtered
X-Gal (5-bromo-chloro-3-indolyl—D-galactoside) : 20mg/ml made in 
dimethylformamide (DMF)
Isopropyl -D-galactopyranoside (IPTG) : 24mg/ml 
DNA isolation
Qiagen column protocol (supplied in kit form)
PI : lOOmM Tris/hydrochloric acid, lOOmM sodium chloride, 25mM EDTA (ethylene 
diamine tetra-acetic acid), pH 7.5
P2 : 4% Sodium dodecylsulphate (SDS)
P3 : 2.55M potassium acetate (KAc), pH 4.8
QBT : 750mMNaCl, 50mM 3-[N-morpholino]propane sulphonic acid (MOPS), 15% 
ethanol, pH 7.0, 0.15% Triton
QC : l.OMNaCl, 50mMMOPS, 15% ethanol, pH 7.0
QF : 1.25MNaCl, 50mMMOPS, 15% ethanol, pH 8.2
241
Glassmax spin cartridge system
DNA binding solution (7.5MNaI), Wash buffer and Spin catridge. (details not given) 
2xCracking buffer : 2ml 5MNaOH, 2.5ml 10% SDS, lOg sucrose
Ligation solutions
lOxLigation buffer (BRL) : 660mM Tris Cl pH 7.5, 6 6 mM MgCl2 , lOmM ATP, 200 
mMDTT
Erase-a-Base System
Acid phenol : 50% TE buffer, 50% phenol
Chloroform/isoamyl alcohol : 24:1 (v/v)
lOxExo III buffer : 660mM Tris-HCl, pH 8 , 6 .6 mM MgCl2
7.4xSl buffer : 0.3M potassium acetate, pH4.6, 2.5MNaCI, 10 mM ZnSO/,, 50% 
glycerol
SI stop buffer : 0.3M, 0.05MEDTA 
Klenow buffer : 20mM Tris-HCl, pH 8 , lOOmM MgCl2  
dNTP mix : 0.125mM for each ofdATP, dCTP, dGTP, dTTP 
lOxLigase buffer : 500mM, 1 0 0 mMMgCl2 , lOmM ATP 
Freshly prepared mixes:
SI nuclease mix (for 25 time points) : \12\x\ distilled water, 27pl 7.4xSl buffer, 60U 
SI nuclease.
Klenow mix : 30pl Klenow buffer, 3-5u Klenow DNA polymerase.
Ligase mix : 790pl distilled water, lOOpl ligase lOxbuffer, lOOpl 50 % PEG, 10pi 100 
mM DTT, 5u T4 DNA ligase
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Gel Electrophoresis
Ethidium bromide (stock) : 20pg/ml in water
IxTAE : 0.04 M Tris-acetate, 0.02 M EDTA. Made from concentrated stock 
solution 5 Ox.
IxTBE (borate) : 0.089 M Tris-borate, 0.089 boric acid. Made from stock solution of 
lOx.
DNA running dye : Bromophenol blue 
DNA sequencing 
Sequencing reagents
Labelling nucleotide mixture : 7.5M 7-deaza-dGTP, 7.5M dCTP, 7.5M dTTP
Termination nucleotide mixtures: 80M 7-deaza-dGTP, 80M dATP, 80M dCTP, 80M 
dTTP, 50M NaCl and 8 M dideoxy-NTP
5x Annealing Buffer : 200mM Tris-HCl pH 5, lOOmM MgC12, 250mM NaCl
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APPENDIX 2 
CONTIG SEQUENCE CONSTRUCTIONS
APPENDIX 2 - CONTIG STRUCTURE MAPS
The following pages contain the individual nucleotide sequences determined during the 
automatic sequencing project.
The sequences have been aligned using the Gelassemble package on the GCG database 
and the resulting consensus sequence (contig) displayed. The algorithm inserts a small 
letter in the consensus sequence if there is not 1 0 0 % homology at that nucleotide.
The contigs are listed in the following order:
1) HG19C0N1
2) HG21C0NU
3)HG21C0N1
4)HG21CON2
5)HG21CONR
6 ) HG22CONU
7)HG22C0N1
8 ) HG22CON2
9) HG22CONR
10) HG23CONU
11)HG23C0N1
12) HG23CON2
13). HG23CONR
14) HG6C0NU
15)HG6C0N1
16) HG6CON2
17) HG6C0NR
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